User Image Cart Icon 0 Search Image

Neuroinflammation

  1. … -(5-methylpyridin-2-yl)− 1H-pyrazol-5-yl) pyrazolo [1, 5-a] pyrimidine-3-carboxamide as a new potential PET agent for imaging of IRAK4 enzyme in neuroinflammation
  2. … -1 gp120 and Methamphetamine-mediated Induction of Proinflammatory Cytokines/chemokines and Oxidative Stress in Astrocytes: Implications in neuroinflammation
  3. … -19 MRI at 21.1 T: enhanced spin–lattice relaxation of perfluoro-15-crown-5-ether and sensitivity as demonstrated in ex vivo murine neuroinflammation
  4. … -19 MRI sensitivity using a cryogenic radiofrequency probe: technical developments and ex vivo demonstration in a mouse model of neuroinflammation
  5. … -276: MAPKAP kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: Relevance to neuroinflammation in a transgenic …
  6. … -activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
  7. … -analytic studies of the glial cell marker TSPO in psychosis–a question of apples and pears?: A commentary on ‘neuroinflammation in schizophrenia: metaanalysis of …
  8. … -cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of …
  9. … -glu-PAL is neuroprotective in a chronic Parkinson’s disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
  10. … -induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: implications for neuroinflammation
  11. … -low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal …
  12. … -rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 …
  13. … -Tetrahydrocannabinol Suppresses Human Monocyte Activation and Monocyte-Mediated Astrocyte Inflammation: Implications for HIV-Associated neuroinflammation
  14. … ‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer’s disease and in patients with chronic neuroinflammation
  15. … , an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota …
  16. … , and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin …
  17. … , based on the paper entitled” The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the brain” by …
  18. … , Ravikanth, ElBakoush, Abdelmeneim, Fiebich, Bernd L. and Olajide, Olumayokun A. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia …
  19. … , Renal, and Metabolic Diseases: Nutrient-sensing mechanisms in hypothalamic cell models: neuropeptide regulation and neuroinflammation in male-and …
  20. … (Cannabis sativa L.) seed phenylpropionamides composition and effects on memory dysfunction and biomarkers of neuroinflammation induced by lipopolysaccharide …
  21. … [(4‐methoxyphenyl)carbamoyl]amino}‐N‐{[1‐(5‐methoxypyridin‐2‐yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of neuroinflammation
  22. … [1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [18F]-Labeling, and in Vivo neuroinflammation PET …
  23. … ]-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
  24. … /maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation
  25. … 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity RELEVANCE TO neuroinflammation IN A TRANSGENIC …
  26. … 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and …
  27. … 3170 The TLR2/4 antagonist (+)-naltrexone blocks contextual long-term memory deficits in experimental autoimmune encephalitis and associated neuroinflammation …
  28. … a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by midkine/M …
  29. … abrogate chronic restraint stress-induced behavioral deficits: implication of oxido-nitrosative, endoplasmic reticulum stress cascade, and neuroinflammation
  30. … acid produces antidepressant‐like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido‐nitrosative stress, and …
  31. … ACTIVATION OF PROAPOPTOTIC KINASE PKCδ IN DOPAMINERGIC NEURONS BY TNFα DEATH RECEPTOR SIGNALING AND neuroinflammation
  32. … administration of neural stem cells after hypoxia–ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice
  33. … administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque …
  34. … after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation
  35. … against 72-h sleep deprivation induced anxiety like behavior: possible roles of oxidative stress, mitochondrial dysfunction and neuroinflammation
  36. … against intrahippocampal aβ-induced long-term memory dysfunction; upregulation of effective neurogenesis with the abrogated apoptosis and neuroinflammation
  37. … AJ, 2012. A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption. Journal of neuroinflammation …
  38. … Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury–Induced neuroinflammation in the Cerebral Cortex of …
  39. … an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
  40. … analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation
  41. … and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
  42. … and brain penetrant p38αMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction
  43. … and Cerebrovascular Physiology, Disease, and Signaling Mechanisms: Sex differences in depression-like behavior and neuroinflammation in rats post-MI …
  44. … and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self …
  45. … and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation
  46. … and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation/M. Vicente-Rodríguez …
  47. … antagonism attenuates the intermittent hypoxia-induced spatial deficits in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress
  48. … Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-b Response in HTLV-1-Associated neuroinflammation.
  49. … antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex Vivo and in vivo IFN-β response in HTLV-1-associated neuroinflammation
  50. … are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation
  51. … attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
  52. … based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
  53. … behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation
  54. … benzodiazepine receptor ligand [11C] DAA1106 can be used to image microglia in animal models of Parkinson’s disease and neuroinflammation in vivo using PET.
  55. … between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and …
  56. … binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis
  57. … bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation
  58. … BioGlue injection in the fetal lamb: a novel model for creation of obstructive congenital hydrocephalus without additional chemically induced neuroinflammation
  59. … cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson’s disease
  60. … cells treated with crude Plasmodium berghei extracts acquire immune‐modulatory properties and suppress the development of autoimmune neuroinflammation
  61. … cerebral ischemia/reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation
  62. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
  63. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
  64. … compound Camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation
  65. … deficit in a pilocarpine-induced status epilepticus rat model via a decrease in the nuclear factor-κB activation and reduction in microglia neuroinflammation
  66. … deficit induced by energy-dense diet in a rat model of early-Alzheimer’s disease is associated to neurotoxic Aβ species and independent of neuroinflammation
  67. … deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
  68. … derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation
  69. … effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with …
  70. … EFFECT OF GINSENG AGAINST HALOPERIDOL-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation AND BIOCHEMICAL ALTERATIONS IN …
  71. … effect of interleukin (IL)‐17 secreted by reactive astrocytes is emerged from a high‐level IL‐17‐containing environment during acute neuroinflammation
  72. … effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation
  73. … effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of neuroinflammation
  74. … effects of intravenous administration of bone marrow stromal cells on sevoflurane-induced neuronal apoptosis and neuroinflammation in neonatal rats
  75. … effects of penta-acetyl geniposide in chronic unpredictable mild stress-induced depression rat model: Involvement of inhibiting neuroinflammation in prefrontal cortex …
  76. … environmental standard impairs neuronal behavior and represses glutamate receptor gene expression and memory-related kinase activation via neuroinflammation …
  77. … epoxide hydrolase and p38 kinase alleviating tau hyperphosphorylation and amyloid neurotoxicity for potential treatment of neuroinflammation in Alzheimer’s disease
  78. … Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, neuroinflammation, Amyloidogenic Gene Expression …
  79. … exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: effects on neuroinflammation and astrocyte arborization
  80. … express low levels of D oublecortin, but their proliferation is unaffected by 6‐OHDA‐induced nigral lesion or M inocycline‐mediated inhibition of neuroinflammation
  81. … extract improves learning and memory of chemically-induced aging mice through upregulating neurotrophins BDNF and FGF2 and sequestering neuroinflammation
  82. … extracts of se-enriched Auricularia auricular attenuates D-galactose-induced cognitive deficits, oxidative stress and neuroinflammation via suppressing RAGE/MAPK …
  83. … factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death
  84. … factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis
  85. … fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation
  86. … FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κ B-dependent neuroinflammation to improve functional …
  87. … fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation
  88. … GINSENG AGAINST CHRONIC UNPREDICTABLE STRESS-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation, AND BIOCHEMICAL ALTERATIONS
  89. … GLIA SHARE CHARACTERISTICS WITH ANTIGEN PRESENTING CELLS AND MAY ALTER SERUM CHEMOKINE LEVELS DURING neuroinflammation
  90. … growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation
  91. … GSK3β-dependent Aβ and p-tau proteins and cognitive loss in young rats: Reduced HB-EGF signaling and downstream neuroinflammation as critical regulators
  92. … high-fat diet-induced obese gerbils but rather elicits neuronal death through increase of abnormal mTOR activation-mediated oxidative stress and neuroinflammation
  93. … hybrid with metal-chelating property ameliorates Cu (II)-induced spatial learning and memory deficits via preventing neuroinflammation and oxido-nitrosative stress in …
  94. … hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress …
  95. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
  96. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
  97. … identify a new natural-based polyphenol, counteracting Aβ oligomerization in vitro and Aβ oligomer-mediated memory impairment and neuroinflammation in an acute …
  98. … IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation
  99. … immune modulator for the treatment of secondary progressive multiple sclerosis acts directly within the CNS to induce Type I IFN and suppress neuroinflammation (P5 …
  100. … improved Alzheimer disease–like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in …
  101. … in molecular biology and proteomics adapted to in vivo peptide phage display define active protein domains as biomarkers in multiple sclerosis neuroinflammation
  102. … in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and neuroinflammation
  103. … in rats causes long-lasting impairments in impulse control that are differentially sensitive to pharmacotherapeutics and associated with chronic neuroinflammation
  104. … in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus
  105. … induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation
  106. … Inhibition Prevents the Adult Excitatory-Inhibitory Imbalance Induced by the Reciprocal Interaction Between neuroinflammation and Oxidative Stress During …
  107. … inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation
  108. … injury‐induced neuronal damage in the somatosensory cortex causes formation of rod‐shaped microglia that promote astrogliosis and persistent neuroinflammation
  109. … investigation of therapeutic mechanisms of exercise in Parkinson’s disease: effects on dopamine release, ventral striatal activity and neuroinflammation
  110. … Levels of Binge Alcohol Reduce Calcium-independent Phospholipase A2 (iPLA2) Levels in Rat Brain: An Unrecognized Initial Sign of neuroinflammation
  111. … lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative …
  112. … long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation
  113. … Maternal Immune Activation in the Aetiology of Schizophrenia: Establishing a Rat Model with a Focus on Cognitive Symptomology and neuroinflammation.
  114. … Mechanism by which 4-Nonylphenol Accelerates Alzheimer’s Pathogenesis and Induces both Tau-amyloid Mediated Toxicity and neuroinflammation (P1. 9-084)
  115. … Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like Behaviour, Oxidative Damage and neuroinflammation
  116. … mechanisms of bone marrow-derived mesenchymal stem cells in the regulation of microglia-mediated neuroinflammation after subarachnoid hemorrhage
  117. … microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development
  118. … Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of neuroinflammation and Neurological Disease
  119. … object discrimination, but not spatial, memory: evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation
  120. … odorifera suppresses lipopolysaccharide-induced mouse BV2 microglial cell activation, which protects mouse hippocampal HT22 cells death from neuroinflammation …
  121. … of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible …
  122. … of cannabinoids, Δ9-tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of …
  123. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
  124. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
  125. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
  126. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
  127. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
  128. … of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of neuroinflammation through AMPK/TBK1 …
  129. … of mid-regional proenkephalin A and N-terminal protachykinin A immune reactivity in cerebrospinal fluid of patients with dementia and acute neuroinflammation
  130. … of Neutrophil Gelatinase-Associated Lipocalin Concentration in Canine Cerebrospinal Fluid and Serum and Its Involvement in neuroinflammation
  131. … of peripheral M1 macrophages reverses motor deficits in MPTP-treated mouse by suppressing neuroinflammation and dopaminergic neurodegeneration
  132. … of pro-inflammatory cytokines and the phosphorylation of p38 in the habenula and reverses depressive-like behaviors induced by neuroinflammation
  133. … of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-κB pathway associated with suppression of platelets activation and neuroinflammation
  134. … of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation …
  135. … of the injured sciatic nerve of mice carrying the Wld (S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration
  136. … of β2–adrenoceptor attenuates sepsis–induced hippocampus–dependent cognitive impairments by reversing neuroinflammation and synaptic abnormalities
  137. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
  138. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
  139. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
  140. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
  141. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
  142. … omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central …
  143. … OXIDANT EFFECT OF N-METHANESULFONYLPYRAZOLINYL SUBSTITUTED HETEROSTEROIDS IN AN LPS-INDUCED neuroinflammation MODEL OF MICE
  144. … p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
  145. … PEPTIDE RECEPTOR 2 (FPR2) AGONISTS WITH NEUROPROTECTIVE PROPERTIES IN MODELS OF neuroinflammation RELATED TO ALZHEIMER’S …
  146. … phospholipase A2 and n− 3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation
  147. … platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation
  148. … Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of neuroinflammation
  149. … post-stroke cognitive impairments via inhibition of peri-infarct astroglial and microglial/macrophage P2 purinoceptors-mediated neuroinflammation and …
  150. … pretreated mesenchymal stem cell culture ameliorates mouse lipopolysaccharide-induced cerebral neuroinflammation-histological and immunohistochemical …
  151. … Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation
  152. … profile. Impaired function of the CO2, AQP1, and AQP4 gas channels may cause hypoxia and thus enhance neuroinflammation in autistic individuals
  153. … profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
  154. … proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in …
  155. … protected against microglial‐mediated neurotoxicity in SH‐SY5Y and BV2 cocultured cells from LPS–induced neuroinflammation and death by inhibiting MAPK, NF …
  156. … radiotracer 2-(7-butyl-2-(4-(2-([18F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide in a preclinical model of neuroinflammation
  157. … regulates the differentiation of CD11b+ Ly-6Chigh monocytes and permeability of blood–brain barrier to galvanize the immune privileged CNS to neuroinflammation
  158. … regulation of ecto-5′-nucleotidase/CD73 and A2AR-mediated adenosine signaling at neurovascular unit: a link between acute and chronic neuroinflammation
  159. … regulation of the major histocompatibility complex class I in the Cns: functional implications for brain aging and sexually dimorphic differences in neuroinflammation
  160. … relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor‐1 knockout mice: the effect of fibrinolysis during neuroinflammation
  161. … Reticulum Calcium ATPase 1 est induite dans la Maladie d’Alzheimer, promeut le métabolisme amyloïdogène de l’APP et provoque la neuroinflammation.
  162. … Reveals Susceptibilities to Spatial Memory Deficits, Decreased Dopamine Marker Expression and Increased neuroinflammation in the Hippocampus of Male …
  163. … reverses depressive-like behaviors and restores the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation
  164. … reverses type 2 diabetes-induced cognitive deficits via attenuation of oxidative/nitrosative stress and NF-κB-mediated neuroinflammation in rat hippocampus
  165. … signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations
  166. … similar pathogenesis with neurodegenerative diseases: Endosome‐autophagosome‐lysosome pathway dysfunction and microglia‐mediated neuroinflammation
  167. … soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation
  168. … SPLENIC AND PERIPHERAL BLOOD IMMUNE CELL POPULATIONS AND MAY CONTRIBUTE TO neuroinflammation AND NEURODEGENERATION IN …
  169. … stem cells alleviate the early brain injury of subarachnoid hemorrhage partly by suppression of Notch1-dependent neuroinflammation: involvement of Botch
  170. … stromal cells modulate peripheral stress-induced innate immune activation indirectly limiting the emergence of neuroinflammation-driven depressive and anxiety-like …
  171. … sulfate affords neuroprotection in an eclampsia-like model induced in pregnant rats by ameliorating brain edema and neuroinflammation: Immune and inflammatory …
  172. … SYSTEM AND MOTOR IMPAIRMENT IN CRITICAL ILLNESS: Experimental Abdominal Sepsis Induces Persistent neuroinflammation And Microglial Activation
  173. … targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
  174. … Tetrahydroxystilbene-2-O-β-d-glucoside prevention of lipopolysaccharide-induced depressive-like behaviors in mice involves neuroinflammation and oxido-nitrosative …
  175. … thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s …
  176. … the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and neuroinflammation in the Brain
  177. … to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats
  178. … tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation …
  179. … traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation
  180. … virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation
  181. … Vital M, Sato MDO Adam GP (2016) Depression in Parkinson’s Disease is Associated with a Serotoninergic System Change Secondary to neuroinflammation
  182. ” Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation“: Corrigendum.
  183. (-)-Phenserine Ameliorates Contusion Volume, neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
  184. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer’s disease challenged mice
  185. (+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation
  186. (−)-Epicatechin Mitigates Oxidative Stress, neuroinflammation and Hyperphosphorylation of TAU in Hippocampus of Senile Mice
  187. (−)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis
  188. (161) Peripheral gene expression changes in the chronic constriction injury (CCI) rat model at the sciatic nerve following administration of neuroinflammation-targeted …
  189. (329) PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy
  190. [11C] PK11195 PET IMAGING REVEALS neuroinflammation IN DEMENTIA WITH LEWY BODIES IS NEGATIVELY ASSOCIATED WITH DISEASE SEVERITY …
  191. [11C] PK11195-PET to assess neuroinflammation in multiple sclerosis (MS) patients undergoing an anti-inflammatory therapy
  192. [11C] PK11195-PET to image neuroinflammation in focal epilepsy
  193. [11C] SSR180575: Preliminary evaluation in rodent models of neuroinflammation
  194. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson’s disease?
  195. [11C]DAC-PET for Noninvasively Monitoring neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis …
  196. [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification …
  197. [11C]PBR28 PET Imaging is Sensitive to neuroinflammation in the Aged Rat
  198. [18F] DBT10 as alpha7-nAChR ligand to image stroke-associated neuroinflammation by PET
  199. [18F] FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain
  200. [18F]DPA-714 PET Imaging Reveals Global neuroinflammation in Zika Virus-Infected Mice
  201. [18F]DPA-714, a potent PET-based radioligand targeted for translocator protein (18kDa) imaging in neuroinflammation: radiolabeling and in vitro evaluation
  202. [18F]DPA‐C5yne, a novel fluorine‐18‐labelled analogue of DPA‐714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with …
  203. [18F]Fluoromethyl-PBR28 as a Potential Radiotracer for TSPO: Preclinical Comparison with [11C]PBR28 in a Rat Model of neuroinflammation
  204. [53-OR]: Magnesium sulfate (MgSO4) increases seizure threshold via reduced neuroinflammation in a rat model of preeclampsia
  205. # 7-The Role of RNF216/TRIAD3 in neuroinflammation Through Interactions with Toll-Like-Receptors
  206. 0071 Topic: S25-Symposium 27: The role of neuroinflammation and infection in bipolar disorder and schizophrenia Therapeutic Trials of Minocycline, Ondansetron …
  207. 1-Methylnicotinamide attenuates lipopolysaccharide-induced cognitive deficits via targeting neuroinflammation and neuronal apoptosis
  208. 1-Trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline (TaClo) Induces the Apoptosis of Dopaminergic Neurons via Oxidative Stress and neuroinflammation
  209. 112. Infiltrating monocytes contribute to neuroinflammation in obese mice with latent herpes simplex virus-1
  210. 117. Imipramine attenuates neuroinflammation and reverses stress-induced social avoidance
  211. 117.1 TSPO in Microglia Activation and “neuroinflammation”: Are We Ready to Go Beyond Metaphors?
  212. 117.4 Pet Imaging of neuroinflammation in Schizophrenia
  213. 11C-DPA-713 versus 18F-GE-180: a preclinical comparison of translocator protein 18 kDa PET tracers to visualize acute and chronic neuroinflammation in a mouse …
  214. 11C-DPA-713 versus 18F-GE-180: A preclinical comparison of TSPO-PET tracers to visualize acute and chronic neuroinflammation in a mouse model of ischemic …
  215. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
  216. 11C-PK11195 PET for the in vivo evaluation of neuroinflammation in the rat brain after cortical spreading depression
  217. 12: Evidence for the crucial role of estrogen signaling with preterm labor and perinatal neuroinflammation
  218. 12/15 lipoxygenase inhibition suppresses neuroinflammation in a thrombotic permanent cerebral ischemia model
  219. 123. Evaluating the role of neuroinflammation in head and neck cancer-related symptoms
  220. 129. Blockade of L-type voltage dependent calcium channels or ryanodine receptors during chronic neuroinflammation improves spatial memory and reduces …
  221. 151. neuroinflammation: An animal model of fatigue induced through interleukin-1 beta
  222. 159 Mitigating Microglial-Mediated neuroinflammation: The Sur1-Trpm4 Channel Regulates Calcium-Sensitive Induction of iNOS.
  223. 16. Methylene blue infusion for treatment of traumatic brain injury-associated neuroinflammation and depressive-like behavior
  224. 17 BETA ESTRADIOL AMELIORATES neuroinflammation DRIVEN NEUROPATHIC PAIN IN CHRONIC CONSTRICTION INJURY-INDUCED PERIPHERAL …
  225. 17-Ethynyl-androst-5-ene-3, 7, 17-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of Parkinson’s …
  226. 17a-Ethynyl-androst-5-ene-3ß, 7ß, 17ß-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of …
  227. 17α-Ethynyl-androst-5-ene-3β, 7β, 17β-triol (HE3286) Is neuroprotective and reduces motor impairment and neuroinflammation in a murine MPTP Model of …
  228. 18F-DPA-714 PET imaging for detecting neuroinflammation in rats with chronic hepatic encephalopathy
  229. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation
  230. 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test–Retest Reproducibility and Quantification of neuroinflammation
  231. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
  232. 194: IRF8 regulates autophagy and activates microglia to exacerbate neuroinflammation
  233. 1H NMR-Based Metabolomics of Clinacanthus nutans Leaves Extracts in Correlation with Their Anti-neuroinflammation Towards LPS-Induced BV2 Cells
  234. 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro
  235. 2‐AG limits Theiler’s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
  236. 200. neuroinflammation in Individuals at Clinical High Risk for Psychosis: A PET Study With [(18) F]-FEPPA
  237. 2163 Molecular imaging of cardiac and neuroinflammation early after myocardial infarction and in progressive heart failure
  238. 2283: Brain thermometry to detect neuroinflammation in traumatic brain injury
  239. 24. Tumor progression increases neuroinflammation, fatigue and depressive-like behavior without altering muscle function
  240. 241 Tnf-α Induction of Infant Murine Brain Inflammation Via Ikk/Nf Kappa B Signalling: A Potential Model for Paediatric neuroinflammation
  241. 249 Serial 11C-methionine PET detects involvement of astroglia in neuroinflammation following acute myocardial infarction
  242. 27. neuroinflammation mediates the delayed behavioral effects of microembolism
  243. 270: Maternal MgSo4 paradoxically increases fetal brain cytokines associated with neuroinflammation: suggestion for focused Mg use
  244. 28. Early-life viral infection causes neuroinflammation, cognitive deficits, and changes in neurogenesis in the neonatal piglet
  245. 3, 4-DAA, an orally active synthetic tryptophan catabolite, treats established autoimmune neuroinflammation
  246. 3, 6′‐dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation
  247. 40. NEW INSIGHTS ON THE ROLE OF neuroinflammation IN SCHIZOPHRENIA PATHOPHYSIOLOGY FROM POST MORTEM AND ANIMAL STUDIES
  248. 40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF neuroinflammation IN THE MATERNAL …
  249. 43: Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
  250. 4Aβ1-15-derived monoclonal antibody reduces more Aβ burdens and neuroinflammation than homologous vaccine in APP/PS1 mice
  251. 5-lipoxygenase inhibitor zileuton attenuates neuroinflammation and brain damage via modulating ERK1/2 signaling pathway in rats of cerebral ischemia
  252. 5-Lipoxygenase-Activating Protein Inhibitors: Promising Drugs for Treating Acute and Chronic neuroinflammation Following Brain Injury
  253. 573. Evidence of both Systemic Inflammation and neuroinflammation in Patients with Chronic Widespread Pain
  254. 5LO GENETIC DELETION ATTENUATES neuroinflammation IN A P301S MOUSE MODEL OF TAUOAPTHY
  255. 6 neuroinflammation
  256. 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation
  257. 6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
  258. 6-O-galloylpaeoniflorin attenuates cerebral ischemia reperfusion-induced neuroinflammation and oxidative stress via PI3K/Akt/Nrf2 activation
  259. 6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotection
  260. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation
  261. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia
  262. 6‐Mer hyaluronan oligosaccharides modulate neuroinflammation and α‐synuclein expression in neuron‐like SH‐SY5Y cells
  263. 6. Crosstalk between mitochondrial dysfunction and neuroinflammation in TBI
  264. 670 Male Vs Female: Structural Susceptibility to neuroinflammation.
  265. 7-Deoxy-trans-dihydronarciclasine Isolated from Lycoris chejuensis Inhibits neuroinflammation in Experimental Models
  266. 7-Fluoro-1, 3-diphenylisoquinoline reverses motor and non-motor symptoms induced by MPTP in mice: role of striatal neuroinflammation
  267. 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory …
  268. 7‐methoxyflavanone alleviates neuroinflammation in lipopolysaccharide‐stimulated microglial cells by inhibiting TLR4/MyD88/MAPK signalling and activating the Nrf2 …
  269. 778: BBB DISRUPTION AFTER CORTICAL IMPACT: A ROLE FOR FIBRIN IN POST-TBI neuroinflammation?
  270. 9: The role of Nur77 in perinatal neuroinflammation in a preterm labor mouse model
  271. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
  272. A blazing landscape: neuroinflammation shapes brain metastasis
  273. A BRAVE NEURO WORLD: UNCOVERING THE ROLE OF RON RECEPTOR TYROSINE KINASE IN neuroinflammation.
  274. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis
  275. A Central Role for neuroinflammation in Vascular Clearance of Amyloid-Beta
  276. A changing perspective on the role of neuroinflammation in Alzheimer’s disease
  277. A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation
  278. A combination of resveratrol and curcumin is effective against aluminum chloride-induced neuroinflammation in rats
  279. A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation
  280. A common (GT) n repeat polymorphism in the heme oxygenase-1 promoter associates with neuroinflammation and cognitive impairment in HIV infection (S29. 002)
  281. A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection
  282. A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models
  283. A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET …
  284. A constraint kinetic modeling approach to quantify [11C] DPA-713 specific binding for PET imaging of neuroinflammation
  285. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases
  286. A Dual Investigation of Questions in Drug Addiction: Exploring the Role of neuroinflammation in Opioid Withdrawal and A Novel Measure of Reward-Seeking …
  287. A dual role for apolipoprotein E in neuroinflammation
  288. A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of neuroinflammation
  289. A FAS LYMPHOPROLIFERATIVE PHENOTYPE REVEALS NON-APOPTOTIC FAS SIGNALING IN HTLV-1-ASSOCIATED neuroinflammation
  290. A fashi lymphoproliferative phenotype reveals non-apoptotic fas signaling in HTLV-1-associated neuroinflammation
  291. A genetic and neurochemical analysis of dopamine regulation in drosophila melanogaster of human neurodegenerative disorders and neuroinflammation
  292. A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
  293. A lack of ovarian function increases neuroinflammation in aged mice
  294. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS-and MPTP-induced neuroinflammation
  295. A Logic Model of Neuronal-Glial Interaction Suggests Altered Homeostatic Regulation in the Perpetuation of neuroinflammation
  296. A Malva parviflora´ s fraction prevents the deleterious effects resulting from neuroinflammation
  297. A mathematical model of neuroinflammation in severe clinical traumatic brain injury
  298. A mechanistic link between glia and neuronal excitability in acute neuroinflammation
  299. A method for personalized brain mapping of neuroinflammation using 11C-DPA-713 PET
  300. A model of systemic inflammation to study neuroinflammation
  301. A mouse model for juvenile, lateral fluid percussion brain injury reveals sex-dependent differences in neuroinflammation and functional recovery
  302. A Multi-Approach Investigation to Evaluate Compounds that Mitigate neuroinflammation.
  303. A Multifunctional Chemical Agent as an Attenuator of Amyloid and Tau Burden and neuroinflammation in Alzheimer’s Disease
  304. A natural variant of the T cell receptor-signaling molecule Vav1 reduces both effector T cell functions and susceptibility to neuroinflammation
  305. A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced neuroinflammation
  306. A neuroinflammation Inhibitor, Hypoxylon xanthone A, from Soil Fungus Hypoxylon sp.
  307. A new avenue for treating Parkinson’s disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
  308. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
  309. A new mouse model of prostaglandin J2 (PGJ2) induced neuroinflammation and parkinsonism: Validation using μPET and C-11 labeled radiotracers
  310. A new road to neuroinflammation in Parkinson’s disease?
  311. A new therapeutic target for Alzheimer’s disease: effects of palmitoylethanolamide with luteolin association on neuroinflammation pathway (845.10)
  312. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat
  313. A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced neuroinflammation in BV2 Microglia and a Mouse Model
  314. A novel animal model for neuroinflammation and white matter degeneration
  315. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
  316. A NOVEL CANNABINOID RECEPTOR 1 ANTAGONIST ALLEVIATES METABOLIC DISORDER AND neuroinflammation IN THE MODELS OF ALZHEIMER’S …
  317. A novel immunosuppressor,(5R)-5-hydroxytriptolide, alleviates movement disorder and neuroinflammation in a 6-OHDA hemiparkinsonian rat model
  318. A Novel Marker for neuroinflammation in Diabetic Neuropathy (P03. 195)
  319. A novel perspective on the ApoM-S1P axis, highlighting the metabolism of ApoM and its role in liver fibrosis and neuroinflammation
  320. A novel PET radioligand,[11C] PS13, successfully images COX-1, a potential biomarker for neuroinflammation.
  321. A novel role for earthworm peptide Lumbricusin as a regulator of neuroinflammation
  322. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation
  323. A novel targeted local analgesia platform to mitigate neuroinflammation and promote neuroregeneration
  324. A NOVEL THERAPEUTIC (NTRX-07) TARGETING neuroinflammation IN ALZHEIMER’S DISEASE IS UNDERGOING PHASE I TRIALS
  325. A novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles
  326. A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation
  327. A Pivotal Role for Thiamine Deficiency in the Expression of neuroinflammation Markers in Models of Alcohol‐Related Brain Damage
  328. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder
  329. A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer’s disease
  330. A Preliminary Model for the Protective Role of the Endocannabinoid 2-Arachydonylglycerol in neuroinflammation
  331. A prenylated xanthone, cudratricusxanthone A, isolated from Cudrania tricuspidata inhibits lipopolysaccharide-induced neuroinflammation through inhibition of NF-κB …
  332. A Primary Neural Cell Culture Model for neuroinflammation
  333. A promising I-123 labeled radioligand for imaging neuroinflammation response by assessment P2X7 receptor expression
  334. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
  335. A research update on the potential roles of aquaporin 4 in neuroinflammation
  336. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia
  337. A review of spinal and peripheral neuromodulation and neuroinflammation: lessons learned thus far and future prospects of biotype development
  338. A Role for CRH and HPA Activation in the Regulation of Plasticity Signaling, neuroinflammation and Emotional/Mnesic Behavior Following Global Cerebral …
  339. A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
  340. A role for hypertension in CAA, neuroinflammation and neuropathology In Alzheimer’s?
  341. A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS
  342. A role for the non-receptor tyrosine kinase Abl2/Arg in experimental neuroinflammation
  343. A silver lining of neuroinflammation: beneficial effects on myelination
  344. A single dose of trichloroethylene given during development does not substantially alter markers of neuroinflammation in brains of adult mice
  345. A Single Lipopolysaccharide (LPS) Injection to the Rat Brain Induces neuroinflammation Two Months After Treatment
  346. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation
  347. A sterile animal model for neuroinflammation?
  348. A strategy to passively reduce neuroinflammation surrounding devices implanted chronically in brain tissue by manipulating device surface permeability
  349. A study of the effects of chronic neuroinflammation on cognition and behaviour in the GFAP-IL6 transgenic mouse and investigation of the flavonoid apigenin as a …
  350. A Study of the Endogenous Control of neuroinflammation, A Leading Cause of Morbidity from Traumatic Brain Injury
  351. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats
  352. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson’s disease and potential molecular targets
  353. A Systematic review of positron emission tomography of tau, amyloid beta, and neuroinflammation in chronic traumatic encephalopathy: the evidence to date
  354. A TELOscopic view of neuroinflammation
  355. A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation
  356. A Tip leads cytotoxic T cells to the crime scene in neuroinflammation
  357. A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation
  358. A Zika Virus Primary Isolate Induces neuroinflammation, Compromises the Blood-Brain Barrier, and Upregulates CXCL12 in Adult Macaques
  359. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis
  360. A16 Endoplasmic reticulum stress: an initiator of neuroinflammation in Huntington’s disease?
  361. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
  362. A31 The development of translational biomarkers of neuroinflammation in a mouse model of huntington’s disease
  363. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease
  364. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen …
  365. AB0050 Irf8 Promotes TH17 Differentiation via Activation of Integrin-Mediated Tgfbeta Signaling in neuroinflammation
  366. ABCA1 influences neuroinflammation and neuronal death
  367. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation
  368. Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher’s disease
  369. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury
  370. Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus
  371. Absence of galectin-3 attenuates neuroinflammation improving functional recovery after spinal cord injury
  372. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis
  373. Abstract OT2-05-03: Does minocycline mitigate chemotherapy induced neuroinflammation? A phase II randomized placebo controlled study
  374. Abstract P2-11-04: Chemotherapy Induces neuroinflammation and Cognitive Deficits in Female Mice
  375. Abstract TMP35: CD200-CD200R1 Inhibitory Signaling Attenuates neuroinflammation and Reduces Behavioral Deficits Following Ischemic Stroke
  376. Abstract TP102: Modulation of neuroinflammation by Haptoglobin Reduces Oxidative Stress and Improves ICH Outcomes
  377. Abstract TP141: Mesenchymal Stem Cell Derived Exosomes as a Modulator of neuroinflammation Following Cortical Injury
  378. Abstract TP226: Aging and Smoking Exacerbates Post-Stroke Complement Driven neuroinflammation
  379. Abstract TP279: Brain-Derived Microparticles Mediate neuroinflammation After Stroke
  380. Abstract TP317: Chemokine Production by Microglia Mediates Blood-Derived Monocytes Trafficking in neuroinflammation
  381. Abstract TP337: Microglial Activation and neuroinflammation Are Mediated by Over-Activation of Cofilin After Intracerebral Hemorrhage
  382. Abstract W P250: Food Restriction Ameliorates neuroinflammation and Provides Protection in a Mouse Model of Ischemic Stroke
  383. Abstract W P369: Inhibitory Effect of FTY720 on neuroinflammation in Cerebral Ischemia-reperfusion
  384. Abstract WMP37: Neurovascular Protection by Telmisartan Via Reducing neuroinflammation in SHR-SR Brain After Ischemic Stroke
  385. Abstract WMP73: Discerning How Vascular Inflammation Modulates neuroinflammation Using Novel Vascular Brain Organ-On-A-Chip: Proof-of-Concept Study
  386. Abstract WMP79: Phosphatidylserine-containing Liposomes Pretreatment Attenuates neuroinflammation in a Rat Model of Surgical Brain Injury
  387. Abstract WP142: Targeting VCAM1 to Reduce Acute and Chronic neuroinflammation After Stroke
  388. Abstract WP159: FPS-ZM1 Alleviates neuroinflammation in Focal Cerebral Ischemia Rats via Blocking the RAGE/DIAPH1/NF-kappa B Pathway
  389. Abstract WP418: Mineralocorticoid Receptor Signaling is Associated With neuroinflammation and Changes in Cognitive Function in Angiotensin II-Induced …
  390. Abstract# 1704 Cardiac surgery causes more extended neuroinflammation and cognitive dysfunction compared to abdominal surgery in rats
  391. Abstract# 1736 The role of endothelial IL-1R1 in anxiogenic neuroinflammation
  392. Abstract# 1831 Repeated social defeat stress-induced neuroinflammation contributes to later fear sensitization and impaired extinction recall of fear conditioning in …
  393. Abstract# 3081 Impaired cognition and fatigue; the role of sleep and neuroinflammation for non-specific symptoms in allergy
  394. Abstract# 3113 The role of estrogen in tumor-induced cognitive performance and neuroinflammation
  395. Abstract# 3114 neuroinflammation and chemotherapy-related fatigue
  396. Abstract# 3175 Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
  397. Abstract# 3182 neuroinflammation and hypertension iteract in the pathogenesis of white matter hyperintensity in subjects with mild cognitive impairment
  398. Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo
  399. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo
  400. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson’s …
  401. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1
  402. Accelerated neurodegeneration and phenotypic switch of neuroinflammation in transgenic mice expressing P301L tau-mutant and tau-tubulin kinase 1
  403. Accessible method for the development of novel sterol analogues with dipeptide-like side chains that act as neuroinflammation inhibitors
  404. Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia
  405. Accumulation of class switched IgD− IgM− memory B cells in the cerebrospinal fluid during neuroinflammation
  406. Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity?
  407. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine
  408. Acetate supplementation attenuates lipopolysaccharide‐induced neuroinflammation
  409. Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2Areceptor levels in rats subjected to neuroinflammation
  410. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation
  411. Acetate, an Ethanol Metabolite Increases neuroinflammation and Neuronal Death: Implications in Ethanol Neurodegeneration
  412. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
  413. Acetylcholinesterase inhibitors reduce neuroinflammation and-degeneration in the cortex and hippocampus of a surgery stress rat model
  414. Acetylcholinesterase-Inhibitoren reduzieren die neuroinflammation und-degeneration im Cortex und Hippocampus in einem Operations-Stressmodell der adulten …
  415. Acetylpuerarin inhibits oxygen‑glucose deprivation‑induced neuroinflammation of rat primary astrocytes via the suppression of HIF‑1 signaling
  416. Achyranthes bidentata polypeptide k suppresses neuroinflammation in BV2 microglia through Nrf2-dependent mechanism
  417. Acid-sensing ion channels as potential therapeutic targets in neurodegeneration and neuroinflammation
  418. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced mouse …
  419. Acrolein Scavenger Hydralazine Prevents Streptozotocin‐Induced Painful Diabetic Neuropathy and Spinal neuroinflammation in Rats
  420. Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain: novel findings on network restoration
  421. Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation
  422. Activation of adenosine monophosphate–activated protein kinase suppresses neuroinflammation and ameliorates bone cancer paininvolvement of inhibition …
  423. Activation of dopamine D2 receptor suppresses neuroinflammation through αB-crystalline by inhibition of NF-κB nuclear translocation in experimental ICH mice model
  424. Activation of glial α7 nAChR promotes neurogenesis by suppressing Aβ-mediated neuroinflammation in Alzheimer’s disease
  425. Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced neuroinflammation in Rats
  426. Activation of Melanocortin-4 Receptor Inhibits Both neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in …
  427. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
  428. Activation of microglial poly (ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal …
  429. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation
  430. Activation of P2X7 receptors in peritoneal and meningeal mast cells detected by uptake of organic dyes: possible purinergic triggers of neuroinflammation in …
  431. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses
  432. Activation of the G Protein-Coupled Estrogen Receptor (GPER) Increases Neurogenesis and Ameliorates neuroinflammation in the Hippocampus of Male …
  433. Activation of the STING-dependent type I interferon response reduces microglial reactivity and neuroinflammation
  434. Acupuncture Resolves Persistent Pain and neuroinflammation in a Mouse Model of Chronic Overlapping Pain Conditions
  435. Acupuncture suppresses stress-induced neuroinflammation in the rat hypothalamus
  436. Acute Alcohol Intoxication is Associated With Sustained neuroinflammation Without Exacerbation of Early Neurobehavioral Outcomes Post Traumatic Brain Injury
  437. Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury
  438. Acute and long-term effects of haloperidol on surgery-induced neuroinflammation and cognitive deficits in aged rats
  439. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome
  440. Acute drivers of neuroinflammation in traumatic brain injury
  441. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury
  442. Acute inhalation of combustion smoke triggers neuroinflammation and persistent anxiety-like behavior in the mouse
  443. Acute Kahweol Treatment Attenuates Traumatic Brain Injury neuroinflammation and Functional Deficits
  444. Acute neuroinflammation and glial reactivity to rebuild neural circuits: Unraveling the role of inflammatory mediators during zebrafish optic nerve regeneration
  445. Acute neuroinflammation and neurogenesis: a role for microglial COX-1
  446. Acute neuroinflammation elicited by TLR-3 systemic activation combined with early life stress induces working memory impairments in male adolescent mice
  447. Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo
  448. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus
  449. Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking
  450. Acute neuroinflammation in Lewis rats—a model for acute multiple sclerosis relapses
  451. Acute neuroinflammation induces AIS structural plasticity in a NOX2-dependent manner
  452. Acute neuroinflammation mediates optic nerve regeneration in adult zebrafish
  453. Acute neuroinflammation promotes cell responses to 1800 MHz GSM electromagnetic fields in the rat cerebral cortex
  454. Acute neuroinflammation provokes intracellular acidification in mouse hippocampus
  455. Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat …
  456. Acute postoperative pain exacerbates neuroinflammation and related delirium-like cognitive dysfunction in rats
  457. Acute social defeat-induced neuroinflammation in the vmPFC of Syrian hamsters via microglial activation
  458. Acute, chronic, and nonclassical neuroinflammation: Definitions in a changing scientific environment
  459. Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1‐40) administration in mice
  460. Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer’s …
  461. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia–reperfusion injury
  462. Adaptive brain shut-down counteracts neuroinflammation in the near-term ovine fetus
  463. Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury
  464. Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia
  465. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
  466. Adenosine Receptors and neuroinflammation
  467. Adenosine Receptors Modulate Acute Injury and neuroinflammation in Brain Ischemia
  468. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult …
  469. Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
  470. AdipoRon Attenuates neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway
  471. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1/Notch pathway
  472. Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption
  473. Adolescent traumatic brain injury induces chronic mesolimbic neuroinflammation with concurrent enhancement in the rewarding effects of cocaine in mice during …
  474. Adult Mice Exposed to Aerosalized Alternaria Exhibit neuroinflammation in the Brainstem but not Rest of Brain
  475. Adult neural stem cells for the treatment of neuroinflammation: Fondazione Centro San Raffaele del Monte Tabor: WO2007015173
  476. Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells
  477. ADVANCING THERAPEUTICS FOR neuroinflammation IN ALZHEIMER’S DISEASE: CLINICAL DEVELOPMENT CONSIDERATIONS
  478. Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH …
  479. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
  480. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
  481. Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague-Dawley rats: the role of IL-4
  482. Age related macular degeneration and drusen: neuroinflammation in the retina
  483. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
  484. AGE-DEPENDENT NEUROPROTECTIVE EFFECTS OF CLUSTERIN IN THE SETTING OF neuroinflammation
  485. AGE-NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS neuroinflammation IN ALZHEIMER’S DISEASE CLINICAL TRIALS
  486. Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I: C in early gestation
  487. Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation
  488. Age-related differences in secondary neuroinflammation and amyloid-β deposition in a rat sepsis model
  489. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-CATENIN signaling in rat hippocampus
  490. Age-specific susceptibility to neuroinflammation during post-natal development
  491. Age‐dependent release of high‐mobility group box protein‐1 and cellular neuroinflammation after traumatic brain injury in mice
  492. Aged Mice Lacking Fatty Acid Amide Hydrolase Show Reduced neuroinflammation, Senescence, and Cognitive Impairment
  493. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
  494. Ageing, neuroinflammation and neurodegeneration
  495. Aging alters Hv1‐mediated microglial polarization and enhances neuroinflammation after peripheral surgery
  496. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
  497. Aging differentially affects the loss of neuronal dendritic spine, neuroinflammation and memory impairment at rats after surgery
  498. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
  499. Aging, Immunity, and neuroinflammation: The Modulatory Potential of Nutrition
  500. Aging, neurogenesis and neuroinflammation in hearing loss and protection
  501. AGK2 Alleviates Lipopolysaccharide Induced neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1
  502. Agmatine Produces Antidepressant Effect via Modulation of neuroinflammation in Chronic Unpredictable Mild Stress Model of Rats: Implication in Inflammatory …
  503. Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats
  504. Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson’s disease
  505. Air pollution & the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease
  506. Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: the clinical impact on children and beyond
  507. Air pollution: mechanisms of neuroinflammation and CNS disease
  508. Akkermansia muciniphila ameliorates depressive symptoms in irritable bowel syndrome via improving neuroinflammation
  509. AKR1B1 upregulation contributes to neuroinflammation and astrocytes proliferation by regulating the energy metabolism in rat spinal cord injury
  510. Alarm or curse? The pain of neuroinflammation
  511. ALCAM regulates BBB integrity and neuroinflammation
  512. ALCAM: cell adhesion molecule or tight junction? The characterization of its role in the context of neuroinflammation
  513. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis
  514. Alcohol and Alzheimer’s Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, neuroinflammation and Neurodegeneration in Alzheimer’s …
  515. Alcohol brain damage and neuroinflammation: Is there a connection?
  516. Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation
  517. Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern
  518. Alcohol-Induced neuroinflammation in an Animal Model of FASD and Neuroprotection by Anti-Inflammatory Agents
  519. Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation
  520. Alcohol, Phospholipase A2-associated neuroinflammation, and ω3 Docosahexaenoic Acid Protection
  521. Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
  522. Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of β-amyloid
  523. All trans retinoic acid attenuates markers of neuroinflammation in rat brain by modulation of SIRT1 and NFκB
  524. All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment in aged rats
  525. All-Trans-Retinoic Acid Augments the Histopathological Outcome of neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice
  526. Alleviation of symptoms of Alzheimer’s disease by diminishing Aβ neurotoxicity and neuroinflammation
  527. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
  528. Allyl sulfide counteracts 1-bromopropane-induced neurotoxicity by inhibiting neuroinflammation and oxidative stress
  529. Allyl-isothiocynate (AITC) ameliorates LPS induced NF-κB mediated neuroinflammation
  530. Alpha-1 antitrypsin attenuates M1 microglia-mediated neuroinflammation in retinal degeneration
  531. Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer’s disease-induced in ovarictomized rats
  532. Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis
  533. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection
  534. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
  535. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with …
  536. Alpha‐7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture
  537. Alteration in nuclear factor-kappaB pathway and functionality of estrogen via receptors promote neuroinflammation in frontal cortex after 1-Methyl-4-Phenyl-1 …
  538. Alteration of Blood Brain Barrier during Cuprizone-Induced neuroinflammation using multi-tracers with PET:[68Ga] EDTA,[11C](R) PK11195, and [11C] DPA713
  539. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl …
  540. ALTERATIONS IN DNA METHYLATION CONTRIBUTE TO neuroinflammation IN ALZHEIMER’S DISEASE
  541. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
  542. Alterations in immune cells and mediators in the brain: it’s not always neuroinflammation!
  543. Alterations in striatal microRNA-mRNA networks contribute to neuroinflammation in multiple system atrophy
  544. Alterations in the endocannabinoid syste m as a link between unbalanced energy homeostasis, neuroinflammation, and neurological and neuropsychiatric disorders
  545. Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation
  546. Altered amyloid metabolism in neuroinflammation
  547. Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
  548. Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline
  549. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation
  550. Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer’s disease
  551. Altered Social Behavior and neuroinflammation in a Mouse Model of Pten Mislocalization
  552. Alternate Activation of Microglia as a Protective Adaptation against Chronic neuroinflammation in Young Rats
  553. Aluminum chloride induces neuroinflammation, loss of neuronal dendritic spine and cognition impairment in developing rat
  554. Alzheimer disease and neuroinflammation
  555. Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
  556. Alzheimer’s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines
  557. Amelioration of age associated neuroinflammation on long term bacosides treatment
  558. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein
  559. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation
  560. Amelioration of neuroinflammation and apoptosis characterizing Alzheimer’s disease by natural products’
  561. Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures
  562. Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation
  563. Amitriptyline and bromazepam in the treatment of vibratory angioedema: which role for neuroinflammation?
  564. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats
  565. Amitriptyline suppresses neuroinflammation-dependent interleukin-10-p38 mitogen-activated protein kinase-heme oxygenase-1 signaling pathway in chronic …
  566. Ampelopsin improves cognitive impairment in Alzheimer’s disease and involvement of neuroinflammation and oxidative stress in the hippocampus.
  567. Amphetamine-Induced Sensitization of Hypertension and Lamina Terminalis neuroinflammation
  568. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
  569. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia
  570. Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer’s disease mouse model
  571. Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke
  572. Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation
  573. Amyloid peptide induced neuroinflammation increases the P2X7R expression in microglial cells impacting to their functionality
  574. Amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration in Alzheimer’s disease and cerebral prion amyloidosis
  575. Amyloid‐β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK‐3β, tau and neuroinflammation
  576. Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation: nationwide epidemiological studies on etiology, comorbidities, and treatment
  577. Amyotrophic Lateral Sclerosis, neuroinflammation, and Cromolyn
  578. An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease
  579. An alternative path to reduce neuroinflammation
  580. An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage
  581. An aqueous extract of herbal medicine ALWPs enhances cognitive performance and inhibits LPS-induced neuroinflammation via FAK/NF-κB signaling …
  582. An eighteen-month helicobacter infection does not induce amyloid plaques or neuroinflammation in brains of wild type C57BL/6J mice
  583. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
  584. An Evaluation of GABAB Receptors on Modulating neuroinflammation in a Non-Transgenic Animal Model of Alzheimer’s Disease
  585. An in vitro experimental model of neuroinflammation: the induction of interleukin‐6 in murine astrocytes infected with Theiler’s murine encephalomyelitis virus, and its …
  586. An integrative approach to neuroinflammation in psychiatric disorders and neuropathic pain
  587. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
  588. AN ISOFORM-SPECIFIC ROLE OF FYNT IN ALZHEIMER’S DISEASE AND ITS RELEVANCE IN neuroinflammation
  589. An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation
  590. Analysis of Aβ and neuroinflammation as a function of brain region and disease progression in the TgCRND8 brain
  591. Analysis of the pain and neuroinflammation after rats with neuropathic pain receive immunoglobulin intervention
  592. Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures
  593. Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65–p300 interaction in LPS …
  594. Andrographolide ameliorates intracerebral hemorrhage induced secondary brain injury by inhibiting neuroinflammation induction
  595. Andrographolide does not protect against neuroinflammation in a Parkinsonism model: Focus on tumor necrosis factor alpha
  596. Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in …
  597. Andrographolide Reduces neuroinflammation and Oxidative Stress in Aged Octodon degus
  598. Anesthesia, surgery and neuroinflammation
  599. Anesthetic immunomodulation of the neuroinflammation in postoperative cognitive dysfunction
  600. Anesthetic modulation of neuroinflammation in Alzheimer’s disease
  601. Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review
  602. Angelicae Gigantis Radix Regulates LPS-Induced neuroinflammation in BV2 Microglia by Inhibiting NF-κB and MAPK Activity and Inducing Nrf-2 Activity
  603. Angiotensin II type 1a receptors in the subfornical organ modulate neuroinflammation in the hypothalamic paraventricular nucleus in heart failure rats
  604. Angiotensin II-Induced neuroinflammation Contributes to Sympathetic Overactivity in Hypertensive Rats.
  605. Angiotensin receptor blockade modulates NFκB and STAT3 signaling and inhibits glial activation and neuroinflammation better than angiotensin-converting enzyme …
  606. Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection
  607. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death
  608. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra
  609. Angiotensin-converting enzyme inhibitor suppresses Type I interferon responses, decreases neuroinflammation and improves depression-like behavior in MRL/lpr …
  610. Animal models of neuroinflammation secondary to acute insults originated outside the brain
  611. Annexin A1 attenuates neuroinflammation through FPR2/p38/COX‐2 pathway after intracerebral hemorrhage in male mice
  612. Annexin A1 Bioactive Peptide Promotes Resolution of neuroinflammation in an Experimental Model of Exsanguinating Cardiac Arrest Treated by Emergency …
  613. Annexin A2 Deficiency Exacerbates neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice
  614. Announcement of Special Issues for 2019: Stress and neuroinflammation
  615. Annual research review: the neuroinflammation hypothesis for stress and psychopathology in children–developmental psychoneuroimmunology
  616. Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis
  617. Antarctic krill oil diet protects against lipopolysaccharide-induced oxidative stress, neuroinflammation and cognitive impairment
  618. Anthocyanins attenuate neuroinflammation through the suppression of MLK3 activation in a mouse model of perioperative neurocognitive disorders
  619. Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide
  620. Anthocyanins from Lycium ruthenicum Murr. Ameliorated d-Galactose-Induced Memory Impairment, Oxidative Stress, and neuroinflammation in Adult Rats
  621. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
  622. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats
  623. Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain: Possible mechanism for neuroinflammation
  624. Anti-Inflammatory and neuroprotective effect of apigenin: Studies in the GFAP-IL6 mouse model of chronic neuroinflammation
  625. Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation
  626. Anti-inflammatory Effect of AZD6244 on Acrolein-Induced neuroinflammation
  627. Anti-inflammatory Effects of ,-Dihydroxyeudesm-4(15)-ene Isolated from Myrrh on LPS-induced neuroinflammation in BV2 cells
  628. Anti-inflammatory mechanism of Isodon japonicas (Burm) Hara on lipopolysaccharide-induced neuroinflammation
  629. Anti-inflammatory mechanism of lonchocarpine in LPS-or poly (I: C)-induced neuroinflammation
  630. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation
  631. Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy
  632. Anti-Malarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APPswe/PS1dE9 Transgenic Mice Via Inhibition of NF-κB and NLRP3 …
  633. Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway: in vivo and in vitro studies
  634. Anti-neuroinflammation ameliorates systemic inflammation-induced mitochondrial DNA impairment in the nucleus of the solitary tract and cardiovascular reflex …
  635. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease
  636. Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation
  637. Anti-neuroinflammatory effects of Quercetin-3-O-glucuronide isolated from the leaf of Vitis labruscana on LPS-induced neuroinflammation in BV2 cells
  638. Anti-NMDAR encephalitis: demonstration of neuroinflammation and the effect of immunotherapy
  639. Antidepressant activity of crocin-I is associated with amelioration of neuroinflammation and attenuates oxidative damage induced by corticosterone in mice
  640. Antidepressant activity of ω-3 polyunsaturated fatty acids in ovariectomized rats: role of neuroinflammation and microglial polarization
  641. Antidepressant effect of Xingnao Jieyu decoction mediated by alleviating neuroinflammation in a rat model of post-stroke depression
  642. Antidepressant-like activity of Myelophil via attenuation of microglial-mediated neuroinflammation in mice undergoing unpredictable chronic mild stress
  643. Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide …
  644. Antidepressant-Like Effect of Bauhinia blakeana Dunn in a neuroinflammation Model in Mice
  645. Antidepressant-like effect of zileuton is accompanied by hippocampal neuroinflammation reduction and CREB/BDNF upregulation in lipopolysaccharide-challenged …
  646. Antidepressants and neuroinflammation: can antidepressants calm glial rage down?
  647. Antigen-independent pathogenic and protective immunity in chronic neuroinflammation
  648. Antihypertensive effects of ACE2 in the paraventricular nucleus: a consequence of reduced neuroinflammation?
  649. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms
  650. Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APP swe/PS 1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κ B and …
  651. Antioxidant treatment limits neuroinflammation in experimental glaucoma
  652. Antiparkinson and antioxidant effect of pyridylpyrazolinyl substituted heterosteroids in LPS induced neuroinflammation model of neurodegenerative disorders
  653. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation
  654. Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease
  655. Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model
  656. Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review
  657. Anxiolytic-like effects of the ethanol extract of Magnolia obovata leaves through its effects on GABA-benzodiazepine receptor and neuroinflammation
  658. Apelin attenuates depressive-like behavior and neuroinflammation in rats co-treated with chronic stress and lipopolysaccharide
  659. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer’s disease through activation of BDNF-TrkB …
  660. Apigenin attenuates isoflurane-induced cognitive dysfunction via epigenetic regulation and neuroinflammation in aged rats
  661. Apigetrin from Scutellaria baicalensis Georgi Inhibits neuroinflammation in BV-2 Microglia and Exerts Neuroprotective Effect in HT22 Hippocampal Cells
  662. APOE ISOFORMS DIFFERENTIALLY REGULATE ALZHEIMER’S neuroinflammation
  663. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer’s disease: current landscape, novel data, and future perspective
  664. Apolipoprotein E alters the association of neuroinflammation with Alzheimer’s disease
  665. Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental …
  666. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
  667. Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation
  668. APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation
  669. Application of europium-doped very small iron oxide nanoparticles to visualize neuroinflammation with MRI and fluorescence microscopy
  670. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment
  671. Applying clustering coefficient to the pattern of international author collaboration in neuroimmunology and neuroinflammation
  672. Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation
  673. Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson’s disease
  674. Aqueous extract of Dendropanax morbiferus leaves effectively alleviated neuroinflammation and behavioral impediments in MPTP-induced Parkinson’s mouse model
  675. Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation
  676. Are the emergence of affective disturbances in neuropathic pain states contingent on supraspinal neuroinflammation?
  677. Are we ready for successful clinical targeting of neuroinflammation?: major challenges and how to overcome them
  678. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
  679. Arginase 2 Deficiency Promotes neuroinflammation and Pain Behaviors Following Nerve Injury in Mice
  680. ARMD 84 AIDS Kaposi’s sarcoma 488 neuroinflammation (M) 12 vitamin E (L) 376
  681. Aromatase and neuroinflammation in rat focal brain ischemia
  682. Aromatic‐turmerone attenuates LPS‐induced neuroinflammation and consequent memory impairment by targeting TLR4‐dependent signaling pathway
  683. Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation
  684. Arterial input function combined with PET to follow longitudinally neuroinflammation in rats
  685. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated …
  686. Asiatic Acid Protects Dopaminergic Neurons from neuroinflammation by Suppressing Mitochondrial ROS Production
  687. Asiatic acid suppresses neuroinflammation in BV2 microglia via modulation of the Sirt1/NF-κB signaling pathway
  688. Assessing neuroinflammation in Obese Individuals Using Diffusion Basis Spectrum Imaging (DBSI)
  689. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia
  690. Assessment of neuroinflammation and microglial activation in Alzheimer’s disease with radiolabelled PK11195 and single photon emission computed tomography
  691. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
  692. Assessment of translocator protein density, as marker of neuroinflammation, in major depressive disorder: a pilot, multicenter, comparative, controlled, brain …
  693. Association between Hippocampal Shape, neuroinflammation, and Cognitive Decline in Alzheimer’s Disease
  694. Association Between Vaccines and neuroinflammation—Reply
  695. Association Between Vaccines and neuroinflammation: Time, Risks, and Benefits
  696. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus
  697. Association of high-fat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats
  698. Association of long-term atorvastatin with escalated stroke-induced neuroinflammation in rats
  699. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks
  700. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells
  701. Astaxanthin ameliorates lipopolysaccharide-induced neuroinflammation, oxidative stress and memory dysfunction through inactivation of the signal …
  702. Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury
  703. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage
  704. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson’s disease …
  705. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis
  706. Astragalus membranaceus-polysaccharides ameliorates obesity, hepatic steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition …
  707. Astrocyte and macrophage regulation of YKL‐40 expression and cellular response in neuroinflammation
  708. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid …
  709. Astrocyte gene expression during neuroinflammation: βC/EBPregulates TIMP-1 and other inflammation genes
  710. Astrocyte neuropathology in autism: role of neuroinflammation & glutamatergic signalling
  711. Astrocyte-and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation
  712. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation
  713. Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function during neuroinflammation in multiple sclerosis
  714. Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP
  715. Astrocyte‐T cell crosstalk regulates region‐specific neuroinflammation
  716. Astrocyte, reactive astrocytes and self-regulative apoptosis in the neuroinflammation
  717. Astrocyte/microglia cocultures as a model to study neuroinflammation
  718. Astrocytes and neuroinflammation in Alzheimer’s disease
  719. Astrocytes in neuroinflammation and Neuronal Disorders: Shifting the Focus from Neurons
  720. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases
  721. Astrocytes: key regulators of neuroinflammation
  722. Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation
  723. Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation
  724. Astrocytic transforming growth factor‐beta signaling reduces subacute neuroinflammation after stroke in mice
  725. Astroglial Connexin 43 Deficiency Protects against LPS-Induced neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA
  726. Astroglial control of neuroinflammation: TLR3-mediated dsRNA-sensing pathways are in the focus
  727. At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo
  728. Atorvastatin Attenuates Cognitive Deficits and neuroinflammation Induced by Aβ1–42 Involving Modulation of TLR4/TRAF6/NF-κB Pathway
  729. Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation
  730. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative 2 stress following amyloid-β1–40 administration in mice: Evidence for …
  731. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation …
  732. Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord
  733. Atp13a2 Deficiency Aggravates Astrocyte‐Mediated neuroinflammation via NLRP3 Inflammasome Activation
  734. Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in …
  735. Atractylodis rhizoma alba attenuates neuroinflammation in BV2 microglia upon LPS stimulation by inducing HO-1 activity and inhibiting NF-κB and MAPK
  736. Atsttrin reduces lipopolysaccharide-induced neuroinflammation by inhibiting the nuclear factor kappa B signaling pathway
  737. Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury
  738. Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy
  739. Attenuation of aluminum chloride-induced neuroinflammation and caspase activation through the AKT/GSK-3β pathway by hesperidin in wistar rats
  740. Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid
  741. Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced neuroinflammation
  742. Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors
  743. Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model
  744. Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
  745. Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol
  746. Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo
  747. Attractylone attenuates sepsis‐associated encephalopathy and cognitive dysfunction by inhibiting microglial activation and neuroinflammation
  748. Aucubin alleviates seizures activity in Li-Pilocarpine-Induced epileptic mice: involvement of inhibition of neuroinflammation and regulation of neurotransmission
  749. Auricular vagus nerve stimulation protects against postoperative cognitive dysfunction by attenuating neuroinflammation and neurodegeneration in aged rats
  750. Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
  751. Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
  752. Author Correction: T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.
  753. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an …
  754. Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE
  755. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model
  756. Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE
  757. Automated Production of [18F] FEPPA as a neuroinflammation Imaging Agent
  758. Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains
  759. Autophagy itself and/or its anti-neuroinflammation action in hippocampus attenuates postoperative cognitive decline in aged rats undergoing splenectomy
  760. Autophagy Modulators and neuroinflammation
  761. AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation
  762. Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats
  763. Axon Guidance Molecules Guiding neuroinflammation
  764. Axonal Injury, neuroinflammation and Amyloid Pathology after Traumatic Brain Injury: Making Connections to Neurodegeneration (I12-1.007)
  765. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
  766. Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa
  767. Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation
  768. Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation …
  769. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis
  770. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
  771. B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition
  772. BACE inhibitor NB-360 reveals strong reduction of amyloid-β generation, robust blockade of amyloid deposition and lowering of neuroinflammation in APP transgenic …
  773. Bacille Calmette-Guérin (BCG) Vaccine in neuroinflammation
  774. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
  775. Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage
  776. Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and …
  777. Baicalein promotes neuronal and behavioral recovery after intracerebral hemorrhage via suppressing apoptosis, oxidative stress and neuroinflammation
  778. Baicalin attenuates lipopolysaccharide-induced neuroinflammation in cerebral cortex of mice via inhibiting nuclear factor kappa B (NF-κB) activation
  779. Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP 3 inflammasomes and TLR 4/NF‐κB …
  780. Basic aspects of the immunology of neuroinflammation
  781. Basic concept of microglia biology and neuroinflammation in relation to psychiatry
  782. BDNF Alleviates neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway
  783. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
  784. Bee venom acupuncture reduces neuroinflammation modulating microglia/macrophage phenotype polarization in spinal cord injury compression model
  785. Bee venom ameliorates cognitive dysfunction caused by neuroinflammation in an animal model of vascular dementia
  786. Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 …
  787. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease
  788. Behavioral and biochemical effects of GSM 900MHz in neuroinflammation and gestational inflammation models
  789. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats
  790. Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi
  791. Benefical effects of mediterranean diet in neuroinflammation and related diseases
  792. Beneficial effect of the flavonoid luteolin on neuroinflammation
  793. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation
  794. Benzimidazole Containing Acetamide Derivatives Attenuate neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration
  795. Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication
  796. Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice
  797. Beta-amyloid oligomers acutely induce memory deficits in association to tlr4-mediated neuroinflammation
  798. Bexarotent attenuated CCI-induced spinal neuroinflammation and neuropathic pain by targeting MKP-1
  799. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation
  800. Bibliometric Analysis of the Journal neuroinflammation
  801. Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors
  802. Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
  803. Bidirectional relationship of mast cells-neurovascular unit communication in neuroinflammation and its involvement in POCD
  804. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by …
  805. Biglycan regulates neuroinflammation by promoting M1 microglial activation in early brain injury after experimental subarachnoid hemorrhage
  806. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia
  807. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
  808. Bile Acid Metabolism is Altered in Multiple Sclerosis and Supplementation Leads to Amelioration of neuroinflammation (S55. 002)
  809. Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice
  810. Bioaccumulation and neuroinflammation of Gold Nanoparticles in the Central Nervous System
  811. Bioactive components from garlic on brain resiliency against neuroinflammation and neurodegeneration
  812. Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge
  813. Bioavailable curcumin alleviates lipopolysaccharide-induced neuroinflammation and improves cognition in experimental animals
  814. Biochemical Aspects of neuroinflammation
  815. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation
  816. Bioengineered 3D glial cell culture systems and applications for neurodegeneration and neuroinflammation
  817. Biology of neuroinflammation: A Common Denominator in Brain Pathologies
  818. Bioluminescence Imaging of neuroinflammation in a Mouse Model of Parkinson’s Disease
  819. Biomarkers For neuroinflammation And Satellite Glia Activation In Dry Eye Disease
  820. Biomaterials and glia: Progress on designs to modulate neuroinflammation
  821. Black Ginseng Extract Prevents neuroinflammation and Enhances Learning Behavior in Mice
  822. Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation
  823. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats
  824. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
  825. Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation
  826. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
  827. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus …
  828. Blood-Brain Barrier Disruption During neuroinflammation
  829. Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation
  830. Blood–Brain Barrier Transporters and neuroinflammation: Partners in Neuroprotection and in Pathology
  831. Blueberries Improve neuroinflammation and Cognition differentially Depending on Individual Cognitive baseline Status
  832. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
  833. BML-111 Reduces neuroinflammation and Cognitive Impairment in Mice With Sepsis via the SIRT1/NF-κB Signaling Pathway
  834. Bombycis excrementum reduces amyloid-β oligomer-induced memory impairments, neurodegeneration, and neuroinflammation in mice
  835. Bone Marrow Chimeras to Study neuroinflammation
  836. Bone marrow mesenchymal stem cells regulate TGF‐β to adjust neuroinflammation in postoperative central inflammatory mice
  837. Bone morphogenetic proteins in multiple sclerosis: role in neuroinflammation
  838. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke
  839. Botch protects neurons from ischemic insult by antagonizing Notch-mediated neuroinflammation
  840. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling
  841. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration
  842. Brain aromatase imaging in an acute neuroinflammation model using µPET and 11C-vorozole
  843. Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis
  844. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report
  845. Brain Consequences of Spinal Cord Injury with and without Neuropathic Pain: Translating Animal Models of neuroinflammation onto Human Neural Networks …
  846. Brain endothelial IL-1R1 mediates central IL-1 induced neuroinflammation and anxiety-like behavior
  847. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging
  848. Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier
  849. Brain injury, neuroinflammation and Alzheimer’s disease
  850. Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
  851. Brain Innate Immunity in the Regulation of neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
  852. Brain interleukin-15 in neuroinflammation and behavior
  853. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
  854. Brain metabolites and peripheral biomarkers associated with neuroinflammation in complex regional pain syndrome using [11C]-(R)-PK11195 positron emission …
  855. Brain Oxidative markers in stress: possible new drug targets against neuroinflammation
  856. Brain pericytes as mediators of neuroinflammation
  857. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users
  858. Brain-derived microparticles (BDMPs) contribute to neuroinflammation and Lactadherin reduces BDMP induced neuroinflammation and improves outcome after stroke
  859. Brain-derived microparticles activate microglia/macrophages and induce neuroinflammation
  860. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation
  861. Brain-immune interactions and neuroinflammation after traumatic brain injury
  862. Brain‐derived neurotrophic factor fused with a collagen‐binding domain inhibits neuroinflammation and promotes neurological recovery of traumatic brain injury mice …
  863. Brazilian green propolis suppresses microglia-mediated neuroinflammation by inhibiting NF-kB activation
  864. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation
  865. Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity
  866. Bushen-Yizhi Formula Alleviates neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease
  867. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice
  868. BV-2 microglial cells used in a model of neuroinflammation
  869. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation
  870. C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation
  871. C/EBPβ and C/EBPδ in neuroinflammation
  872. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
  873. C5b‐9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection
  874. Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice
  875. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
  876. Caffeine and modafinil ameliorate the neuroinflammation and anxious behavior in rats during sleep deprivation by inhibiting the microglia activation
  877. Caffeine attenuates lipopolysaccharide-induced neuroinflammation
  878. Caffeine May Abrogate LPS-Induced Oxidative Stress and neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
  879. Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 in vivo and in vitro
  880. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain
  881. Calcineurin and glial signaling: neuroinflammation and beyond
  882. Calcineurin/nuclear factor-κB signaling mediates isoflurane-induced hippocampal neuroinflammation and subsequent cognitive impairment in aged rats
  883. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction
  884. Call for papers: Neurology: Neuroimmunology & neuroinflammation, a new Neurology journal
  885. CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation
  886. Can cocaine-induced neuroinflammation explain maladaptive cocaine-associated memories?
  887. Can GPCR, such as Kappa Opioid Receptor, be a Viable Therapeutic Target for Reducing or Preventing neuroinflammation
  888. Can neuroinflammation influence the development of autism spectrum disorders?
  889. Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort?
  890. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
  891. Can the emerging field of immunometabolism provide insights into neuroinflammation?
  892. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro
  893. Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression
  894. Cannabidiol Reduces Ab-Induced neuroinflammation and Promotes Hippocampal
  895. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
  896. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
  897. Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation
  898. Cannabinoid control of neuroinflammation related to multiple sclerosis
  899. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice
  900. Cannabinoid receptor 2 agonist reduces immune cell migration in neuroinflammation via inhibition of matrix metalloproteinase-9
  901. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model
  902. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation
  903. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental …
  904. Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in …
  905. Cannabinoids and innate immunity: taking a toll on neuroinflammation
  906. Cannabinoids and neuroinflammation
  907. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
  908. Cannabinoids for the treatment of neuroinflammation
  909. Cannabinoids in health and disease: Pharmacological potential in metabolic syndrome and neuroinflammation
  910. Cannabis sativa L. constituents and their role in neuroinflammation
  911. Canonical Transient Receptor Potential Channel 3 Contributes to Febrile Seizure Inducing Neuronal Cell Death and neuroinflammation
  912. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation
  913. CAP37: A Marker of neuroinflammation
  914. Cardiotonic steroids as modulators of neuroinflammation
  915. Care Giving As a Chronic Psychosocial Distress: neuroinflammation Trajectory
  916. Caruifolin D from Artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB …
  917. Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells
  918. Cas9 Ribonucleoprotein complex delivery: methods and applications for neuroinflammation
  919. Caspase inhibition in neuroinflammation induced by soluble β amyloid monomer, protects cells from abnormal survival and proliferation, via attenuation of NFқB …
  920. Caspase inhibitors may attenuate opioid-induced hyperalgesia and tolerance via inhibiting microglial activation and neuroinflammation
  921. Caspases playing in the field of neuroinflammation: old and new players
  922. Catechin supressed LPS-induced neuroinflammation in BV-2, C6 and NG108-15 cells by modulating CCL21 through PI3K-Akt
  923. Cathepsin C aggravates neuroinflammation involved in disturbances of behaviour and neurochemistry in acute and chronic stress-induced murine model of …
  924. Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis
  925. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system
  926. Caveolin1 is required for Th1 cell infiltration, but not tight junction remodeling, at the blood-brain barrier in autoimmune neuroinflammation
  927. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammationCCDC88B regulates neuroinflammation
  928. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
  929. CCL2 disrupts the adherens junction: implications for neuroinflammation
  930. CCR1 Activation Promotes neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
  931. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward
  932. CD11chi Dendritic Cells Regulate Ly-6Chi Monocyte Differentiation to Preserve Immune-privileged CNS in Lethal neuroinflammation
  933. CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1
  934. CD200 negatively regulates β-amyloid-induced microglial activation and neuroinflammation in vivo and in vitro
  935. CD38 and CD157 Expression: Glial Control of Neurodegeneration and neuroinflammation
  936. CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV‐1 brain infection
  937. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia
  938. CD4+ NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation
  939. CD40-CD40 ligand pathway is a major component of acute neuroinflammation and contributes to long-term cognitive dysfunction after sepsis
  940. CD49d/CD29‐integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation
  941. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation
  942. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration
  943. Celecoxib Prevents Cognitive Impairment and neuroinflammation
  944. Celecoxib prevents cognitive impairment and neuroinflammation in soluble amyloid β-treated rats
  945. Cell-Derived Microparticles/Exosomes in neuroinflammation
  946. Cell-selective gene ablation as a tool to resolve site-specific roles of CCL2 at the blood-brain barrier during neuroinflammation
  947. Cellular and Molecular Mechanisms of neuroinflammation in Epilepsy
  948. Cellular and molecular mediators of neuroinflammation in Alzheimer disease
  949. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease
  950. Cellular aspect of neuroinflammation in Guillain-Barre syndrome: a key to a new therapeutic option?
  951. Cellular components of neuroinflammation—an introduction
  952. Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide
  953. cellular Inhibitor of Apoptosis Protein2–A critical regulator of neuroinflammation
  954. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model
  955. Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury
  956. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
  957. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice
  958. Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?
  959. Central modulation of neuroinflammation by neuropeptides and energy-sensing hormones during obesity
  960. Central nervous system parasitosis and neuroinflammation ameliorated by systemic IL-10 administration in trypanosoma brucei-infected mice
  961. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin
  962. Central nervous system stromal cells control local CD8+ T cell responses during virus-induced neuroinflammation
  963. Central neuroinflammation in Cerebral Ischemia: The Role of Glia
  964. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein
  965. Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation
  966. Cerebral FDG PET CT in pediatric neuroinflammation: an exploration in the application of statistical parametric mapping
  967. Cerebral focal neuroinflammation after acute stroke: Preliminary study with 18F-DPA-714
  968. Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
  969. Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic …
  970. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice
  971. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice
  972. Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats
  973. Cerebrospinal Fluid Biomarkers of neuroinflammation and Axonal Degeneration in Patients with Multiple Sclerosis
  974. Cerebrospinal Fluid Markers in neuroinflammation: The Paradigm of Optic Neuritis
  975. Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
  976. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture
  977. Cerebrovascular remodeling and neuroinflammation is a late effect of radiation-induced brain injury in non-human primates
  978. Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation
  979. cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition
  980. Changes in brain oxysterols at different stages of Alzheimer’s disease: Their involvement in neuroinflammation
  981. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ
  982. Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
  983. Characterization and modulation of immunoregulatory molecules in neuroinflammation
  984. Characterization of 11C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation
  985. Characterization of a novel acetamidobenzoxazolone‐based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain
  986. Characterization of a rat model to study acute neuroinflammation on histopathological, biochemical and functional outcomes
  987. Characterization of an in vivo model of neuroinflammation and evaluation of the anti-inflammatory and neuroprotective effects of curcumin as a potential lead …
  988. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation
  989. Characterization of MCAM contribution to neuroinflammation using a new murine knockout model
  990. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
  991. Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with disc herniation and degenerative disc disease
  992. Characterization of platelet–monocyte complexes in HIV-1–infected individuals: Possible role in HIV-associated neuroinflammation
  993. Characterization of rTg4510 mice yields evidence of significant neuroinflammation
  994. Characterization of the early neuroinflammation after spinal cord injury in mice
  995. Characterization of the lipopolysaccharide induced model of Parkinson’s disease: Role of oxidative stress and neuroinflammation
  996. Characterization of the Role of Nicotine and Delta 9-THC in Modulation of neuroinflammation
  997. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation
  998. Charcot‐Marie‐Tooth disease and neuroinflammation
  999. Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats
  1000. Chemical Biology Probes for Extracellular Vesicles Facilitate Studies of neuroinflammation
  1001. Chemical Elements and Oxidative Status in neuroinflammation
  1002. Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors
  1003. Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?
  1004. Chemokine receptor expression and function in experimental autoimmune neuroinflammation
  1005. Chemokine receptors in neuroinflammation
  1006. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning
  1007. Chemokines and chemokine receptors: multipurpose players in neuroinflammation
  1008. Chemokines and cytokines in neuroinflammation leading to neuropathic pain
  1009. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation
  1010. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
  1011. CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study
  1012. Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation
  1013. Childhood Autoimmune and neuroinflammation-Related Epilepsies
  1014. Chitinases, neuroinflammation and biomarkers in ALS
  1015. Cholinergic protection via α7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation
  1016. Cholinergic system and neuroinflammation: implication in multiple sclerosis
  1017. Chronic alcohol-induced liver injury correlates with memory deficits: Role for neuroinflammation
  1018. Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice
  1019. Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease
  1020. Chronic Binge Alcohol-Associated Differential Brain Region Modulation of Growth Factor Signaling Pathways and neuroinflammation in Simian Immunodeficiency …
  1021. Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice
  1022. Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
  1023. Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23
  1024. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia
  1025. Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice
  1026. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer’s disease without inducing overt neurodegeneration
  1027. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
  1028. Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice
  1029. Chronic Intermittent Hypoxia-Induced neuroinflammation Undermines Respiratory Motor Plasticity After Chronic Incomplete Cervical Spinal Cord Injury
  1030. Chronic intra-ocular pressure induces neuroinflammation in retina and cerebral structures in an ocular hypertensive rat model
  1031. Chronic intracerebral LPS as a model of neuroinflammation
  1032. Chronic lithium administration attenuates up‐regulated brain arachidonic acid metabolism in a rat model of neuroinflammation
  1033. Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation
  1034. Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?
  1035. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling (877.1)
  1036. Chronic neuroinflammation impacts the recruitment of adult-born neurons into behaviorally relevant hippocampal networks
  1037. Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
  1038. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease
  1039. Chronic neuroinflammation underlying pathogenesis of Alzheimer’s disease
  1040. Chronic neuroinflammation: Contribution of IL-1β to Prostaglandin Production and Alzheimer’s Disease Pathology
  1041. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation
  1042. Chronic noise exposure acts cumulatively to exacerbate Alzheimer’s disease-like amyloid-β pathology and neuroinflammation in the rat hippocampus
  1043. Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces neuroinflammation, Oxidative Stress, and Glutamate Levels in A …
  1044. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia
  1045. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood–brain barrier integrity
  1046. Chronic traumatic stress impairs memory in mice: potential roles of acetylcholine, neuroinflammation and corticotropin releasing factor expression in the hippocampus
  1047. Chronic treatment with combined chemotherapeutic agents affects hippocampal micromorphometry and function in mice, independently of neuroinflammation
  1048. Chronic viral neuroinflammation: speculation on underlying mechanisms
  1049. Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson’s disease mouse model
  1050. Ciproxifan improves cholinergic transmission, attenuates neuroinflammation and oxidative stress but does not reduce amyloid level in transgenic mice
  1051. Circadian clock protein Rev-erbα regulates neuroinflammation
  1052. Circadian control of pain and neuroinflammation
  1053. Circadian rhythms, neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
  1054. Clarifying the Role of Microglia Versus Macrophages in Facilitating neuroinflammation Surrounding Intracortical Microelectrodes
  1055. CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality
  1056. Clec7a is a Potential Target to Relieve Neuropathic Pain via Inhibiting neuroinflammation Activation Through Regulating TLR4 Expression
  1057. CLG from Hemp Seed Inhibits LPS-Stimulated neuroinflammation in BV2 Microglia by Regulating NF-κB and Nrf-2 Pathways
  1058. Clinical clues for autoimmunity and neuroinflammation in patients with autistic regression
  1059. Clinical Features and Outcomes of Patients with Status Epilepticus Caused by neuroinflammation (P2. 5-019)
  1060. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming
  1061. Clofibrate, a PPAR‐α agonist, abrogates sodium fluoride‐induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba‐1/anti …
  1062. CNI-1493 Attenuates neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson’s Disease
  1063. CNS immune surveillance and neuroinflammation: endocannabinoids keep control
  1064. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature
  1065. CNS TLR2 mediates innate neuroinflammation but not autoimmune pathogenesis and demyelination
  1066. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation
  1067. Cobalt (II) β-ketoaminato complexes as novel inhibitors of neuroinflammation
  1068. Cocaine mediated neuroinflammation: role of dysregulated autophagy in pericytes
  1069. Cocaine self‐administration is increased after frontal traumatic brain injury and associated with neuroinflammation
  1070. Cofilin Knockdown Attenuates Collagenase-Induced ICH Injury in Mice by Combating Oxidative stress and Modulating neuroinflammation
  1071. Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
  1072. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration
  1073. Cognitive trajectory of patients in the recovery period after ischemic stroke: role of neuroinflammation and structural cerebral factors
  1074. Cold-inducible RNA-binding protein mediates neuroinflammation in cerebral ischemia
  1075. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease
  1076. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
  1077. COMBINED ADMINISTRATION OF AN A2A RECEPTOR ANTAGONIST AND A 5-HT1A/1B RECEPTOR AGONIST REVERSES neuroinflammation IN THE 6 …
  1078. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers
  1079. Combining ceftriaxone with doxycycline and daptomycin reduces mortality, neuroinflammation, brain damage, and hearing loss in infant rat pneumococcal meningitis
  1080. Commentary (Complement-Initiated neuroinflammation and Its Role in Early Stage Alzheimer’s Disease)
  1081. Commentary: Important considerations on bone morphogenetic protein-2 and neuroinflammation
  1082. Commentary: Low-Grade Non-Resolving neuroinflammation: Age Does Matter
  1083. Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of …
  1084. Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study
  1085. Communication between enteric neurons, glia, and nociceptors underlies the effects of tachykinins on neuroinflammation
  1086. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation
  1087. Comparative evaluation of three TSPO PET radiotracers in a LPS-induced model of mild neuroinflammation in rats
  1088. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
  1089. Comparison of [18F] FEPPA and [11C] PBR28, novel peripheral benzodiazepine receptor ligands for PET, in a rat model of neuroinflammation
  1090. Comparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhage
  1091. Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice
  1092. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
  1093. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep …
  1094. Complement in neuroinflammation
  1095. Complement in neuroinflammation: Studies in Leprosy and Amyotrophic Lateral Sclerosis
  1096. Complement, neuroinflammation and neuronal degeneration in Alzheimer disease
  1097. Compounds acting on the renin-angiotensin-aldosterone system as potential regulators of autoimmune neuroinflammation
  1098. Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer’s disease
  1099. Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation
  1100. Connecting metainflammation and neuroinflammation through the PTN-MK-RPTPβ/ζ axis: Relevance in therapeutic development
  1101. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases
  1102. Connexin43-and pannexin-based channels in neuroinflammation and cerebral neuropathies
  1103. Construction and optimization of novel recombinant Adeno-Associated Virus rAAV2/5 for targeting microglia to regulate immune responses during neuroinflammation
  1104. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice
  1105. Contribution of C5aR1 to neuroinflammation and Neuronal Dysfunction in Alzheimer’s Disease
  1106. Contribution of Dietary Fat in neuroinflammation
  1107. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases
  1108. Contribution of microglia‐mediated neuroinflammation to retinal degenerative diseases
  1109. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions
  1110. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use
  1111. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
  1112. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
  1113. Contribution of neuroinflammation to the development of Alzheimer’s disease-like pathology in OXYS rats
  1114. Contribution of neuroinflammation to the pathogenesis of cancer cachexia
  1115. Contribution of Receptors, Transcription Factors, and Genes in the Induction of neuroinflammation
  1116. Contribution of Schwann cells to remyelination in a naturally occurring canine model of CNS neuroinflammation
  1117. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
  1118. Control of neuroinflammation for Therapeutic Gain
  1119. Controlling the activation of the B v8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
  1120. CONTROLLING THE ACTIVATION OF THE PROKINETICIN SYSTEM REDUCES neuroinflammation AND ABOLISHES PAIN HYPERSENSITIVITY IN …
  1121. Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation
  1122. Convergence between microglia and peripheral macrophages phenotype during development and neuroinflammation
  1123. Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination
  1124. Core-cross-linked nanoparticles reduce neuroinflammation and improve outcome in a mouse model of traumatic brain injury
  1125. Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-κB and STAT3
  1126. Correction to Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like …
  1127. Correction to In Vivo Imaging of Human neuroinflammation
  1128. Correction to: Cathepsin C Aggravates neuroinflammation Involved in Disturbances of Behaviour and Neurochemistry in Acute and Chronic Stress-Induced Murine …
  1129. Correction to: TREM2 Attenuates Aβ1-42-Mediated neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
  1130. Correction: Acetylcholinesterase Inhibitors Reduce neuroinflammation and-Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model
  1131. Correction: Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of neuroinflammation
  1132. Correction: Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral …
  1133. Correction: Imatinib Ameliorates neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral …
  1134. Correction: P-Glycoprotein Acts as an Immunomodulator during neuroinflammation
  1135. Correction: Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote neuroinflammation
  1136. Correction: Tau Overexpression Impacts a neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
  1137. Correlation of CSF and plasma antioxidative capacity in patients with different clinical phenotypes of neuroinflammation and clinical and radiological findings
  1138. Correlations between blood–brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury
  1139. Corrigendum to “Characterization of MCAM contribution to neuroinflammation using a new murine knockout model”[J. Neuroimmunol., 275 (1–2)(2014) 143]
  1140. Corrigendum to’Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of …
  1141. Corrigendum to” 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia”[BBRC 449 (2014) 8-13] …
  1142. Corrigendum to” Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease”[Brain …
  1143. Corrigendum to” Parkinson’s disease: Autoimmunity and neuroinflammation“[Autoimmun Rev 15 (10)(2016) 1005-1011].
  1144. Corrigendum to” Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder-A combined magnetic resonance imaging and positron emission …
  1145. Corrigendum to” α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a …
  1146. Corrigendum: neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
  1147. Corrigendum: Versatility of the complement system in neuroinflammation, neurodegeneration, and brain homeostasis
  1148. Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats
  1149. Cortical Neuron-Derived Exosomal MicroRNA-181c-3p Inhibits neuroinflammation by Downregulating CXCL1 in Astrocytes of a Rat Model with Ischemic Brain Injury
  1150. Corticosterone and pyridostigmine/DEET exposure attenuate peripheral cytokine expression: Supporting a dominant role for neuroinflammation in a mouse …
  1151. Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain
  1152. Corticosterone potentiates DFP-induced neuroinflammation and affects high-order diffusion imaging in a rat model of Gulf War Illness
  1153. Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research
  1154. Could probiotics be used to mitigate neuroinflammation?
  1155. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
  1156. COX-1 ACTIVITY PRECEDES THE COX-2 INDUCTION IN Aβ INDUCED neuroinflammation
  1157. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain
  1158. Crashing the computer: apoptosis vs. necroptosis in neuroinflammation
  1159. CREB is upregulated in hepatic encephalopathy and contributes to the neuroprotection against neuroinflammation
  1160. Critical function of myeloid SOCS3 is in limiting the neuroinflammation of EAE (147.21)
  1161. Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery
  1162. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
  1163. Cross-talk between glia, neurons and mast cells in neuroinflammation associated with Parkinson’s disease
  1164. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
  1165. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders
  1166. Crystallins and neuroinflammation: The glial side of the story
  1167. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells
  1168. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
  1169. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
  1170. CSF biomarkers related to sleep, cognition and neuroinflammation in patients with Kleine Levin Syndrome
  1171. Cu II (atsm) Attenuates neuroinflammation
  1172. Cues Guiding Leukocyte Transendothelial Migration across the Blood-Brain Barrier in neuroinflammation: Endothelial Heterogeneity, Chemokines, and …
  1173. CuII (atsm) Attenuates neuroinflammation
  1174. Curcumin Alleviates Lipopolysaccharide (LPS)-Activated neuroinflammation via Modulation of miR-199b-5p/IκB Kinase β (IKKβ)/Nuclear Factor Kappa B (NF …
  1175. Curcumin alleviates lipopolysaccharide-induced neuroinflammation in fetal mouse brain
  1176. Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors
  1177. Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer’s disease
  1178. Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
  1179. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of …
  1180. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells
  1181. Curcumin prevents acute neuroinflammation and long-term memory impairment induced by systemic lipopolysaccharide in mice
  1182. Curcumin protects axons from degeneration in the setting of local neuroinflammation
  1183. Curcumin reduces neuroinflammation stimulated by Aβ25-35 in primary rat microglial cells
  1184. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease
  1185. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
  1186. Current perspectives on the link between neuroinflammation and neurogenesis
  1187. Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine
  1188. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities
  1189. Cutting Edge: IL-27 Attenuates Autoimmune neuroinflammation via Regulatory T Cell/Lag3–Dependent but IL-10–Independent Mechanisms In Vivo
  1190. Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease
  1191. CX3CR1‐dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
  1192. CXCL12 in control of neuroinflammation
  1193. CXCL12-γ expression is inhibited in neuroinflammation
  1194. CXCL12: role in neuroinflammation
  1195. CXCL5 signaling is a shared pathway of neuroinflammation and blood–brain barrier injury contributing to white matter injury in the immature brain
  1196. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF‐κB‐signaling pathway in mice with ischemic …
  1197. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
  1198. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation
  1199. CXCR2 signaling regulates neuroinflammation in models of viral and autoimmune-induced neurodegenerative disease
  1200. CXCR3 promotes cerebellar inflammation but prevents ocular destruction in transgenic mice with a TH1-driven neuroinflammation
  1201. Cyanidin attenuates Aβ 25-35-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells
  1202. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage …
  1203. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage polarization at …
  1204. Cyclin dependent kinase‐11, neuroinflammation and Alzheimer’s disease: a review
  1205. Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation
  1206. Cyclooxygenase and neuroinflammation in Parkinson’s disease neurodegeneration
  1207. Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation
  1208. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
  1209. Cyclooxygenase-2-dependent neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension following chronic …
  1210. CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice
  1211. Cystatin F involvement in adenosine A 2A receptor-mediated neuroinflammation in BV2 microglial cells
  1212. Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation
  1213. Cytoglobin attenuates neuroinflammation in lipopolysaccharide-activated primary preoptic area cells via NFkB pathway inhibition
  1214. Cytokine adaptations to repeated ethanol exposure and the role of internal and external cues in ethanol-driven neuroinflammation
  1215. Cytokine Dynamics, Diagnosis and Treatment of neuroinflammation In Chronic Constriction Injury Rat Model
  1216. Cytokine networks in neuroinflammation
  1217. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2
  1218. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain
  1219. Cytokines as mediators of neuroinflammation in experimental autoimmune encephalomyelitis
  1220. Cytokines in neuroinflammation and Alzheimer’s disease
  1221. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
  1222. Cytotoxicity of acute neuroinflammation induced by lipopolysaccharide can be attenuated by ginkgolide B
  1223. CZ2HF mitigates β-amyloid 25-35 fragment-induced learning and memory impairment through inhibition of neuroinflammation and apoptosis in rats
  1224. D-4F increases microRNA-124a and reduces neuroinflammation in diabetic stroke rats
  1225. D27 neuroinflammation and changes in serotonin metabolism in presymptomatic HD gene carriers: a dual tracer positron emission tomography (PET) study
  1226. Daily Administration of Ibuprofen Modifies neuroinflammation Gene Expression, but not Neuroplasticity Gene Expression in Traumatic Brain Injured Rats
  1227. Dampening neuroinflammation
  1228. Dangguishaoyao-san attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway
  1229. Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation
  1230. DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells
  1231. Dcf1 deficiency attenuates the role of activated microglia during neuroinflammation
  1232. DE NOVO NAD+ SYNTHESIS RESCUES neuroinflammation AND ALZHEIMER’S DISEASE PHENOTYPES: MODULATING IMMUNE CELL RESPONSES AND …
  1233. Debate:“is increasing neuroinflammation beneficial for neural repair?”
  1234. DECIPHERING THE ROLE OF neuroinflammation IN THE EARLY EVENTS OF ALZHEIMER’S DISEASE
  1235. Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer’s …
  1236. Decrease in neuroinflammation after immunisation with synthetic prion peptides in an animal model of scrapie
  1237. Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced neuroinflammation via TNFAIP3-Mediated NF-κB …
  1238. Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated …
  1239. Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti …
  1240. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide
  1241. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease
  1242. Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy
  1243. Deep hypothermia therapy attenuates LPS-induced microglia neuroinflammation via the STAT3 pathway
  1244. Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex
  1245. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
  1246. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction
  1247. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice
  1248. Deficiency of tPA Exacerbates White Matter Damage, neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice
  1249. Deficiency of TREK-1 potassium channel exacerbates blood-brain barrier damage and neuroinflammation after intracerebral hemorrhage in mice
  1250. Deficiency of α1, 6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators
  1251. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy
  1252. Defining “neuroinflammation” Lessons from MPTP‐and Methamphetamine‐Induced Neurotoxicity
  1253. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
  1254. Defining the role of IL-23 in autoimmune neuroinflammation
  1255. Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice
  1256. Definition of genetic and pathogenic mechanisms regulating neuroinflammation
  1257. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation
  1258. Degenerative joint diseases and neuroinflammation
  1259. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury
  1260. Deletion of CD38 suppresses glial activation and neuroinflammation in a mouse model of demyelination
  1261. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of neuroinflammation by STAT6-dependent M2 microglial inactivation in …
  1262. Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice
  1263. Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation
  1264. Deletion of μ-Opioid Receptor in Mice Alters the Development of Acute neuroinflammation
  1265. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury
  1266. Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African …
  1267. Demyelinating Diseases and neuroinflammation
  1268. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation
  1269. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model
  1270. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration
  1271. Dendrimer-based targeted systemic therapies for neuroinflammation in CNS disorders
  1272. Dendrimer-Fluocinolone Acetonide Nanodevices Supress Retinal neuroinflammation and Are Neuroprotective in RCS Rats
  1273. Dendritic cells as therapeutic targets in neuroinflammation
  1274. Dendritic cells, CD4+ T cells, and α synuclein triangle fuels neuroinflammation in Parkinson’s disease (P3. 053)
  1275. Dental Pulp Stem Cell-Derived Factors Alleviate Subarachnoid Hemorrhage-Induced neuroinflammation and Ischemic Neurological Deficits
  1276. Department of neuroinflammation, Institute of Neurology, Queen Square, London, UK
  1277. Depression comorbid with hyperalgesia: Different roles of neuroinflammation induced by chronic stress and hypercortisolism
  1278. Depression-like behavior, hyperglycemia, oxidative stress, and neuroinflammation presented in diabetic mice are reversed by the administration of 1-methyl-3 …
  1279. Depression-like behaviors and heme oxygenase-1 are regulated by Lycopene in lipopolysaccharide-induced neuroinflammation
  1280. Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation
  1281. Design of a Novel PAMAM-Based Nanomedicine with Sustained NAC Release for Treatment of neuroinflammation
  1282. Design of antioxidant nanotherapeutics for attenuation of atherogenesis and neuroinflammation
  1283. Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including …
  1284. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
  1285. Designing of multi-target-directed ligands against the enzymes associated with neuroinflammation: an in silico approach
  1286. Detecting neuroinflammation Following Traumatic Brain Injury: Novel Quantitative, Multianalyte Immunoassay Improves Detection
  1287. Detecting neuroinflammation in the brain following chronic alcohol exposure in rats: A comparison between in vivo and in vitro TSPO radioligand binding
  1288. Detecting neuroinflammation with molecular MRI
  1289. Detection of cytotoxic activation of microglia in a rat neuroinflammation model using a novel translocator protein ligand,[18F] FEPPA
  1290. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180
  1291. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation
  1292. Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [18 F] DPA-714 imaging
  1293. Detection of neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging
  1294. Detection of Zika virus (ZIKV)-induced neuroinflammation in a murine infection model with translocator protein (TSPO) ligand 3H-PK11195
  1295. Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation
  1296. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
  1297. Detrimental effects of HMGB-1 require microglial-astroglial interaction: Implications for the status epilepticus-induced neuroinflammation
  1298. Developing a Novel In-Vitro neuroinflammation Model for Huntington’s Disease
  1299. Development and characterisation of a novel NF-κB reporter cell line for investigation of neuroinflammation
  1300. DEVELOPMENT AND ELUCIDATION OF MECHANISM OF ACTION OF NEW LEADS TO ATTENUATE neuroinflammation IN STROKE MODEL
  1301. Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With neuroinflammation
  1302. Development of a human innervated tissue engineered skin for the study of neuroinflammation
  1303. Development of a methodology for monitoring spinal neuroinflammation mechanisms in the neuropathic rat in vivo
  1304. Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model
  1305. Development of a positron emission tomography radiotracer for imaging elevated levels of superoxide in neuroinflammation
  1306. Development of an in vitro model of neuroinflammation for studying secondary injury mechanisms in traumatic brain injury
  1307. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of …
  1308. Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of neuroinflammation
  1309. Development of PET neuroimaging methods for stroke and neuroinflammation
  1310. Development of rodent in vivo models: neuroinflammation and neurodegeneration relevant to Alzheimer’s disease
  1311. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
  1312. Developmental neuroinflammation and schizophrenia
  1313. Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells
  1314. Dexmedetomidine Attenuates neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340
  1315. Dexmedetomidine Inhibits neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway
  1316. Dexmedetomidine mitigates microglia-mediated neuroinflammation through upregulation of programmed cell death protein 1 in a rat spinal cord injury model
  1317. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury
  1318. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK
  1319. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia
  1320. Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway
  1321. Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation
  1322. Diagnostic approaches and outcomes in patients with neuroinflammation
  1323. Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In Vivo
  1324. DICAM: A novel molecular effector in neuroinflammation
  1325. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice
  1326. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity
  1327. Diet induced neuroinflammation and cognitive decline
  1328. Diet-induced cellular neuroinflammation in the hypothalamus: Mechanistic insights from investigation of neurons and microglia
  1329. Diet-Induced neuroinflammation: Microgliosis Due to Binge Eating
  1330. Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
  1331. Diet-induced obesity and low testosterone interact to increase neuroinflammation and reduce neuron survival
  1332. Diet-induced obesity prolongs neuroinflammation and recruits CCR2+ monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice
  1333. Dietary Acetate Supplementation Attenuates neuroinflammation
  1334. Dietary and donepezil modulation of mTOR signaling and neuroinflammation in the brain
  1335. Dietary broccoli mildly improves neuroinflammation in aged mice but does not reduce lipopolysaccharide-induced sickness behavior
  1336. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
  1337. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model
  1338. Dietary magnesium and copper affect survival time and neuroinflammation in chronic wasting disease
  1339. Dietary Restriction and neuroinflammation: A Potential Mechanistic Link
  1340. Dietary Saturated Fatty Acids Promote Differentiation of Th1 and Th17 Cells And Aggravate neuroinflammation (P6. 149)
  1341. Dietary Spray-Dried Porcine Plasma Prevents Cognitive Decline in Senescent Mice and Reduces neuroinflammation and Oxidative Stress
  1342. Dietary Supplementation of the Antioxidant Curcumin Halts Systemic LPS-Induced neuroinflammation-Associated Neurodegeneration and Memory/Synaptic …
  1343. Dietary supplementation with α-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus
  1344. Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced …
  1345. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model
  1346. Differential effects of blueberry polyphenols on age-associated neuroinflammation and cognition.
  1347. Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus
  1348. Differential effects of propofol and dexmedetomidine on neuroinflammation induced by systemic endotoxin lipopolysaccharides in adult mice
  1349. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson’s disease
  1350. Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism
  1351. Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF β and IL 6
  1352. Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats
  1353. Differentiation and transmigration of CD4 T cells in neuroinflammation and autoimmunity
  1354. Digested raspberries polyphenols for brain health: attenuation of neuroinflammation
  1355. Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat
  1356. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation
  1357. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP/PS 1 transgenic mice
  1358. Dihydromyricetin protects against cerebral ischemia/reperfusion injury via suppressing microglia-mediated neuroinflammation and activation of ERK1/2-CREB …
  1359. Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury
  1360. Dimethyl fumarate limits neuroinflammation and oxidative stress and improves cognitive impairment after polymicrobial sepsis
  1361. Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
  1362. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice
  1363. Direct Test for neuroinflammation with [11C] DAP-713-PET Scanning
  1364. Direct Test for neuroinflammation with [11C] DPA-713-PET Scanning
  1365. Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
  1366. Discovery of 2‐(3, 4‐dialkoxyphenyl)‐2‐(substituted pyridazin‐3‐yl) acetonitriles as phosphodiesterase 4 inhibitors with anti‐neuroinflammation potential based on …
  1367. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson’s …
  1368. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non …
  1369. Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation
  1370. Disease-induced neuroinflammation and depression
  1371. Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice
  1372. Dissecting the complex landscape of neuroinflammation at single-cell resolution
  1373. Dissociation of frontotemporal dementia–related deficits and neuroinflammation in progranulin haploinsufficient mice
  1374. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice
  1375. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip
  1376. Distinct contributions of hyperglycemia and high-fat feeding in metabolic syndrome-induced neuroinflammation
  1377. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
  1378. Distinct role of Glutaminyl Cyclases (QCs) in inflammation/neuroinflammation: First results from QC and isoQC knock out mice
  1379. Distribution of different isoforms of receptor protein tyrosine phosphatase γ (Ptprg-RPTP γ) in adult mouse brain: upregulation during neuroinflammation
  1380. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis
  1381. Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice
  1382. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia
  1383. Dl-3-n-butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation
  1384. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington’s mice (R6/2) reveals neuroinflammation and insulin associations
  1385. DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in neuroinflammation Multiple Sclerosis Model
  1386. Docosahexaenoic acid (DHA) in stroke, Alzheimer’s disease, and blinding retinal degenerations: coping with neuroinflammation and sustaining cell survival
  1387. Docosahexaenoic acid decreased neuroinflammation in rat pups after controlled cortical impact
  1388. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative …
  1389. Doenjang, A Korean Traditional Fermented Soybean Paste, Ameliorates neuroinflammation and Neurodegeneration in Mice Fed a High-Fat Diet
  1390. Does Anticholinergic Activity Affect Neuropathology Implication of neuroinflammation in Alzheimer’s Disease
  1391. DOES MEDITERRANEAN DIET CONFER NEUROPROTECTION AGAINST neuroinflammation AND RELATED DISEASES? AN OVERVIEW
  1392. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
  1393. Does neuroinflammation fan the flame in neurodegenerative diseases?
  1394. Does neuroinflammation induce systemic aging?
  1395. Does neuroinflammation sustain neurodegeneration in ALS?
  1396. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1397. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1398. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1399. Does the interplay between aging and neuroinflammation modulate Alzheimer’s disease clinical phenotypes? A clinico-pathological perspective
  1400. Dopaminochrome induces neuroinflammation in the substantia nigra of Sprague Dawley rats
  1401. Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation
  1402. Double-negative T cells remarkably promote neuroinflammation after ischemic stroke
  1403. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
  1404. Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence …
  1405. Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain.
  1406. Doxycycline counteracts neuroinflammation restoring memory in Alzheimer’s disease mouse models
  1407. Doxycycline for Alzheimer’s disease: fighting β-amyloid oligomers and neuroinflammation
  1408. Drug Abuse-Related neuroinflammation in Human Postmortem Brains: An Immunohistochemical Approach
  1409. Drug development for Alzheimer’s disease: microglia induced neuroinflammation as a target?
  1410. Drug-and cell-based therapies for targeting neuroinflammation in traumatic brain injury
  1411. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1
  1412. Dual bioactivity of resveratrol fatty alcohols: differentiation of neural stem cells and modulation of neuroinflammation
  1413. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
  1414. Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a Rodent model of Parkinson’s disease
  1415. Dual Inhibitors of ROCK I and NOX to Attenuate neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening
  1416. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence
  1417. Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis
  1418. Dual role of vitamin C on the neuroinflammation mediated neurodegeneration and memory impairments in colchicine induced rat model of Alzheimer disease
  1419. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
  1420. Dual Targeting of Amyloid-beta Clearance and neuroinflammation as a Novel Therapeutic Approach against Alzheimer’s Disease
  1421. Dual therapeutic effects of C-10068, a dextromethorphan derivative, against post-traumatic nonconvulsive seizures and neuroinflammation in a rat model of …
  1422. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood–brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis
  1423. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α …
  1424. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences
  1425. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation
  1426. Dynamic visualization of neuroinflammation in multiple sclerosis animal model with animal positron emission tomography
  1427. Dynamically Monitor neuroinflammation in a Mouse Model of Mo/Hu APPswePS1dE9 Mice with [18F]-DPA714 PET Imaging
  1428. Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns
  1429. Dynamics of Regulatory T Cell-Mediated Control of Antigen Responses and Autoimmune neuroinflammation
  1430. Dysfunction of brain pericytes in chronic neuroinflammation
  1431. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration
  1432. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
  1433. Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment
  1434. Dysregulation of intestinal IL17 signaling & the microbiome exacerbate autoimmune neuroinflammation.
  1435. Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders
  1436. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson’s disease
  1437. Early detection of neuroinflammation in p25 inducible mouse model
  1438. Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury
  1439. Early enteral feeding reduces sepsis response and neuroinflammation in a pig model of neonatal bloodstream infection
  1440. Early gene activation initiates neuroinflammation prior to VSV neuroinvasion: Impact on antiviral responses and sleep
  1441. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model
  1442. Early immune response in MPTP-induced neuroinflammation in the mouse myenteric plexus and central nervous system
  1443. Early intervention with ABA prevents neuroinflammation and memory impairment in a triple transgenic mice model of Alzheimer´ s disease
  1444. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
  1445. Early minocycline and late FK506 treatment improves survival and alleviates neuroinflammation, neurodegeneration, and behavioral deficits in prion-infected …
  1446. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer’s disease triple transgenic mouse model
  1447. Early Treatment of Experimental Autoimmune Encephalomyelitis with Cannabidiol Suppresses Tc1 Cells and Reduces neuroinflammation
  1448. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic …
  1449. Eating as a motivated behavior: modulatory effect of high fat diets on energy homeostasis, reward processing and neuroinflammation
  1450. EBI2–Sensor for dihydroxycholesterol gradients in neuroinflammation
  1451. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
  1452. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1
  1453. Editor’s Perspective:“Connecting the Dots” from Blood Brain Barrier Dysfunction to neuroinflammation and Alzheimer’s Disease
  1454. Effect of adenovirus-mediated overexpression of PTEN on brain oxidative damage and neuroinflammation in a rat kindling model of epilepsy
  1455. Effect of agmatine on impairment of hippocampal neurogenesis and neuroinflammation in streptozotocin-induced diabetes in rats
  1456. Effect of anti-dementia drugs on LPS induced neuroinflammation in mice
  1457. Effect of antidepressant treatment on plasma levels of neuroinflammation‐associated molecules in patients with somatic symptom disorder with predominant pain …
  1458. Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis
  1459. Effect of Cafeteria Diet Induced Obesity on neuroinflammation in the Orbitofrontal Cortex
  1460. Effect of chronic stress in the onset of Parkinson’s disease: possible role of microglial cells in neuroinflammation
  1461. Effect of cigarette smoking on a marker for neuroinflammation: A [11 C] DAA1106 positron emission tomography study
  1462. Effect of Clostridium butyricum against Microglia‐Mediated neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabolites Butyrate
  1463. Effect of dimethyl fumarate on neuroinflammation and apoptosis in pentylenetetrazol kindling model in rats
  1464. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment …
  1465. Effect of IL-17A on lipopolysaccharide-induced neuroinflammation and fear conditioning test
  1466. Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage
  1467. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of …
  1468. Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi
  1469. Effect of low-dose cyclophosphamide, ACTH, and IVIg combination immunotherapy on neuroinflammation in pediatric-onset OMS: a retrospective pilot study
  1470. EFFECT OF MANGOSTEEN EXTRACT ON neuroinflammation IN RAT MODEL OF ACUTE TRAUMATIC BRAIN INJURY
  1471. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain
  1472. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
  1473. Effect of NALP1 inflammasome and Lipoxin in methamphetamine-induced on neuroinflammation in rats
  1474. Effect of neuroinflammation on ABC transporters: possible contribution to refractory epilepsy
  1475. Effect of neuroinflammation on Mitochondrial Quality Control Pathways in Parkinson’s Disease–Affected Neurons
  1476. Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative …
  1477. Effect of Novel ERβ Agonist in Controlling neuroinflammation and Apoptosis in Cerebral Ischemia in Rat Model
  1478. Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells
  1479. Effect of Q-VD-OPh on neurodegeneration and neuroinflammation of sarin-exposed mice (877.6)
  1480. Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κB pathways
  1481. Effect of stress on neuroinflammation in the substantia nigra and striatum of LRRK2 (R1441G) mouse model for Parkinson’s disease
  1482. Effect of systemic inflammation on rat attentional function and neuroinflammation: Possible protective role for food restriction
  1483. Effect of the Broad-Spectrum Caspase Inhibitor Q-VD-OPh on Neurodegeneration and neuroinflammation of Sarin Exposed Mice
  1484. Effect of the Lipid Peroxidation Product 4-Hydroxynonenal on neuroinflammation in Microglial Cells: Protective Role of Quercetin and …
  1485. Effect of Toxoplasma gondii on altering dopaminelevels and neuroinflammation contributing to an increased risk of developingschizophrenia
  1486. Effect of TRPC6 knock-out on the mouse neuroinflammation induced by MPTP
  1487. Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease
  1488. Effects of 900 MHz radiofrequency on corticosterone, emotional memory and neuroinflammation in middle-aged rats
  1489. Effects of a High-Fat Diet on neuroinflammation and Apoptosis in Acute Stage After Moderate Traumatic Brain Injury in Rats
  1490. Effects of a high-fat diet on the cerebrovasculature and neuroinflammation in an experimental model of Alzheimer’s disease
  1491. Effects of a standardized phenolic-enriched maple syrup extract on β-amyloid aggregation, neuroinflammation in microglial and neuronal cells, and β-amyloid induced …
  1492. Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation
  1493. Effects of bexarotene on neuroinflammation in an ad mouse model
  1494. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease
  1495. Effects of CDP-choline on macrophages and oligodendrocytes in neuroinflammation
  1496. Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of …
  1497. Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis
  1498. Effects of Clinacanthus nutans leaf extract on lipopolysaccharide-induced neuroinflammation in rats: A behavioral and 1H NMR-based metabolomics study
  1499. Effects of curcumin on neuroinflammation in animal models and in patients with Alzheimer disease
  1500. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of …
  1501. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson’s …
  1502. Effects of estrogen on expression of P2X7 receptor and neuroinflammation after subarachnoid hemorrhage in rats
  1503. Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation
  1504. Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation
  1505. EFFECTS OF GSK-3 INHIBITION ON LPS-INDUCED neuroinflammation AND IL-10 PRODUCTION IN MICROGLIA
  1506. Effects of human Adipose-derived Stem Cell and their secretome on neuropathic pain, neuroinflammation and peripheral cytokines in a preclinical model of diabetes
  1507. Effects of intermittent alcohol exposure on emotion and cognition: a potential role for the endogenous cannabinoid system and neuroinflammation
  1508. Effects of leonurine on intracerebral haemorrhage by attenuation of perihematomal edema and neuroinflammation via the JNK pathway
  1509. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats
  1510. Effects of LPLI on microglial phagocytosis in LPS-induced neuroinflammation model
  1511. Effects of Macrophage Migration Inhibitory Factors'(MIF) Inhibition on Chronic neuroinflammation
  1512. Effects of Mild Traumatic Brain Injury on Ethanol Consumption and the Combined Effects on neuroinflammation, Cognition, and Behavior in Mice
  1513. Effects of nanoparticles on neuroinflammation in a mouse model of asthma
  1514. Effects of neuroinflammation on glia–glia gap junctional intercellular communication: a perspective
  1515. Effects of neuroinflammation on neural stem cells
  1516. Effects of neuroinflammation on the regenerative capacity of brain stem cells
  1517. Effects of neuroinflammation on vascular dysfunction in Alzheimer’s disease
  1518. Effects of Ocrelizumab on Neurofilament Light Chain and Other Biomarkers of neuroinflammation and Neurodegeneration in MS: OBOE Study Design (P6. 337)
  1519. Effects of oral dimethyl fumarate on intestinal immune regulation in autoimmune neuroinflammation (P1. 164)
  1520. Effects of oxytocin on fear memory and neuroinflammation in a rodent model of posttraumatic stress disorder
  1521. Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings
  1522. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis
  1523. Effects of Rhei Undulati Rhizoma on lipopolysaccharide‐induced neuroinflammation in vitro and in vivo
  1524. Effects of RO27-3225 on neurogenesis, PDGFRβ+ cells and neuroinflammation after cerebral infarction
  1525. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer’s disease: studies in an S100B …
  1526. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation
  1527. Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats
  1528. Effects of syringic acid on chronic MPTP/probenecid induced motor dysfunction, dopaminergic markers expression and neuroinflammation in C57BL/6 mice
  1529. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats …
  1530. Effects of the Saturated Fatty Acid Palmitate on neuroinflammation,ER Stress, and Pomc mRNA Expression in Hypothalamic mHypoA-POMC/GFPNeurons
  1531. EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, neuroinflammation AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL
  1532. Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
  1533. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage
  1534. Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide
  1535. Electro-acupuncture alleviates chronic unpredictable stress-induced depressive-and anxiety-like behavior and hippocampal neuroinflammation in rat model …
  1536. Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke
  1537. Electroacupuncture alleviates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal neuroinflammation activated via microglia/TLRs pathway
  1538. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats
  1539. Electroacupuncture preconditioning and postconditioning inhibit apoptosis and neuroinflammation induced by spinal cord ischemia reperfusion injury through …
  1540. Electroacupuncture prevents cognitive impairment induced by lipopolysaccharide via inhibition of oxidative stress and neuroinflammation
  1541. Electroencephalography Findings in Autoimmune and neuroinflammation-Related Epilepsies
  1542. Elevated Brain MCP-1 Contributes to neuroinflammation in Hypertension
  1543. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy …
  1544. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and …
  1545. Elevated Neuroglobin Lessens neuroinflammation and Alleviates Neurobehavioral Deficits Induced by Acute Inhalation of Combustion Smoke in the Mouse
  1546. Elevation of USP4 antagonizes oxygen glucose deprivation/reoxygenation-evoked microglia activation and neuroinflammation-mediated neurotoxicity via the …
  1547. Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced neuroinflammation in a Rat Model of Parkinson’s
  1548. Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson’s disease
  1549. Elucidating the link between the modifiable risk factors of Alzheimer’s disease and neuroinflammation
  1550. Elucidation of relevant neuroinflammation mechanisms using gene expression profiling in patients with amyotrophic lateral sclerosis
  1551. Emerging CSF biomarkers of neuroinflammation, neuronal injury and synaptic integrity in the ADNI cohort
  1552. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO
  1553. Emerging role of diet and microbiota interactions in neuroinflammation
  1554. Emerging roles of protein kinases in microglia-mediated neuroinflammation
  1555. Emerging targets in neuroinflammation-driven chronic pain
  1556. Endocannabinoid degradation inhibition improves neurobehavioral function, blood–brain barrier integrity, and neuroinflammation following mild traumatic brain injury
  1557. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
  1558. Endocannabinoid modulation of TLR4-induced neuroinflammation: implications for autism spectrum disorders
  1559. Endocannabinoid regulation of amyloid-induced neuroinflammation
  1560. Endocrine influence on neuroinflammation: the use of reporter systems
  1561. Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral …
  1562. Endogenous sex steroids dampen neuroinflammation and improve outcome of traumatic brain injury in mice
  1563. Endoplasmic Reticulum Stress and neuroinflammation in the RVLM: A Novel Mechanism Related to Sympathoexcitation in Preserved Ejection Fraction Heart Failure
  1564. Endoplasmic Reticulum Stress Contributes to Nociception via neuroinflammation in a Murine Bone Cancer Pain Model.
  1565. Endoplasmic reticulum stress induction by an endogenous retrovirus glycoprotein during neuroinflammation: regulation by a free radical scavenger
  1566. Endothelin and Endothelin Receptors in Retinal neuroinflammation
  1567. Endotoxin-and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation
  1568. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
  1569. Enhanced network activity despite clinical recovery in experimental neuroinflammation using two-photon calcium imaging
  1570. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1
  1571. Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK …
  1572. Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid
  1573. Enlarged Perivascular Spaces Correlate With CSF Biomarkers for Abnormal Blood-brain Barrier Permeability and neuroinflammation in Patients With Vascular …
  1574. Enteric neuroinflammation Driven by Exposure to Pyridostigmine Bromide is a Possible Contributing Factor to Gulf War Illness
  1575. Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection
  1576. Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid β-protein oligomers
  1577. Enzyme Selective Flim in Microglia: Studying the Role of NADPH Oxidase in Chronic neuroinflammation
  1578. Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation
  1579. Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
  1580. Ephedra-Cinnamomi Attenuates Cerebral Ischemia-Induced neuroinflammation via TLR4/NF-κB Pathway
  1581. Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy
  1582. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma
  1583. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
  1584. Epigenetic regulation of neuroinflammation in the aged mouse brain
  1585. Epigenetics and the modulation of neuroinflammation
  1586. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype
  1587. Epstein–Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis
  1588. ER stress and neuroinflammation: connecting the unfolded protein response to JAK/STAT signaling (P5196)
  1589. ER stress: an initiator of neuroinflammation in Alzheimer’s disease?
  1590. Erigeron linifolius attenuates lipopolysachharide-induced depressive-like behavior in mice by impeding neuroinflammation, oxido-nitrosative stress, and …
  1591. Eriodictyol attenuates LPS-induced neuroinflammation, amyloidogenesis, and cognitive impairments via the inhibition of NF-κB in male C57BL/6J mice and BV2 …
  1592. Erratum to “Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults”[Alzheimer’s & Dementia 2018; 14: 1640-50.]
  1593. Erratum to: MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal …
  1594. Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
  1595. Erratum: Corrigendum to “Parkinson’s disease: Autoimmunity and neuroinflammation”(Autoimmunity Reviews (2016) 15 (10)(1005–1011)(S1568997216301677) …
  1596. Erratum: Corrigendum: Toll-like receptor 2 and poly (ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
  1597. Erratum: REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
  1598. Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation
  1599. Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
  1600. Erythrocytes’ antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation
  1601. Erythropoietin ameliorates neonatal hypoxia-ischemia-induced neurobehavioral deficits, neuroinflammation, and hippocampal injury in the juvenile rat
  1602. Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
  1603. Erythropoietin and CCL3 antagonise their functional properties during neuroinflammation
  1604. Esculentoside A suppresses Aβ1–42-induced neuroinflammation by down-regulating MAPKs pathways in vivo
  1605. ESE1 is associated with neuronal apoptosis in lipopolysaccharide induced neuroinflammation
  1606. Essay: TNF in neuroinflammation; what can be learned from TNF research in non-neuronal autoimmune diseases
  1607. Estradiol inhibits astrocytic GFAP expression in an animal model of neuroinflammation.
  1608. Estradiol inhibits ongoing autoimmune neuroinflammation and NFκB-dependent CCL2 expression in reactive astrocytes
  1609. Estrogen and neuroinflammation
  1610. Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in …
  1611. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration
  1612. Estrogen-dependent modulation of neuroinflammation in endometriosis
  1613. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration
  1614. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
  1615. Estrogens, neuroinflammation, and neurodegeneration
  1616. Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis
  1617. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats
  1618. Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice
  1619. Ethanol Exposure Induces Microglia Activation and neuroinflammation through TLR4 Activation and SENP6 Modulation in the Adolescent Rat Hippocampus
  1620. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB
  1621. Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice
  1622. Ethanol induced modulation of microglial P2X7 receptor expression and its role in neuroinflammation
  1623. Ethyl-acetate fraction of Trichilia catigua protects against oxidative stress and neuroinflammation after cerebral ischemia/reperfusion
  1624. Etidronate–zinc Complex Ameliorated Cognitive and Synaptic Plasticity Impairments in 2-Vessel Occlusion Model Rats by Reducing neuroinflammation
  1625. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection‐related epilepsy …
  1626. Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling
  1627. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity
  1628. Evaluating white matter changes and executive function in rat models of mediodorsal thalamic stroke and neuroinflammation
  1629. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis
  1630. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
  1631. Evaluation of [18F] DPA-716 in a rat model of neuroinflammation: Comparison with [11C] DPA-713 and [18F] DPA-714 radiotracer for the TSPO 18 kDa
  1632. Evaluation of [18F] PBR111 in a rat model of neuroinflammation: A new radiotracer for the TSPO 18 kDa (peripheral benzodiazepine receptor)
  1633. Evaluation of a novel positron emission tomographic radioligand to measure cyclooxygenase-2 in a model of neuroinflammation in rhesus macaque
  1634. Evaluation Of Anti-Inflammatory Nutraceuticals In Lps-Induced Mouse neuroinflammation Model: An Update.
  1635. Evaluation of Antiinflammatory Activity of 4′-О-Methylhonokiol Derivatives in a neuroinflammation Model
  1636. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation
  1637. Evaluation of neuroinflammation in amyotrophic lateral sclerosis with 18F-DPA-714
  1638. Evaluation of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) mice with animal PET and MRI
  1639. Evaluation of neuroinflammation in X-linked adrenoleukodystrophy
  1640. Evaluation of neuroprotective activity of carvacrol against neuroinflammation induced by chronic stress in mice
  1641. Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …
  1642. Evaluation of Novel PET ligands for Imaging neuroinflammation
  1643. Evaluation of Some Medicinal Plant Extracts against neuroinflammation Characterizing Alzheimer’s Disease in Experimental Rat Model
  1644. Evaluation of the effects of chlorpyrifos combined with lipopolysaccharide stress on neuroinflammation and spatial memory in neonatal rats
  1645. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
  1646. Evidence for neuroinflammation after myocardial infarction in a mouse model
  1647. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy
  1648. Evidence for neuroinflammation in Alzheimer’s disease
  1649. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal …
  1650. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET
  1651. Evidence of neuroinflammation in subgroups of schizophrenia and mood disorder patients: a semiquantitative postmortem study of CD3 and CD20 immunoreactive …
  1652. EVIDENCE OF neuroinflammation IN THE RETINA IN PRESYMPTOMATIC ALZHEIMER’S DISEASE
  1653. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model
  1654. Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia
  1655. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific
  1656. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system
  1657. Examining the Role of Gut Dysbiosis in neuroinflammation and Hypertension in a Model of Obstructive Sleep Apnea
  1658. Examining the role of neuroinflammation in major depression
  1659. Excess administration of miR-340-5p ameliorates spinal cord injury-induced neuroinflammation and apoptosis by modulating the P38-MAPK signaling pathway
  1660. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E
  1661. Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation
  1662. Exercise and neuroinflammation in health and disease
  1663. Exercise prevents enhanced postoperative neuroinflammation and cognitive decline and rectifies the gut microbiome in a rat model of metabolic syndrome
  1664. Exercise-induced modulation of neuroinflammation in models of Alzheimer’s disease
  1665. Exogenous melatonin restrains neuroinflammation in high fat diet induced diabetic rats through attenuating indoleamine 2, 3-dioxygenase 1 expression
  1666. Exosomes as mediators of neuron-glia communication in neuroinflammation
  1667. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury
  1668. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating …
  1669. Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation
  1670. EXPERIMENTAL INTESTINAL DYSBIOSIS IN RATS INCREASES THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER AND INDUCES neuroinflammation
  1671. Experimental neuroinflammation: a focus on mitochondria, oxygen and function
  1672. Experimental neuroinflammation: a study of hypoxia and protein translation
  1673. Experimental Pulmonary Hypertension Is Associated With neuroinflammation in the Spinal Cord
  1674. Exploration of Novel Ureidobenzothiazole Library Against neuroinflammation
  1675. Exploring COX-2 as a biomarker of microglia-dependent neuroinflammation
  1676. Exploring Glial Marker Activation and neuroinflammation in Schizophrenia: A multimodal Approach
  1677. Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids
  1678. Exploring the Effects of neuroinflammation on Microglial Cytoskeletal Proteins
  1679. Exploring the neuroprotective function of extracellular vesicles containing small heat-shock proteins (HSPB1 and HSPB8) upon neuroinflammation
  1680. Exposure to a polluted urban environment and to chronic low doses of lipopolysaccharides produces neuroinflammation in mice, and is ameliorated by dark chocolate
  1681. Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model
  1682. Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons, and cognitive changes in rat offspring
  1683. Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation
  1684. Exposure to Inhalational Anaesthetics Causes neuroinflammation
  1685. Exposure to nanoscale diesel exhaust particles: Oxidative stress, neuroinflammation, anxiety and depression on adult male mice
  1686. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy
  1687. Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats
  1688. Expression of CD300lf by microglia contributes to resistance to cerebral malaria by impeding the neuroinflammation
  1689. Expression of metallothionein-I,-II, and-III in Alzheimer disease and animal models of neuroinflammation
  1690. Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity
  1691. Extinguishing neuroinflammation
  1692. Extracellular HSP70, neuroinflammation and Protection Against Viral Virulence
  1693. Extracellular interactions of alpha-synuclein with astrocytes and microglia linked to neuroinflammation and spread in multiple system atrophy
  1694. Extracellular matrix-degrading metalloproteinases and neuroinflammation in stroke
  1695. Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis
  1696. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys
  1697. Extract of Fructus Schisandrae chinensis Inhibits neuroinflammation Mediator Production from Microglia via NF-κ B and MAPK Pathways
  1698. Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on neuroinflammation in Microglia
  1699. Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation
  1700. Ezetimibe Attenuates Oxidative Stress and neuroinflammation via the AMPK/Nrf2/TXNIP Pathway after MCAO in Rats
  1701. EZH2 regulates spinal neuroinflammation in rats with neuropathic pain
  1702. F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON neuroinflammation AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE
  1703. FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus
  1704. Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation
  1705. Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation
  1706. Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies
  1707. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?
  1708. Fatty acid and lipid profiles in models of neuroinflammation and mood disorders: application of high field NMR, gas chromotography and liquid chromotography …
  1709. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity
  1710. FEATURES OF neuroinflammation IN TRANSGENIC RAT EXPRESSING MISFOLDED TAU PROTEIN VARY WITH GENETIC BACKGROUND AND INFLUENCE …
  1711. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
  1712. FGF21 Protects Dopaminergic Neurons in Parkinson’s Disease Models Via Repression of neuroinflammation
  1713. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer’s disease
  1714. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
  1715. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
  1716. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
  1717. Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression
  1718. Fighting Chronic neuroinflammation by Boosting Autoimmunity: The Distinction Between Neurodegenerative Diseases and Multiple Sclerosis
  1719. Finding our way through the ‘neuroinflammation‘fog
  1720. Finding the’ubiquitous’ threads in infection and autoimmune neuroinflammation
  1721. Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat
  1722. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
  1723. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model
  1724. Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?
  1725. Fingolimod up-regulates BDNF expression within the CNS and Down-regulates tissue pathology in a pre-clinical model of chronic neuroinflammation (P1. 159)
  1726. Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway
  1727. Fisetin nanoparticles protect against PM2. 5 exposure-induced neuroinflammation by down-regulation of astrocytes activation related NF-κB signaling …
  1728. Fisetin protects against intracerebral hemorrhage-induced neuroinflammation in aged mice
  1729. Fish oil prevents lipopolysaccharide-induced depressive-like behavior by inhibiting neuroinflammation
  1730. Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide
  1731. Fish oil–rich lipid emulsion modulates neuroinflammation and prevents long-term cognitive dysfunction after sepsis
  1732. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson’s disease
  1733. Flavonoid-Rich Ethanol Extract from the Leaves of Diospyros kaki Attenuates D-Galactose-Induced Oxidative Stress and neuroinflammation-Mediated Brain Aging in …
  1734. Flavonoids have modulatory effects on neuroinflammation in microglia
  1735. FLUID BIOMARKERS OF neuroinflammation
  1736. Fluoride induces neuroinflammation and alters Wnt signaling pathway in BV2 microglial cells
  1737. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4/MyD88/NF-κB …
  1738. FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
  1739. Focusing on the Mitochondrial Expression of TSPO as a Marker and Promoter of neuroinflammation
  1740. Follistatin-like protein 1 suppressed pro-inflammatory cytokines expression during neuroinflammation induced by lipopolysaccharide
  1741. Forced Wakefulness Enhances neuroinflammation in Postoperative Mice
  1742. Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in neuroinflammation Conditions in High-Fat Diet-Induced Mice
  1743. Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia
  1744. Forsythiae fructus and its active component, arctigenin, provide neuroprotection by inhibiting neuroinflammation
  1745. Foxo3 controls CD4 T cells differentiation and severity to neuroinflammation (IRM15P. 604)
  1746. Fractalkine Expression Is Suppressed During Hepatic Encephalopathy in Mice and Promotes neuroinflammation: 2495
  1747. Fractionated whole brain radiation-induced behavioral changes in athymic nude mice is associated with sustained neuroinflammation and microglial M1-phenotype
  1748. Fragmented sleep enhances postoperative neuroinflammation but not cognitive dysfunction
  1749. Fragmented Sleep Enhances Postoperative neuroinflammation but Not Cognitive Dysfunction: Really?
  1750. From classic aspects of the stress response to neuroinflammation and sickness: implications for individuals and offspring
  1751. From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
  1752. From systemic inflammation to neuroinflammation: the case of neurolupus
  1753. From the “little brain” gastrointestinal infection to the “big brain” neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis
  1754. Fructose-derived advanced glycation end products (AGEs) enhance neuroinflammation and alter immune function in the brain
  1755. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple …
  1756. Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of neuroinflammation and Brain Edema
  1757. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
  1758. Function of Protein Kinase CK2 in Innate Immune Cells in neuroinflammation
  1759. Functional aspects of redox control during neuroinflammation
  1760. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders
  1761. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
  1762. Funding free and universal access to Journal of neuroinflammation
  1763. Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation
  1764. Future Perspectives: New Strategies for Antagonism of Excitotoxicity, Oxidative Stress and neuroinflammation in Neurodegenerative Diseases
  1765. G-CSF attenuates neuroinflammation and stabilizes the blood–brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats
  1766. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
  1767. GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone
  1768. GABAB receptor mediate hippocampal neuroinflammation in adolescent male and female mice after cold expose
  1769. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
  1770. Gabrb2 knockout mice displayed schizophrenia-like and comorbid phenotypes with GABAergic interneuron-astrocyte-microglia dysregulation and neuroinflammation
  1771. Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation
  1772. Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway
  1773. Galectin-1 reduces neuroinflammation via modulation of nitric oxide-arginase signaling in HIV-1 transfected microglia: a gold nanoparticle-Galectin-1 “Nanoplex” a …
  1774. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: neuroprotective role in maintaining blood brain …
  1775. Galectins and neuroinflammation
  1776. Gallic Acid Attenuated LPS-Induced neuroinflammation: Protein Aggregation and Necroptosis
  1777. Gallic acid, a histone acetyltransferase inhibitor, suppresses β‐amyloid neurotoxicity by inhibiting microglial‐mediated neuroinflammation
  1778. Gamisoyo-San Ameliorates neuroinflammation in the Spinal Cord of hSOD1G93A Transgenic Mice
  1779. Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute neuroinflammation
  1780. Gamma-linolenic acid ameliorates Aβ-induced neuroinflammation through NF-κB and MAPK signalling pathways
  1781. Garcinia kola seeds may prevent cognitive and motor dysfunctions in a type 1 diabetes mellitus rat model partly by mitigating neuroinflammation
  1782. Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis
  1783. Gastrodin attenuates neuroinflammation in DOI‐induce Tourette syndrome in rats
  1784. Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson’s disease model rats
  1785. Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
  1786. Gatekeeper role of brain antigen‐presenting CD11c+ cells in neuroinflammation
  1787. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s …
  1788. Gene therapy with mesenchymal stem cells expressing IFN‐ß ameliorates neuroinflammation in experimental models of multiple sclerosis
  1789. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation
  1790. General physiology and pathophysiology of microglia during neuroinflammation
  1791. Generation of neuroinflammation in human African trypanosomiasis
  1792. Genetic and Immunological Regulation of neuroinflammation
  1793. Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation
  1794. Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke
  1795. Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of …
  1796. Genetic regulation of autoimmune neuroinflammation
  1797. Genetic regulation of autoimmunity in experimental neuroinflammation
  1798. Genetic regulation of neuroinflammation after infection and injury
  1799. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson’s disease
  1800. Genetic variability commonly affecting neurodegeneration and neuroinflammation
  1801. Genetically engineered resveratrol-enriched rice inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia via downregulating mitogen-activated …
  1802. Genetics of autoimmune neuroinflammation
  1803. Genetics of neuroinflammation in Alzheimer disease
  1804. Genetics of rat neuroinflammation
  1805. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling …
  1806. Genistein alleviates neuroinflammation and restores cognitive function in rat model of hepatic encephalopathy: underlying mechanisms
  1807. Gestational Diabetes Mellitus Induces neuroinflammation, Synaptic Reduction, Behavioural Changes, and Impaired Memory in the Offspring.
  1808. Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats
  1809. Gestational intermittent hypoxia induces neuroinflammation and impairs compensatory respiratory plasticity in adult offspring
  1810. Ghrelin attenuates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis involving NLRP3 inflammasome signaling pathway and …
  1811. Ginger Extract Reduces Chronic Morphine-Induced neuroinflammation and Glial Activation in Nucleus Accumbens of Rats
  1812. Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1
  1813. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system
  1814. Ginsenoside Rb1 Attenuates Isoflurane/surgery-induced Cognitive Dysfunction via Inhibiting neuroinflammation and Oxidative Stress
  1815. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture
  1816. Ginsenoside Re attenuates neuroinflammation in a symptomatic ALS animal model
  1817. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model
  1818. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein …
  1819. Ginsenoside Rg1 attenuates neuroinflammation following systemic lipopolysaccharide treatment in mice
  1820. Ginsenoside Rg1 prevents chemotherapy-induced cognitive impairment: associations with microglia-mediated cytokines, neuroinflammation, and neuroplasticity
  1821. Ginsenoside Rg18 suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglia and amyloid-β-induced oxidative stress in SH-SY5Y neurons via …
  1822. Ginsenoside Rg3 and Rh2 protect trimethyltin‐induced neurotoxicity via prevention on neuronal apoptosis and neuroinflammation
  1823. Glia as a link between neuroinflammation and neuropathic pain
  1824. Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated receptor-2 in neuroinflammation
  1825. Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
  1826. Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer’s disease
  1827. Glia-neuron sandwich cocultures: an in vitro approach to evaluate cell-to-cell communication in neuroinflammation and neurotoxicity
  1828. Glial activation and synaptic neurotoxicity in Alzheimer’s disease: a focus on neuroinflammation
  1829. Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids
  1830. Glial communication via gap junction in neuroinflammation
  1831. Glial epigenetics in neuroinflammation and neurodegeneration
  1832. Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease
  1833. Glimepiride prevents paraquat‐induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation
  1834. Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering neuroinflammation
  1835. Global and 3D spatial assessment of neuroinflammation in rodent models of multiple sclerosis
  1836. Global neuroinflammation patterns in experimental neonatal hydrocephalus
  1837. Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
  1838. Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents
  1839. Glucocorticoid induced leucine zipper in lipopolysaccharide induced neuroinflammation
  1840. Glucocorticoid induced leucine zipper is inversely related with neuroinflammation in the brain
  1841. GLUCOCORTICOID-INDUCED LEUCINE ZIPPER ANALOGS SUPPRESS neuroinflammation IN ALZHEIMER’S DISEASE
  1842. Glucocorticoids in the control of neuroinflammation
  1843. Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats
  1844. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation
  1845. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice
  1846. Glutaminyl cyclases: enzyme targets to treat Alzheimer’s disease and neuroinflammation
  1847. Glutathione depletion: Starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats
  1848. Glycine inhibits ethanol-induced oxidative stress, neuroinflammation and apoptotic neurodegeneration in postnatal rat brain
  1849. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease
  1850. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice
  1851. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage
  1852. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
  1853. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early-onset Tay-Sachs disease.
  1854. Going with the flow: neuroinflammation
  1855. Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst
  1856. Gonadal hormone modulation of chronic neuroinflammation
  1857. GPER agonist G1 attenuates neuroinflammation and dopaminergic neurodegeneration in Parkinson disease
  1858. Gracilin A Derivatives Target Early Events in Alzheimer’s Disease: in Vitro Effects on neuroinflammation and Oxidative Stress
  1859. Granulocyte colony-stimulating factor attenuates chronic neuroinflammation in the brain of amyloid precursor protein transgenic mice: an Alzheimer’s disease mouse …
  1860. Graphene Oxide Nanosheets and Neural System: From Synaptic Modulation to neuroinflammation
  1861. Graphene quantum dots inhibit T cell-mediated neuroinflammation in rats
  1862. Green Tea Polyphenol (−)-Epigallocatechin Gallate (EGCG) Attenuates neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced …
  1863. GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury
  1864. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing neuroinflammation
  1865. Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
  1866. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease
  1867. Gut microbiota to counteract metabolic disorders and neuroinflammation
  1868. Gut microbiota to counteract metabolic disorders and neuroinflammation: Impact of dietary factors and their potential to prevent Alzheimer’s disease
  1869. Gut microbiota–brain axis in depression: The role of neuroinflammation
  1870. Gx-50 inhibits neuroinflammation via α7 nAChR activation of the JAK2/STAT3 and PI3K/AKT pathways
  1871. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
  1872. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and memory impairment in rats
  1873. Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation
  1874. Hashimoto’s thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice
  1875. HDAC8 inhibitor WK2-16 therapeutically targets lipopolysaccharide-induced mouse model of neuroinflammation and microglial activation
  1876. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
  1877. Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes
  1878. Heat Shock Proteins in neuroinflammation
  1879. Heat stress-induced neuroinflammation and aberration in monoamine levels in hypothalamus are associated with temperature dysregulation
  1880. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
  1881. Helminth products potently modulate experimental autoimmune encephalomyelitis by downregulating neuroinflammation and promoting a suppressive …
  1882. Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1β-mediated neuroinflammation
  1883. Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation
  1884. Hemorrhage Associated Mechanisms of neuroinflammation in Experimental Traumatic Brain Injury
  1885. Heparan sulfate proteoglycans as relays of neuroinflammation
  1886. Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage
  1887. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells
  1888. Herbal Complement inhibitors in the treatment of neuroinflammation
  1889. Herbal compounds with special reference to gastrodin as potential therapeutic agents for microglia mediated neuroinflammation
  1890. Herbicide paraquat induces sex-specific variation of neuroinflammation and neurodegeneration in Drosophila melanogaster
  1891. Herpes viruses and neuroinflammation
  1892. Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis
  1893. HERV-W envelope is significantly expressed in Multiple Sclerosis and causes neuroinflammation in animal models with specific antibody inhibition
  1894. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways
  1895. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats
  1896. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
  1897. Hesperidin alleviates lipopolysaccharide-induced neuroinflammation in mice by promoting the miRNA-132 pathway
  1898. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke
  1899. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis
  1900. High and Low Molecular Weight Hyaluronic Acid Differentially Influences Oxylipins Synthesis in Course of neuroinflammation
  1901. High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent neuroinflammation and Cell Death
  1902. High cholesterol‐induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice
  1903. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation
  1904. High Dietary Salt Aggravates Experimental neuroinflammation in Mice Via Induction of Th17 Cells (S50. 003)
  1905. High dimensional cytometry of central nervous system leukocytes during neuroinflammation
  1906. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system
  1907. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
  1908. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
  1909. High fat diet increases neuroinflammation and alters behavior in mice latently-infected with HSV-1
  1910. HIGH GLUCOSE CONCENTRATIONS INCREASE LEUKOCYTE ADHESION TO ASTROCYTES IN A POST-TRAUMATIC neuroinflammation MODEL.: 144
  1911. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts …
  1912. High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
  1913. High Pulsatile Pressure Promotes Cerebrovascular Damage and Endothelial Cell Death, Leading to Hypoperfusion, neuroinflammation and Cognitive Decline in Mice
  1914. High Sensitivity C-Reactive Protein as a Potential Biomarker of neuroinflammation in Major Psychiatric Disorders
  1915. High-energy diet consumption predisposes rats to cognitive impairments, neuroinflammation, and neurovascular damage
  1916. High-fat diet and aging interact to produce neuroinflammation and impair hippocampal-and amygdalar-dependent memory
  1917. High-Fat Diet Causes Increased neuroinflammation and Decreased Motor Function in a Rodent Model of Parkinson’s Disease
  1918. High-Fat Diet Induces neuroinflammation and Mitochondrial Impairment in Mice Cerebral Cortex and Synaptic Fraction
  1919. High-fat diet–induced dysbiosis as a cause of neuroinflammation
  1920. High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke
  1921. High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats
  1922. High-refined carbohydrate diet consumption induces neuroinflammation and anxiety-like behavior in mice
  1923. Higher-Resolution MR Elastography Reveals Early Mechanical Signatures of neuroinflammation in Patients with Clinically Isolated Syndrome
  1924. Higher‐resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome
  1925. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
  1926. Highly selective activation of heat shock protein 70 by allosteric regulation provides an insight into efficient neuroinflammation inhibition
  1927. Highly selective cyclooxygenase-1 inhibitors P6 and Mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation
  1928. Hippo Signaling Pathway has a critical role in Zika Virus Replication and in the Pathogenesis of neuroinflammation
  1929. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures
  1930. Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer’s disease in CRND8 mice
  1931. Hippocampal Neurogenesis and neuroinflammation after Cranial Irradiation with 56Fe Particles
  1932. Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression
  1933. Hippocampal neuroinflammation and depression: Relevance to multiple sclerosis and other neuropsychiatric illnesses
  1934. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis
  1935. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
  1936. Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis
  1937. Histamine H4 receptor agonist‐induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress
  1938. Histological and direct evidence for the role of complement in the neuroinflammation of AD
  1939. Histone deacetylase 2 inhibitor CAY10683 alleviates lipopolysaccharide induced neuroinflammation through attenuating TLR4/NF-κB signaling pathway
  1940. Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal neuroinflammation
  1941. Histone deacetylase inhibitor trichostatin a ameliorated endotoxin-induced neuroinflammation and cognitive dysfunction
  1942. HIV gp120‐induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK
  1943. HIV-1 associated neuroinflammation: effects of two complimentary medicines illustrated in an in vitro model of the blood-brain barrier
  1944. HIV-1 Envelope Glycoprotein 120 Induced neuroinflammation Does Not Result in Neurocognitive Impairment in An in vivo Rat Model
  1945. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes
  1946. HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation
  1947. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation
  1948. HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation
  1949. HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin
  1950. HMGB-1 AND ANNEXIN A1: IMPORTANT MEDIATORS OF neuroinflammation IN THE SYNDROME OF ALZHEIMER’S DEMENTIA WITH CONCOMITANT …
  1951. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration
  1952. HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-κB signaling in primary hippocampal neurons induced by Aβ25–35
  1953. HMGB1-mediated differential response on hippocampal neurotransmitter disorder and neuroinflammation in adolescent male and female mice following cold …
  1954. HMGB1-RAGE signaling plays a role in organic dust-induced microglial activation and neuroinflammation
  1955. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
  1956. HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction
  1957. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke
  1958. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice
  1959. Honokiol ameliorates amyloidosis and neuroinflammation and improves cognitive impairment in Alzheimer’s disease transgenic mice
  1960. Honokiol ameliorates cognitive impairment by attenuating amyloidosis and neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  1961. Honokiol Attenuates the Memory Impairments, Oxidative Stress, neuroinflammation, and GSK-3 β Activation in Vascular Dementia Rats
  1962. Hormesis, cellular stress response and neuroinflammation in schizophrenia: early onset versus late onset state
  1963. How air pollution alters brain development: the role of neuroinflammation
  1964. How can viruses influence the neuroinflammation and neurodegeneration in the aged human brain
  1965. How do statins control neuroinflammation?
  1966. How neuroinflammation contributes to neurodegeneration
  1967. HSPA12B regulates SSeCKS-mediated astrocyte inflammatory activation in neuroinflammation
  1968. Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
  1969. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1
  1970. Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation
  1971. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats
  1972. Human brain pericytes as mediators of neuroinflammation: Implications for disease and therapeutics
  1973. Human endogenous retrovirus and neuroinflammation in chronic inflammatory demyelinating polyradiculoneuropathy
  1974. Human herpesvirus 6 and neuroinflammation
  1975. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury
  1976. Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer’s disease
  1977. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic …
  1978. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease
  1979. Human TBK1: a gatekeeper of neuroinflammation
  1980. Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal neuroinflammation via Toll-Like Receptor 4 Pathway
  1981. Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced neuroinflammation and Oxidative Stress in BV-2 Cells
  1982. Human whole-body biodistribution and dosimetry of a new PET tracer,[{sup 11} C] ketoprofen methyl ester, for imagings of neuroinflammation
  1983. Human whole-body biodistribution and dosimetry of a new PET tracer,[11C] ketoprofen methyl ester, for imagings of neuroinflammation
  1984. Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury
  1985. Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid‐induced epileptic rats by antioxidant activity and NLRP 3/caspase‐1 pathway …
  1986. Hydrogen sulfide and neuroinflammation
  1987. Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ1–42 synthesis by suppressing the activation of STAT3 and cathepsin S
  1988. Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation
  1989. Hydrogen sulfide protects hippocampal neurons against methamphetamine neurotoxicity via inhibition of apoptosis and neuroinflammation
  1990. Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
  1991. Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ1–42 in BV-2 cells
  1992. Hydroxysafflor yellow A attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation in primary mesencephalic cultures
  1993. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by …
  1994. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy
  1995. Hyperbaric oxygen effects on depression-like behavior and neuroinflammation in traumatic brain injury rats
  1996. Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics
  1997. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation
  1998. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury.
  1999. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase‐9 in the rat model of traumatic brain injury
  2000. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models
  2001. Hyperpolarized 13C magnetic resonance spectroscopy detects toxin‐induced neuroinflammation in mice
  2002. Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model
  2003. Hypothermia Attenuates Neuro-Glial Injury and neuroinflammation in Prolonged Status Epilepticus (S56. 004)
  2004. Hypoxia as an initiator of neuroinflammation: microglial connections
  2005. Hypoxia-induced neuroinflammation and learning–memory impairments in adult zebrafish are suppressed by glucosamine
  2006. Hypoxic preconditioning suppresses glial activation and neuroinflammation in neonatal brain insults
  2007. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 …
  2008. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia–ischemia in the immature rodent brain
  2009. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation …
  2010. Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice
  2011. Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation
  2012. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats
  2013. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice
  2014. Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation
  2015. Identification of ADAM proteinase substrates in neurodegeneration and neuroinflammation
  2016. Identification of brain regions predicting epileptogenesis by serial [18F] GE-180 positron emission tomography imaging of neuroinflammation in a rat model of …
  2017. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation
  2018. Identification of novel candidate protein biomarkers for the post-polio syndrome—implications for diagnosis, neurodegeneration and neuroinflammation
  2019. Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats
  2020. Identifying the role of complement in triggering neuroinflammation after traumatic brain injury
  2021. Identifying the role of IL-1 in neuroinflammation of MPSIIIA
  2022. IFN-β induces IL-6 production by B cells to promote TH17-mediated neuroinflammation
  2023. IL-1-induced Bhlhe40 identifies pathogenic TH cells in a model of autoimmune neuroinflammation
  2024. IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
  2025. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis
  2026. IL-11 antagonist suppresses Th17 cells-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis (P2. 406)
  2027. IL-12p35 inhibits neuroinflammation and ameliorates autoimmune encephalomyelitis
  2028. IL-13 ameliorates neuroinflammation and promotes functional recovery after traumatic brain injury
  2029. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson’s disease
  2030. IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage
  2031. IL-17A promotes microglial activation and neuroinflammation in mouse models of intracerebral haemorrhage
  2032. IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway
  2033. IL-18 is differently regulated in specific areas of rat brain during neuroinflammation: relevance for neurodegenerative disease
  2034. IL-18: a key player in neuroinflammation and neurodegeneration?
  2035. IL-1β-mediated changes in cerebral perfusion and neural activity in a rat model of neuroinflammation and excitotoxicity
  2036. IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
  2037. IL-27 and IL-35 as gene therapy of neuroinflammation
  2038. IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
  2039. IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
  2040. Imaging Amnestic Mild Cognitive Impairment: neuroinflammation, Beta-Amyloid and Glutathione
  2041. Imaging biomarkers and the role of neuroinflammation in neuropathic pain
  2042. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis
  2043. IMAGING MARKER OF neuroinflammation PREDICTS DISEASE PROGRESSION IN ALZHEIMER DISEASE
  2044. Imaging marker of neuroinflammation predicts progression in Alzheimer’s disease
  2045. Imaging microglial activation during neuroinflammation and Alzheimer’s disease
  2046. Imaging neuroinflammation after brain injuries by ultrasensitive MRI and two-photon laser-scanning microscopy
  2047. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies
  2048. Imaging neuroinflammation in Alzheimer disease with [1–11C] arachidonic acid and positron emission tomography
  2049. Imaging neuroinflammation in Alzheimer’s disease and other dementias: recent advances and future directions
  2050. Imaging neuroinflammation in Alzheimer’s disease with radiolabeled arachidonic acid and PET
  2051. IMAGING neuroinflammation IN AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) USING A NOVEL PET RADIOLIGAND:[18F]-FEPPA
  2052. Imaging neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [ 18 F]-FEPPA
  2053. Imaging neuroinflammation in ischemic stroke and in the atherosclerotic vascular disease
  2054. Imaging neuroinflammation in multiple sclerosis using TSPO-PET
  2055. Imaging neuroinflammation in neurodegenerative diseases (INMIND): Concepts and future directions
  2056. Imaging neuroinflammation in Post Traumatic Stress Disorder
  2057. Imaging neuroinflammation in Progressive Multiple Sclerosis
  2058. Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and 19F magnetic resonance
  2059. Imaging neuroinflammation using 18F-DPA-714 microPET after low intensity pulsed focused ultrasound treatment with microbubbles.
  2060. Imaging neuroinflammation using18F-DPA-714 PET after disrupting the blood brain barrier with pulsed focused ultrasound.
  2061. Imaging neuroinflammation–from bench to bedside
  2062. Imaging neuroinflammation: quantification of astrocytosis in a multitracer PET approach
  2063. Imaging neuroinflammation? A perspective from MR spectroscopy
  2064. Imaging of neuroinflammation
  2065. Imaging of neuroinflammation in Alzheimer’s disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
  2066. Imaging of neuroinflammation in dementia: a review
  2067. Imaging of neuroinflammation in migraine with aura: A [11C] PBR28 PET/MRI study
  2068. Imaging of neuroinflammation in parkinsonian syndromes with positron emission tomography
  2069. Imaging of neuroinflammation with an ICAM-1 Specific Paramagnetic and Fluorescent Nanoparticle
  2070. Imaging of neuroinflammation: TSPO and beyond
  2071. Imaging Tau, neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep‐Phenotyping Case Report
  2072. Imaging the Breakdown of the BBB and neuroinflammation in Models of Neurodegeneration
  2073. Imaging toxin-induced neuroinflammation in mice using hyperpolarized 13C magnetic resonance spectroscopy
  2074. Imaging translocator protein as a biomarker of neuroinflammation in dementia
  2075. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune …
  2076. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood–brain barrier integrity and by modulating the peripheral immune …
  2077. Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms
  2078. Immune dysfunction and neuroinflammation in autism spectrum disorder.
  2079. Immune heterogeneity in neuroinflammation: dendritic cells in the brain
  2080. IMMUNE MECHANISMS ASSOCIATED TO neuroinflammation IN ALZHEIMER¿ S DISEASE
  2081. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation
  2082. Immune System in Acute and Chronic neuroinflammation
  2083. Immune System in Acute and Chronic neuroinflammation
  2084. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica
  2085. Immunity, neuroglia and neuroinflammation in autism
  2086. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving …
  2087. Immunobiology of WNV-induced neuroinflammation
  2088. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury
  2089. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury
  2090. Immunological Approaches to Prevent Neuronal Apoptosis During neuroinflammation
  2091. Immunomodulatory influence of bone marrow-derived mesenchymal stem cells on neuroinflammation in astrocyte cultures
  2092. Immunomodulatory properties of bone marrow-derived mesenchymal stem cells: influence on neuroinflammation
  2093. Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation
  2094. Immunotherapy against APP β-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on …
  2095. Immunotherapy in Autoimmune and neuroinflammation-Related Epilepsies
  2096. Impact of indomethacin on neuroinflammation and hippocampal neurogenesis in aged mice
  2097. Impact of long-term RF-EMF on oxidative stress and neuroinflammation in aging brains of C57BL/6 mice
  2098. Impact of metabolic syndrome on neuroinflammation and the blood–brain barrier
  2099. Impact of neuroinflammation on hippocampal neurogenesis: relevance to aging and Alzheimer’s disease
  2100. Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation
  2101. Impact of opiate addiction on neuroinflammation in HIV
  2102. Impact of Titanium Dioxide Nanoparticles on neuroinflammation in a Mouse Model of Asthma
  2103. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
  2104. Impaired remission from autoimmune neuroinflammation upon T cell-specific knockout of the stress kinase GCN2
  2105. Impairment of blood brain barrier is related with the neuroinflammation induced peripheral immune status in intracerebroventricular colchicine injected rats: An …
  2106. Implications of heparan sulfate and heparanase in neuroinflammation
  2107. Improved 3D hydrogel cultures of primary glial cells for in vitro modelling of neuroinflammation
  2108. Improved brain insulin/IGF signaling and reduced neuroinflammation with T3D-959 in an experimental model of sporadic Alzheimer’s disease
  2109. In a Model of neuroinflammation Designed to Mimic Delirium, Quetiapine Reduces Cortisol Secretion and Preserves Reversal Learning in the Attentional Set Shifting …
  2110. In silico design of novel gold-phosphate containing compounds as selective inhibitors of cathepsin B in neuroinflammation
  2111. In vitro assessment of neurotoxicity and neuroinflammation of homemade MWCNTs
  2112. In Vitro Model of neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
  2113. In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db …
  2114. In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke
  2115. In vivo assessment of amyloid deposition, neuroinflammation, and metabolic changes in neurodegenerations of different origin
  2116. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
  2117. In vivo detection of age-and disease-related increases in neuroinflammation by 18F-GE180 TSPO microPET imaging in wild-type and Alzheimer’s transgenic mice
  2118. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
  2119. In vivo evaluation of” Meriva” curcumin, and apigenin as anti-inflammatory drugs in a mouse model of chronic neuroinflammation
  2120. In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
  2121. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester
  2122. In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies-towards clinical translation
  2123. In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation
  2124. In vivo imaging of human neuroinflammation
  2125. In vivo imaging of neuroinflammation
  2126. In Vivo Imaging of neuroinflammation in Acute Brain Injury
  2127. In vivo imaging of neuroinflammation in Alzheimer’s disease
  2128. In vivo imaging of neuroinflammation in neurodegenerative diseases
  2129. In vivo imaging of neuroinflammation in schizophrenia
  2130. In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)
  2131. In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model
  2132. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia
  2133. In vivo imaging of”neuroinflammation”. Principles and applications
  2134. In vivo imaging of”neuroinflammation”. Principles and applications; In-vivo-Darstellung”neuroinflammatorischer”Veraenderungen mit [{sup 11} C] PK11195-PET …
  2135. In vivo molecular imaging of neuroinflammation in Alzheimer’s disease
  2136. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms
  2137. In vivo peptide biomarker screening for molecular imaging in eae neuroinflammation
  2138. In vivo PET imaging of neuroinflammation in Alzheimer’s disease
  2139. In Vivo Retinal Imaging of neuroinflammation in a Mouse Model of Traumatic Brain Injury
  2140. In vivo study of a PET radiotracer for imaging P2X7 receptors for neuroinflammation in animal model
  2141. In vivo targeting of Abeta and tau amyloidogeneses, neuroinflammation, calcium-mediated neurotoxicity and their interplays
  2142. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study
  2143. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand,[18 F]-FEPPA
  2144. In-vivo imaging of neuroinflammation in Veterans with Gulf War Illness
  2145. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation
  2146. Increase in core body temperature of Alzheimer’s disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis
  2147. Increased brain docosahexaenoic acid has no effect on the resolution of neuroinflammation following intracerebroventricular lipopolysaccharide injection
  2148. Increased cerebral Tff1 expression in two murine models of neuroinflammation
  2149. Increased cortical infarction and neuroinflammation in ischemic stroke mice with experimental periodontitis
  2150. Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation
  2151. Increased neuroinflammation in Asymptomatic LRRK2 Mutation Carriers: A Pilot PET Imaging Study (P4. 321)
  2152. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer …
  2153. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease’s …
  2154. Increased olfactory bulb volume due to treatment of chronic rhinosinusitis: neuroinflammation and adult neurogenesis
  2155. Increased P2X7 receptor binding is associated with neuroinflammation in acute but not chronic rodent models for Parkinson’s disease
  2156. Increases in neuroinflammation and Astrocyte Activation in a Murine Model of Mixed Dementia
  2157. Increasing extracellular cGMP in cerebellum in vivo reduces neuroinflammation, GABAergic tone and motor in-coordination in hyperammonemic rats
  2158. Indirect effects of radiation induce apoptosis and neuroinflammation in neuronal SH-SY5Y cells
  2159. Indispensable role of CX3CR1+ dendritic cells in regulation of virus-induced neuroinflammation through rapid development of antiviral immunity in peripheral …
  2160. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia
  2161. Inducible ablation of Cxcr2 in oligodendroglia attenuates autoimmune, but not viral, mediated neuroinflammation and demyelination
  2162. INDUCTION AND RESOLUTION OF neuroinflammation AND NEUROTOXICITY
  2163. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation
  2164. Induction of neuroinflammation and Neurotoxicity by Synthetic Hemozoin
  2165. Induction of Nrf2/HO-1 pathway suppresses neuroinflammation in ischemic stroke
  2166. Induction of suppressor of cytokine signaling 3 via HSF-1-HSP70-TLR4 axis attenuates neuroinflammation and ameliorates postoperative pain
  2167. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation
  2168. Infiltrating macrophages contribute to age-related neuroinflammation in C57/BL6 mice
  2169. Infiltrating regulatory B cells control neuroinflammation following viral brain infection
  2170. Inflamed in vitro retina: cytotoxic neuroinflammation and galectin-3 expression
  2171. Inflammasomes in neuroinflammation and changes in brain function: a focused review
  2172. Inflammasomes link vascular disease with neuroinflammation and brain disorders
  2173. Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease
  2174. Inflammasomes: An emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson’s disease
  2175. Inflammatory cell populations in early neuroinflammation in the core and peri-ischemic lesions of rat brain after transient focal cerebral ischemia: A …
  2176. Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?
  2177. Influence of caffeine on 3, 4‐methylenedioxymethamphetamine‐induced dopaminergic neuron degeneration and neuroinflammation is age‐dependent
  2178. Influence of chronic Helicobacter pylori infection on systemic and neuroinflammation and its impact on cognition
  2179. Influence of HAART on HIV-related CNS disease and neuroinflammation
  2180. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain
  2181. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (IN9-1.001)
  2182. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (S44. 003)
  2183. Influence of neuroinflammation on the regulation of glutamate handling in astrocytes, link with neuropathies
  2184. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury
  2185. Influenza infection induces neuroinflammation and impacts hippocampal structure and function
  2186. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice
  2187. Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis
  2188. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain
  2189. Inheritance of autoimmune neuroinflammation
  2190. Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions
  2191. Inhibiting RIPK1 limits neuroinflammation and alleviates postoperative cognitive impairments in D-galactose-induced aged mice
  2192. Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation
  2193. Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage
  2194. Inhibition of activator protein 1 attenuates neuroinflammation and brain injury after experimental intracerebral hemorrhage
  2195. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB …
  2196. Inhibition of Amyloid-Beta Production, Associated neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology …
  2197. Inhibition of Aβ production, associated neuroinflammation, and HDAC2-mediated epigenetic modifications prevent neuropathology in Alzheimer’s disease in vitro …
  2198. Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation
  2199. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced neuroinflammation in mice
  2200. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced sickness behavior and neuroinflammation in mice
  2201. Inhibition of Endocannabinoid Degradation Improves Recovery of Neurobehavioral Function and Resolution of neuroinflammation and Synaptic Hyperexcitability in a …
  2202. Inhibition of fibrin formation reduces neuroinflammation and improves long-term outcome after intracerebral hemorrhage
  2203. Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice
  2204. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
  2205. Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice
  2206. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of neuroinflammation
  2207. Inhibition of microRNA-155 Alleviates Neurological Dysfunction Following Transient Global Ischemia and Contribution of neuroinflammation and Oxidative Stress in …
  2208. Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice
  2209. Inhibition of miR-429 improves neurological recovery of traumatic brain injury mice and attenuates microglial neuroinflammation
  2210. Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammation
  2211. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson’s disease
  2212. Inhibition of neuroinflammation by AIBP: spinal effects upon facilitated pain states
  2213. Inhibition of neuroinflammation by artemisinin and its derivatives
  2214. Inhibition of neuroinflammation by cinnamon and its main components
  2215. Inhibition of neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia
  2216. Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2/ARE signalling
  2217. Inhibition of neuroinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protective mechanism
  2218. Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine
  2219. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain
  2220. INHIBITION OF neuroinflammation REDUCES DEGENERATION OF DOPAMINERGIC NEURONS IN THE SUBSTANTIANIGRA INDUCED BY …
  2221. Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia
  2222. Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat hippocampus
  2223. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model
  2224. Inhibition of RAGE-Related Pathway Prevents Subarachnoid Hemorrhage (sah)-Associated neuroinflammation and Neurologic Dysfunction in Rats
  2225. Inhibition of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 reduces lipopolysaccharide‐induced neuroinflammation
  2226. Inhibition of SERPINA3N‐dependent neuroinflammation is essential for melatonin to ameliorate trimethyltin chloride–induced neurotoxicity
  2227. Inhibition of sPLA2-IIA Prevents LPS-Induced neuroinflammation by Suppressing ERK1/2-cPLA2α Pathway in Mice Cerebral Cortex
  2228. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson’s disease models
  2229. Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
  2230. Inhibition of the P2X7–PANX1 complex suppresses spreading depolarization and neuroinflammation
  2231. Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental …
  2232. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage
  2233. Inhibition of TNF-alpha protein synthesis restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
  2234. Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of …
  2235. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
  2236. Inhibitory effect of ethanol extract of Nannochloropsis oceanica on lipopolysaccharide-induced neuroinflammation, oxidative stress, amyloidogenesis and …
  2237. Inhibitory effect of ferulic acid on neuroinflammation in LPS-activated microglia
  2238. Inhibitory effect of INT-777 on lipopolysaccharide-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
  2239. Inhibitory effect of memantine on streptozotocin-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and neurotrophic factor decline in …
  2240. Inhibitory effect of Petalonia binghamiae on neuroinflammation in LPS-stimulated microglial cells
  2241. Inhibitory effect of punicalagin on lipopolysaccharide-induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor-kappaB
  2242. Inhibitory effects of betulinic acid on LPS-induced neuroinflammation involve M2 microglial polarization via CaMKKβ-dependent AMPK activation
  2243. Inhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in mice
  2244. Inhibitory Effects of Myricetin on Lipopolysaccharide-Induced neuroinflammation
  2245. Inhibitory effects of walnut (Juglans regia) peptides on neuroinflammation and oxidative stress in lipopolysaccharide-induced cognitive impairment mice
  2246. Initial evaluation in healthy humans of [18F] DPA-714, a potential PET biomarker for neuroinflammation
  2247. Initial Parkinson’s and healthy control studies of 123-I CLINDE, a SPECT marker of the peripheral benzodiazepine receptor and neuroinflammation
  2248. Injecting mitochondria into mouse hippocampi induces neuroinflammation and raises app expression
  2249. INMiND: getting to the bottom of neuroinflammation
  2250. Innate and adaptive immune-mediated neuroinflammation and neurodegeneration in Parkinson’s disease
  2251. Innate immunity and neuroinflammation
  2252. Innate immunity and neuroinflammation
  2253. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury
  2254. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins
  2255. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication
  2256. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats
  2257. INSIGHTS FROM FLUID BIOMARKERS OF neuroinflammation
  2258. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder
  2259. Insights into neuroinflammation in Parkinson’s disease: from biomarkers to anti-inflammatory based therapies
  2260. Insights into the Role of neuroinflammation in the Pathogenesis of Multiple Sclerosis
  2261. Insights on the pathophysiology of Alzheimer’s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
  2262. Insulin resistance, neuroinflammation, and Alzheimer’s disease
  2263. Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
  2264. Insulin Signaling Suppresses Virus Replication and neuroinflammation in HIV/AIDS (S53. 005)
  2265. Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats
  2266. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration
  2267. Insulin treatment protects the brain against neuroinflammation by reducing cerebral cytokines and modulating mitochondrial function
  2268. Insulin-like growth factor-1 and neuroinflammation
  2269. Integration of Th17-and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation
  2270. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
  2271. Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke
  2272. Intensive Combination Immunotherapy and neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies
  2273. Interaction between CNS-resident cells and gut dysbiosis in multiple sclerosis: consequences on neuroinflammation
  2274. Interactions Between Neurons and Microglia During neuroinflammation
  2275. Interactions between the canonical WNT/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis
  2276. Interactions of Aβ with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer’s disease
  2277. Interfering with the CCL2–glycosaminoglycan axis as a potential approach to modulate neuroinflammation
  2278. Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity
  2279. Interferon-β plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration
  2280. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice
  2281. Interleukin-1, neuroinflammation, and Alzheimer’s disease
  2282. Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway
  2283. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice
  2284. Interleukin-18, from neuroinflammation to Alzheimer’s disease
  2285. INTERLEUKIN-1α AS PLEIOTROPIC BIOMARKER FOR neuroinflammation IN ALZHEIMER’S DISEASE
  2286. Interleukin-1β in neuroinflammation associated to Alzheimer disease
  2287. Interleukin-6 trans-signaling: implications for neuroinflammation and cognitive deficits in the aged
  2288. Interleukin-6: A Marker of neuroinflammation in Glaucoma
  2289. Interleukin-7 is required for CD4+ T cell activation and autoimmune neuroinflammation
  2290. Interleukin‐1: A master regulator of neuroinflammation
  2291. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment
  2292. Intermittent low-level lead exposure provokes anxiety, hypertension, autonomic dysfunction and neuroinflammation
  2293. Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammation
  2294. Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions
  2295. INTERPLAY OF CELLULAR ADAPTIVE IMMUNITY AND INNATE neuroinflammation IN ALZHEIMER’S DISEASE
  2296. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques
  2297. Intra-and intercellular functions of redoxins during neuroinflammation
  2298. Intracellular delivery of dendrimer-based nanoconjugates for cancer and neuroinflammation
  2299. Intracellular Effectors of Synaptic Dysfunction and neuroinflammation in Alzheimer’s and other Neurodegenerative Diseases
  2300. Intracerebral delivery of brain-derived neurotrophic factor using HyStem®-C hydrogel implants improves functional recovery and reduces neuroinflammation in a rat …
  2301. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study
  2302. Intracerebroventricular Aβ-Induced neuroinflammation Alters Peripheral Immune Responses in Rats
  2303. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats
  2304. Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment
  2305. Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves …
  2306. Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats
  2307. Intracranial injection of LPS in rat as animal model of neuroinflammation
  2308. Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation
  2309. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
  2310. Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation
  2311. Intranasal delivery of nerve growth factor attenuates neuroinflammation following traumatic brain injury in rats
  2312. Intranasal Exosomes for Treatment of neuroinflammation?: Prospects and Limitations
  2313. Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment …
  2314. Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation
  2315. Intranasal Methylprednisolone Effectively Reduces neuroinflammation in Mice With Experimental Autoimmune Encephalitis
  2316. Intranasal MMI-0100 attenuates Aβ1-42-and LPS-induced neuroinflammation and memory impairments via the MK2 signaling pathway
  2317. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation
  2318. Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction
  2319. Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype
  2320. Intrathecal application of the antimicrobial peptide CRAMP reduced mortality and neuroinflammation in an experimental model of pneumococcal meningitis
  2321. Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: equally diverse and compartmentalized, but more mutated, biased and …
  2322. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis
  2323. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
  2324. Intrauterine inflammation induces sex-specific effects on neuroinflammation, white matter, and behavior
  2325. Intravenously infusing the secretome of adipose-derived mesenchymal stem cells ameliorates neuroinflammation and neurological functioning after traumatic brain …
  2326. Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation
  2327. Intravitreal injection of adenosine A 2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice
  2328. Introduction to a special issue on cytokines in neuroinflammation and immunity
  2329. INVESTIGATE THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION RATE MODELLING
  2330. Investigating Imaging Biomarkers of neuroinflammation and Neurodegeneration in Rodent Models of Alzheimer’s Disease
  2331. Investigating neuroinflammation and demyelination in the nervous system of Twitcher mice by the use of immunohistochemistry
  2332. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer’s disease
  2333. INVESTIGATING THE LINK BETWEEN PATHOLOGICAL TAU ACCUMULATION, neuroinflammation AND BRAIN ATROPHY IN A MODEL OF TAUOPATHY
  2334. Investigating the mechanistic link between neuroinflammation and biometal homeostasis in neurodegenerative diseases
  2335. Investigating the role of the locus coeruleus-noradrenergic system during social stress on neuroinflammation and resulting changes in serotonin
  2336. Investigation into RAGE as a biomarker of the LPS-induced murine model of neuroinflammation
  2337. investigation into the effects of tenilsetam on markers of neuroinflammation in GFAP-IL6 mice
  2338. Investigation of consequences of chronic neuroinflammation in the cerebellum and brainstem regions of young rats
  2339. Investigation of how endoplasmic reticulum stress causes insulin resistance and neuroinflammation
  2340. Investigation of the Effects of Image Signal-to-noise Ratio on TSPO PET Quantification of neuroinflammation
  2341. Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin
  2342. INVESTIGATION OF THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION MODELLING
  2343. Investigations into the role of 26S proteasome non-ATPase regulatory subunit 13 in neuroinflammation
  2344. Involvement of acute neuroinflammation in postoperative delirium-like cognitive deficits in rats
  2345. Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain
  2346. Involvement of bone marrow cells and neuroinflammation in hypertension
  2347. Involvement of early growth response-2 (Egr-2) in lipopolysaccharide-induced neuroinflammation
  2348. INVOLVEMENT OF ELEVATED neuroinflammation IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER’S DISEASE
  2349. Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia
  2350. Involvement of neuroinflammation in models of neurodegeneration
  2351. Involvement of neuroinflammation in the pathogenesis of monocrotaline-induced pulmonary hypertension
  2352. Involvement of NLRC4 inflammasome through caspase-1 and IL-1β augments neuroinflammation and contributes to memory impairment in an experimental model of …
  2353. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
  2354. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
  2355. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
  2356. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
  2357. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
  2358. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
  2359. Iron, neuroinflammation, and Alzheimer’s disease
  2360. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
  2361. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
  2362. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
  2363. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
  2364. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
  2365. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
  2366. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
  2367. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
  2368. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
  2369. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
  2370. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
  2371. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
  2372. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
  2373. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
  2374. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
  2375. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
  2376. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
  2377. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
  2378. Janus faces of amyloid proteins in neuroinflammation
  2379. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
  2380. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
  2381. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
  2382. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
  2383. Iron, neuroinflammation, and Alzheimer’s disease
  2384. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
  2385. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
  2386. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
  2387. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
  2388. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
  2389. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
  2390. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
  2391. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
  2392. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
  2393. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
  2394. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
  2395. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
  2396. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
  2397. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
  2398. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
  2399. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
  2400. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
  2401. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
  2402. Janus faces of amyloid proteins in neuroinflammation
  2403. JNK signaling pathway regulates the process of neuroinflammation and apoptosis of nigral cells in the MPTP mouse model of subacute Parkinson′ s disease [J]
  2404. JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
  2405. JNK‐IN‐8, ac‐Jun N‐terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
  2406. JSH‐23 targets nuclear factor‐kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence
  2407. Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway
  2408. Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats
  2409. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
  2410. Kaempferol acts through mitogen‐activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells
  2411. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway
  2412. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
  2413. Kaempferol attenuates LPS-induced striatum injury in mice involving anti-neuroinflammation, maintaining BBB integrity, and down-regulating the HMGB1 …
  2414. Kaempferol attenuates neuroinflammation and blood brain barrier dysfunction to improve neurological deficits in cerebral ischemia/reperfusion rats
  2415. KCa3. 1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
  2416. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid …
  2417. Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced …
  2418. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo
  2419. Kinin B1 Receptor Blockade Prevents Angiotensin II-induced neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons
  2420. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
  2421. Kinins and neuroinflammation: dual effect on prostaglandin synthesis
  2422. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation‐mediated neurotoxicity through inhibition of NF‐κB signalling pathway in …
  2423. Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
  2424. Knockdown of endogenous circulating C1 inhibitor induces neurovascular impairment, neuroinflammation and cognitive decline
  2425. Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
  2426. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior
  2427. Korean Red Ginseng alleviates neuroinflammation and promotes cell survival in the intermittent heat stress-induced rat brain by suppressing oxidative stress …
  2428. Koumine decreases astrocyte-mediated neuroinflammation and enhances autophagy, contributing to neuropathic pain from chronic constriction injury in rats
  2429. Krabbe disease: cytototicity and neuroinflammation
  2430. KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
  2431. Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer’s disease
  2432. Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation
  2433. Kukoamine A prevents radiation-induced neuroinflammation and preserves hippocampal neurogenesis in rats by inhibiting activation of NF-κB and AP-1
  2434. Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation
  2435. Kynurenines, gender and neuroinflammation; showcase schizophrenia
  2436. L-8 is a key mediator of neuroinflammation in severe traumatic brain injuries
  2437. L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: involvement of NF-κB inhibition and Nrf2 pathway activation
  2438. l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
  2439. l‐DOPA‐induced dyskinesia in Parkinson’s disease: Are neuroinflammation and astrocytes key elements?
  2440. Lack of chronic neuroinflammation in the absence of focal hemorrhage in a rat model of low-energy blast-induced TBI
  2441. Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice
  2442. Lack of Rhes increases MDMA-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age
  2443. Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth
  2444. Laser Moxibustion Alleviates Knee Osteoarthritis Pain by Inhibiting Spinal Microglial Activation-Mediated neuroinflammation in Rats
  2445. Late aging–associated increases in L-DOPA–induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat
  2446. Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis
  2447. Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury
  2448. Lateral cerebellar nucleus stimulation promotes motor recovery and suppresses neuroinflammation in a fluid percussion injury rodent model
  2449. Lateral fluid percussion brain injury in the mouse: regional and temporal characterization of neuroinflammation
  2450. Leishmania infection and neuroinflammation: Specific chemokine profile and absence of parasites in the brain of naturally-infected dogs
  2451. Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase
  2452. Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury
  2453. Leonurine exerts antidepressant-like effects in the chronic mild stress-induced depression model in mice by inhibiting neuroinflammation
  2454. Leonurine suppresses neuroinflammation through promoting oligodendrocyte maturation
  2455. Leptin, neuroinflammation and obesity
  2456. Less estrogen, more neuroinflammation
  2457. Letter to the Editor. Impaired glymphatic pathway as potential contributing factor in amyloid beta accumulation and enhanced neuroinflammation after IVH
  2458. Leucine rich repeats and calponin homology domain containing 1 inhibits microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model
  2459. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders
  2460. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning
  2461. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury
  2462. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord
  2463. Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation
  2464. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling
  2465. Limiting Autoimmune neuroinflammation using Novel T Cell Suppressants & Investigating Overlapping Lysosomal Reductase Function in Macrophages and …
  2466. LIMITING FACTORS IN SELF-PACED EXERCISE TOLERANCE-THE ROLE OF neuroinflammation AND CENTRAL SENSITISATION
  2467. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
  2468. Linking Gut Dysbiosis and neuroinflammation Observed in Individuals with Autism Spectrum Disorder and Possible Treatment with Bacteroides Fragilis
  2469. Linking neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
  2470. Linking neuroinflammation and neurodegeneration in Parkinson’s disease
  2471. Lipid dynamics in LPS-induced neuroinflammation by DESI-MS imaging
  2472. Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
  2473. Lipid rafts in glial cells: Role in neuroinflammation and pain processing
  2474. Lipid-core nanocapsules improve the effects of resveratrol against Aβ-induced neuroinflammation
  2475. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice
  2476. Lipocalin-2: a new regulator of nonpathogen-associated neuroinflammation
  2477. Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats
  2478. Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
  2479. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat
  2480. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular …
  2481. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
  2482. Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration …
  2483. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
  2484. Lipopolysacharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced …
  2485. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
  2486. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
  2487. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury
  2488. Lithium and memantine improve spatial memory impairment and neuroinflammation induced by β-amyloid 1-42 oligomers in rats
  2489. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation
  2490. Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury
  2491. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse
  2492. Liver X Receptor α Is Involved in Counteracting Mechanical Allodynia by Inhibiting neuroinflammation in the Spinal Dorsal Horn
  2493. Liver X receptors activation decreases neuroinflammation in Parkinson’s disease (846.5)
  2494. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
  2495. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer’s disease
  2496. Lnhibitory effects of hua feng dan on microglia-mediated neuroinflammation
  2497. Loading into nanoparticles improves quercetin’s efficacy in preventing neuroinflammation induced by oxysterols
  2498. Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury
  2499. Local neuroinflammation and the progression of Alzheimer’s disease
  2500. Localized calcium accumulations prime synapses for phagocyte removal in cortical neuroinflammation
  2501. Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration
  2502. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates …
  2503. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1–dependent M1 microglial polarization
  2504. Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson’s disease via regulating miR-7/NLRP3 pathway
  2505. Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
  2506. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate …
  2507. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  2508. Long-term impact of intrauterine neuroinflammation and treatment with magnesium sulphate and betamethasone: Sex-specific differences in a preterm labor …
  2509. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function
  2510. Long-term pain, neuroinflammation and glial activation
  2511. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid …
  2512. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson’s disease
  2513. Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe×PS1Δe9 transgenic mouse model of Alzheimer’s disease
  2514. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron …
  2515. Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration
  2516. Loss of function due to neuroinflammation: A role for oxygen therapy?
  2517. Loss of G as6 and A xl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone …
  2518. Loss of IGF1R from oligodendrocytes ameliorates neuroinflammation without affecting cell survival
  2519. Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation
  2520. Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
  2521. Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in …
  2522. Low avidity CD8+ T cells in viral infection: From neuroinflammation to adoptive T cell therapy
  2523. Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury
  2524. Low sucrose, omega-3 enriched diet has region-specific effects on neuroinflammation and synaptic function markers in a mouse model of doxorubicin-based …
  2525. Low-density lipoprotein receptor deficiency attenuates neuroinflammation through the induction of apolipoprotein E
  2526. Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat
  2527. Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates neuroinflammation
  2528. Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments
  2529. Low-intensity pulsed ultrasound attenuates LPS-induced neuroinflammation and memory impairment by modulation of TLR4/NF-κB signaling and CREB/BDNF …
  2530. Low-level primary blast induces neuroinflammation and neurodegeneration in rats
  2531. Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating neuroinflammation
  2532. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation …
  2533. LPS and neuroinflammation: a matter of timing
  2534. LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative …
  2535. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals
  2536. LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammation
  2537. LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
  2538. LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation
  2539. LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infection
  2540. Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy
  2541. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression …
  2542. Luteolin could improve cognitive dysfunction by inhibiting neuroinflammation
  2543. Luteolin reduces primary hippocampal neurons death induced by neuroinflammation
  2544. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway
  2545. LW-AFC Attenuates LPS-Induced neuroinflammation via Inhibiting Nuclear Factor-Kappa B Signaling
  2546. Lychee seed fraction inhibits Aβ (1-42)-induced neuroinflammation in BV-2 cells via NF-κB signaling pathway
  2547. Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats
  2548. Lycopene supplementation attenuates oxidative stress, neuroinflammation, and cognitive impairment in aged CD-1 mice
  2549. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and neuroinflammation in a Rat Model of Parkinson’s Disease
  2550. Lymphatic Drainage of the CNS and Its Role in neuroinflammation and Neurodegenerative Disease
  2551. Lymphoid chemokines in chronic neuroinflammation
  2552. Lysosomal Dysfunction in Brain Aging and Neurodegeneration: Roles in Trophic Signaling and neuroinflammation
  2553. Macranthol attenuates lipopolysaccharide-induced depressive-like behaviors by inhibiting neuroinflammation in prefrontal cortex
  2554. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation
  2555. Macrophage migration inhibitory factor (MIF) decreases neuroinflammation in the solitary tract nucleus (NTS) of spontaneously hypertensive rats (SHR).
  2556. Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation
  2557. Macrophage migration inhibitory factor promotes central nervous system pathology in a model of neuroinflammation (35.8)
  2558. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
  2559. Macrophage-inducible C-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats
  2560. Macrophages in neuroinflammation: role of the renin-angiotensin-system
  2561. Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation
  2562. Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β
  2563. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in …
  2564. Magnesium sulfate attenuates brain edema by lowering AQP4 expression and inhibits glia-mediated neuroinflammation in a rodent model of eclampsia
  2565. Magnesium sulfate provides neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema
  2566. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia
  2567. Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of P arkinson’s disease–phagocyte influx to the brain is promoted by bilberry …
  2568. Magnetic resonance imaging of glutamate in neuroinflammation
  2569. Magnetic resonance molecular imaging of post‐stroke neuroinflammation with a P‐selectin targeted iron oxide nanoparticle
  2570. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain
  2571. Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice
  2572. Mammary tumor and mastectomy synergistically promote neuroinflammation in a breast cancer survivor model
  2573. Mammary tumors induce neuroinflammation, but not behavioral deficits in Balb/C mice
  2574. Management of glia-mediated neuroinflammation and related patents
  2575. Manganese Exposure Induces neuroinflammation by Impairing Mitochondrial Dynamics in Astrocytes
  2576. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
  2577. Manganese induces neuroinflammation via NF-κB/ROS NLRP3 pathway in rat brain striatum and HAPI cells
  2578. Manganese-induced neurotoxicity: new insights into protein misfolding, mitochondrial impairment and neuroinflammation
  2579. Manipulation of the Gut Microbiome: Influencing alcohol-induced neuroinflammation
  2580. MAPK-activated protein kinase 2 (MK2) in neuroinflammation, Hsp27 phosphorylation and cell cycle: Role and Targeting
  2581. MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation–relevance in a mouse model of Parkinson’s disease
  2582. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
  2583. Mapping neuroinflammation in vivo in healthy aging and Alzheimer’s disease: A PET study using a novel translocator protein 18kDA (TSPO) radioligand,[18F]-FEPPA
  2584. Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
  2585. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
  2586. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
  2587. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
  2588. Markers of neuroinflammation influence measures of cortical thickness in bipolar depression
  2589. Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
  2590. Mast cells and neuroinflammation
  2591. Mast Cells Augment neuroinflammation and Neurodegeneration
  2592. Mast cells in neuroinflammation and brain disorders
  2593. Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer’s disease
  2594. Mast cells, glia and neuroinflammation: partners in crime?
  2595. Mast Cells, neuroinflammation and Pain in Fibromyalgia Syndrome
  2596. Matairesinol suppresses neuroinflammation and migration associated with Src and ERK1/2-NF-κB pathway in activating BV2 microglia
  2597. Maternal alcohol binge drinking induces persistent neuroinflammation associated with myelin damage and behavioural dysfunctions in offspring mice
  2598. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring
  2599. Maternal immune activation increases neuroinflammation and aggravates EAE in adult offspring
  2600. Maternal separation induces neuroinflammation and long-lasting emotional alterations in mice
  2601. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver …
  2602. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration
  2603. Matrix metalloproteinase 9 in epilepsy: the role of neuroinflammation in seizure development
  2604. Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
  2605. MATRIX METALLOPROTEINASE-12 ACTIVITY IN A NEUROPATHIC PAIN RODENT MODEL: IMPACT ON neuroinflammation RESPONSE: 29
  2606. Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain
  2607. Matrix metalloproteinase-8 plays a pivotal role in neuroinflammation by modulating TNF-α activation
  2608. Matrix metalloproteinase-mediated neuroinflammation in vascular cognitive impairment of the Binswanger type
  2609. Matrix metalloproteinases and neuroinflammation in multiple sclerosis
  2610. Matrix metalloproteinases and proteolytic opening of the blood-brain barrier in neuroinflammation
  2611. Matrix metalloproteinases in neuroinflammation
  2612. Matrix metalloproteinases in neuroinflammation and cerebral ischemia
  2613. MATRIX METALOPROTEINASE INHIBITOR PROTECTS FROM neuroinflammation AND PAIN.
  2614. MDA5-Associated neuroinflammation and the Singleton–Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum
  2615. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex
  2616. Measuring neuroinflammation in hemiparkinsonian rhesus treated with iPSC-derived dopaminergic neuronal grafts using [18F] FEPPA PET
  2617. Mechanism of antrocytic connexin-43 autophagy degradation in oxygen-glucose deprivation and its effect on neuroinflammation
  2618. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding
  2619. Mechanism of Non-receptor Tyrosine Kinase Src Regulating neuroinflammation Through Phosphatase and Tensin Homology Protein in Microglia.
  2620. Mechanisms and implications of regional sensitivity to neuroinflammation: in vivo and in vitro studies
  2621. Mechanisms behind T cell-mediated neuroinflammation
  2622. Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
  2623. Mechanisms of glucocorticoids in the control of neuroinflammation
  2624. Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.
  2625. Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
  2626. Mechanisms of stress-dependent neuroinflammation and their implications for understanding consequences of alcohol exposure
  2627. Mechanisms of Synaptic Alterations in a neuroinflammation Model of Autism
  2628. Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons
  2629. Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration
  2630. Mediators of neuroinflammation
  2631. Mediators of neuroinflammation
  2632. Mediators of neuroinflammation
  2633. Medicinal Chemistry: ARTICLE; Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
  2634. Melanoma-secreted Amyloid Beta Supresses neuroinflammation and Promotes Brain Metastasis
  2635. Melastatin-related transient receptor potential 2 channel in Aβ42-induced neuroinflammation: implications to Alzheimer’s disease mechanism and …
  2636. Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats
  2637. Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of neuroinflammation by Suppressing the mTOR Signaling …
  2638. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat …
  2639. Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF‐KB/JNK signaling pathway in aging …
  2640. Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line
  2641. Melatonin attenuates pain hypersensitivity and decreases astrocyte-mediated spinal neuroinflammation in a rat model of oxaliplatin-induced pain
  2642. Melatonin inhibits neuronal dysfunction‐associated with neuroinflammation by atopic psychological stress in NC/Nga atopic‐like mouse models
  2643. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF‐κB and Nrf2 cascades
  2644. Melatonin protects methamphetamine-induced neuroinflammation through NF-κB and Nrf2 pathways in glioma cell line
  2645. Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement …
  2646. Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase
  2647. Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model
  2648. Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats
  2649. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat
  2650. Membrane damage induced by amyloid beta and a potential link with neuroinflammation
  2651. Menin deficiency leads to depressive-like behaviors in mice by modulating astrocyte-mediated neuroinflammation
  2652. Meningeal Lymphatic Network: the Middleman of neuroinflammation
  2653. Meningeal lymphatics, immunity and neuroinflammation
  2654. Mesenchymal Stem Cell Derived Exosomes as a Mediator of neuroinflammation and Neuronal Damage Following Cortical Injury
  2655. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the …
  2656. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5
  2657. Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus
  2658. Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality
  2659. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6
  2660. Mesenchymal stem cells transplantation delays functional deterioration by inhibiting neuroinflammation response in aged mice.
  2661. Mesenchymal stem cells transplantation delays functional deteriorationby inhibiting neuroinflammation response in aged mice
  2662. Mesuagenin C mitigated LPS-induced neuroinflammation in BV-2 and NG108-15 cells through pMTOR-PI3K-Akt and ccl21 downregulation
  2663. Metabolic control of glia-mediated neuroinflammation
  2664. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia
  2665. Metabolomic signatures in peripheral blood associated with Alzheimer’s disease amyloid-β-induced neuroinflammation
  2666. Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation
  2667. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
  2668. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
  2669. Metal toxicity links to alzheimer’s disease and neuroinflammation
  2670. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation
  2671. Metalloproteinases in neuroinflammation
  2672. Metallothionein and neuroinflammation
  2673. Metals and neuroinflammation
  2674. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway
  2675. Metformin attenuates neurological deficit after intracerebral hemorrhage by inhibiting apoptosis, oxidative stress and neuroinflammation in rats
  2676. Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
  2677. METH-induced neurotoxicity is alleviated by lactulose pretreatment through suppressing oxidative stress and neuroinflammation in rat striatum
  2678. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function
  2679. Methamphetamine induces neuroinflammation and neuronal dysfunction in the mice hippocampus
  2680. Methamphetamine neurotoxicity, microglia, and neuroinflammation
  2681. Methamphetamine-induced neuroinflammation and Neurotoxicity: a Role for Interleukin-1β
  2682. Methamphetamine‐induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin
  2683. Methionine Sulfoxide Reductase A Negatively Controls Microglia-Mediated neuroinflammation via Inhibiting ROS/MAPKs/NF-κB Signaling Pathways Through a …
  2684. Method of Passsive Immunization Against Disease or Disorder Charcterized by Amyloid Aggregation with Diminished Risk of neuroinflammation
  2685. Methods to assess neuroinflammation
  2686. Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice
  2687. Methylene blue attenuates neuroinflammation after subarachnoid hemorrhage in rats through the Akt/GSK-3β/MEF2D signaling pathway
  2688. Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice
  2689. Methylene Blue Infusion for Treatment of Traumatic Brain Injury-associated neuroinflammation
  2690. Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
  2691. Methylene blue mitigates acute neuroinflammation after spinal cord injury through inhibiting NLRP3 inflammasome activation in microglia
  2692. Methylene Blue Reduced Brain Edema, neuroinflammation, and Behavioral Deficits associated with a Moderate Traumatic Brain Injury
  2693. Methylene Blue: A Novel Disease-modifying Drug for neuroinflammation in Parkinson’s Disease
  2694. Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis
  2695. MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation
  2696. MG17, A Novel Triazole Derivative Abrogated neuroinflammation and Related Neurodegenerative Symptoms in Rodents
  2697. MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-κB pathway in vitro and in vivo
  2698. Microarray analysis identifies the potential role of long non-coding RNA in regulating neuroinflammation during Japanese encephalitis virus infection
  2699. Microbial Translocation is associated with neuroinflammation in HIV-infected subjects on ART
  2700. Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and neuroinflammation in a Rat Model of Alzheimer’s-Like Amyloidosis
  2701. Microglia Activated by Excess Cortisol Induce HMGB1 Acetylation and neuroinflammation in the Hippocampal DG Region of Mice Following Cold Exposure
  2702. Microglia and astroglia: the role of neuroinflammation in lead toxicity and neuronal injury in the brain
  2703. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
  2704. Microglia and calcium dysregulation during chronic neuroinflammation and aging: causes and consequences
  2705. Microglia and mast cells: two tracks on the road to neuroinflammation
  2706. Microglia contribute to the glia limitans around arteries, capillaries and veins under physiological conditions, in a model of neuroinflammation and in human brain …
  2707. Microglia in neurodegenerative disorders and neuroinflammation
  2708. Microglia Mediated neuroinflammation: Focus on PI3K Modulation
  2709. Microglia modulate Ang II induced neuronal activity and neuroinflammation
  2710. Microglia morphological categorization in a rat model of neuroinflammation by hierarchical cluster and principal components analysis
  2711. Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune …
  2712. Microglia TREM2 is required for electroacupuncture to attenuate neuroinflammation in focal cerebral ischemia/reperfusion rats
  2713. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of neuroinflammation Effective in Alzheimer’s Disease Models
  2714. Microglia-dependent presynaptic disruption in an organotypic hippocampal slice culture model of neuroinflammation
  2715. Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson’s disease-lessons from transgenic mice
  2716. Microglia-mediated neuroinflammation in neurodegenerative diseases
  2717. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
  2718. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
  2719. Microglial activation and neuroinflammation in Alzheimer’s disease: a critical examination of recent history
  2720. Microglial activation in neuroinflammation: Implications for the etiology of neurodegeneration
  2721. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype
  2722. Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia
  2723. Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease
  2724. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation
  2725. Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats
  2726. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes
  2727. Microglial Kv1. 3, a voltage-gated potassium channel, mediates neuroinflammation and neurodegeneration in cell culture and animal models of Parkinson’s disease
  2728. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity
  2729. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury
  2730. Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
  2731. Microglial mitophagy mitigates neuroinflammation in Alzheimer’s disease
  2732. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy
  2733. Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation
  2734. MicroRNA 155 and viral-induced neuroinflammation
  2735. MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial …
  2736. MicroRNA-125b mimic inhibits ischemia reperfusion-induced neuroinflammation and aberrant p53 apoptotic signalling activation through targeting TP53INP1
  2737. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice
  2738. MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome …
  2739. MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation
  2740. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation
  2741. MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice
  2742. MicroRNA-23b alleviates neuroinflammation and brain injury in intracerebral hemorrhage by targeting inositol polyphosphate multikinase
  2743. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
  2744. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
  2745. MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson’s disease mouse model
  2746. MicroRNA‑195 triggers neuroinflammation in Parkinson’s disease in a Rho‑associated kinase 1‑dependent manner
  2747. microRNA‐200b modulates microglia‐mediated neuroinflammation via the cJun/MAPK pathway
  2748. microRNA‐9‐5p alleviates blood‐brain barrier damage and neuroinflammation after traumatic brain injury
  2749. MicroRNAs and the genetic nexus of brain aging, neuroinflammation, neurodegeneration, and brain trauma
  2750. MicroRNAs as novel regulators of neuroinflammation
  2751. MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications
  2752. MicroRNAs in the brain: it’s regulatory role in neuroinflammation
  2753. MicroRNAs: roles in regulating neuroinflammation
  2754. MICROVESICLES: MESSENGERS AND MEDIATORS OF neuroinflammation
  2755. Midkine is a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by …
  2756. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (IN3-1.008)
  2757. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (S37. 003)
  2758. Mildronate and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression
  2759. Mincle/Syk Signaling Pathway Contributes to neuroinflammation after Subarachnoid Hemorrhage in Rats
  2760. Mineralocorticoid receptors, neuroinflammation and hypertensive encephalopathy
  2761. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
  2762. Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague …
  2763. Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2
  2764. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE in a transgenic model of Alzheimer’s-like amyloid pathology
  2765. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer’s disease-like amyloid pathology
  2766. MINOCYCLINE IMPROVES MEMORY AND REDUCES THE neuroinflammation OF MICE SUBJECT TO AMYLOID B (1-42) PEPTIDE ADMINISTRATION
  2767. Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess
  2768. Minocycline plus N-acteylcysteine induces remyelination, synergistically protects oligodendrocytes and modifies neuroinflammation in a rat model of mild traumatic …
  2769. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
  2770. Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration
  2771. miR-140-5p Attenuates neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4
  2772. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation
  2773. miR‐194 relieve neuropathic pain and prevent neuroinflammation via targeting FOXA1
  2774. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy
  2775. miRNA-3473b contributes to neuroinflammation following cerebral ischemia
  2776. Mitigating Role Of Chrysin Loaded Solid Lipid Nanoparticles Against Cognitive Decline neuroinflammation And Impaired Brain Aand# 946; Clearance In …
  2777. Mitigation effects of a novel herbal medicine, hepad, on neuroinflammation, neuroapoptosis, and neuro-oxidation
  2778. Mitigation of postnatal ethanol-induced neuroinflammation ameliorates trace fear memory deficits in juvenile rats
  2779. Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson’s disease
  2780. Mitochondria and the link between neuroinflammation and neurodegeneration
  2781. Mitochondria as the core of neuroinflammation and neurodegeneration in models of neuronal and astrocytic dysfunction
  2782. Mitochondria at the interface between neurodegeneration and neuroinflammation
  2783. Mitochondria in neuroinflammation–Multiple sclerosis (MS), Leber hereditary optic neuropathy (LHON) and LHON-MS
  2784. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease
  2785. Mitochondrial damage and axon degeneration in chronic neuroinflammation
  2786. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders
  2787. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
  2788. Mitochondrial dysfunctioning and neuroinflammation: Recent highlights on the possible mechanisms involved in Traumatic Brain Injury
  2789. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage
  2790. Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration
  2791. Mitochondrial transcription factor A (TFAM) as a novel intercellular signaling molecule of the brain: its role in glial cell activation and neuroinflammation
  2792. Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation
  2793. Mitogen-activated protein kinase–activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting
  2794. MKP1 reduces neuroinflammation via inhibiting endoplasmic reticulum stress and mitochondrial dysfunction
  2795. MLKL mediated necroptosis accelerates JEV-induced neuroinflammation in mice
  2796. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson’s disease
  2797. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation …
  2798. Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum
  2799. MODELING AMYLOID-β INDUCED neuroinflammation IN ZEBRAFISH
  2800. Modeling cytokine regulatory network dynamics driving neuroinflammation in central nervous system disorders
  2801. Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction
  2802. Modeling neuroinflammation in Individuals with Parkinson’s
  2803. Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation
  2804. Modeling the Effect of HIV-1 Induced neuroinflammation on the Cerebral Vasculature: Acute Intracranial Exposure to HIV-1 Tat Leads to Dysregulation of …
  2805. Modelling neuroinflammation In Vitro: A Tool to Test the Potential
  2806. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents
  2807. Modest reductions in BACE1 activity significantly reduce beta-amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease
  2808. Modifiable risk factors of Alzheimer’s disease and neuroinflammation: what are the links?
  2809. Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis
  2810. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
  2811. Modulating neuroinflammation to treat neuropsychiatric disorders
  2812. Modulating neuroinflammation with Porous Templated Scaffolds
  2813. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways
  2814. Modulation of adult hippocampal neurogenesis during myelin‐directed autoimmune neuroinflammation
  2815. Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation
  2816. Modulation of glutamate transmission during amyotrophic lateral sclerosis: regulation of glutamate transporters and implication of neuroinflammation
  2817. Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors
  2818. Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase
  2819. Modulation of LPS-induced memory insult, γ-secretase and neuroinflammation in 3xTg mice by 5-Lipoxygenase
  2820. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate
  2821. Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation
  2822. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice
  2823. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer’s disease using a biased and selective beta-1 adrenergic receptor partial …
  2824. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: Implications for cerebral ischemia and neurodegenerative diseases
  2825. Modulation of neuroinflammation by dietary flavonoids
  2826. Modulation of neuroinflammation by Taklisodok-um in a Spinal Cord Injury Model
  2827. Modulation of neuroinflammation in Experimental Subarachnoid Hemorrhage
  2828. Modulation of neuroinflammation in the central nervous system: role of chemokines and sphingolipids
  2829. Modulation of neuroinflammation with the phytoestrogen, formononetin
  2830. Modulation of neuroinflammation: role and therapeutic potential of TRPV1 in the neuro-immune axis
  2831. Modulation of post-traumatic epilepsy by MIS416, a novel innate immune modulator for the treatment of neuroinflammation (P6. 232)
  2832. Modulation of pro-inflammatory response of retina by adenosinergic systems: neuroinflammation/neuroprotection
  2833. Modulation of the endocannabinoid system and PanX1-mediated neuroinflammation in an in vitro model of Alzheimer’s disease
  2834. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3
  2835. Modulatory Effect of a Standardised Andrographis Paniculata Aqueous Extract on Urine Metabolomics in a Rat Model of neuroinflammation
  2836. Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats
  2837. Modulatory role of ketogenic diet on neuroinflammation; a possible drug naïve strategy to treatment of Parkinson’s disease
  2838. Molecular and cellular insights: neuroinflammation and amyotrophic lateral sclerosis
  2839. Molecular and Cellular Mechanisms of neuroinflammation
  2840. Molecular and Cellular Mechanisms of neuroinflammation
  2841. Molecular and Cellular Substrates of neuroinflammation in Alzheimer Disease and Depression
  2842. Molecular basis of etiological implications in Alzheimer’s disease: focus on neuroinflammation
  2843. Molecular chaperone α-crystallin prevents detrimental effects of neuroinflammation
  2844. Molecular cross-talk between Lrrk2 and NF-κ/INS; B in neuroinflammation in an/INS; animal model of Parkinson’s disease (PD)
  2845. Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway
  2846. Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice
  2847. Molecular imaging of neuroinflammation in Alzheimer’s disease
  2848. Molecular imaging of neuroinflammation in Alzheimer’s disease and mild cognitive impairment
  2849. Molecular imaging of neuroinflammation in HIV
  2850. Molecular Imaging of neuroinflammation in Idiopathic Parkinson’s Disease
  2851. Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging
  2852. Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I‐CLINDE single photon emission computed tomography study
  2853. Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography.
  2854. Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder
  2855. Molecular Indicators of Stress-Induced neuroinflammation in a Mouse Model Simulating Features of Post-Traumatic Stress Disorder (Open Access)
  2856. Molecular insights into NR4A2 (Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death
  2857. Molecular mechanism of aluminum induced neuroinflammation
  2858. MOLECULAR MECHANISMS IN P25/CDK5-MEDIATED neuroinflammation AND SUBSEQUENT NEURODEGENERATION: THERAPEUTIC …
  2859. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS
  2860. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis
  2861. Molecular Mechanisms Of neuroinflammation Following Global Cerebral Ischemia: The Role Of Hypothermia Therapy
  2862. Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer’s disease
  2863. Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency
  2864. Molecular pathogenesis of neuroinflammation
  2865. Molecular Tipping Points in neuroinflammation
  2866. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases
  2867. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
  2868. monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
  2869. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2
  2870. Morin attenuates ifosfamide-induced neurotoxicity in rats via suppression of oxidative stress, neuroinflammation and neuronal apoptosis
  2871. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia
  2872. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy
  2873. Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-activation and neuroinflammation
  2874. Moringa oleifera inhibit neuroinflammation in LPS activated BV2 microglia
  2875. Morphine activates neuroinflammation in a manner parallel to endotoxin
  2876. Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit
  2877. Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
  2878. MP47-04 CYCLOPHOSPHAMIDE-INDUCED CYSTITIS TRIGGERS NLRP3–DEPENDENT neuroinflammation IN THE HIPPOCAMPUS AND DEPRESSION IN …
  2879. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
  2880. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus
  2881. MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain
  2882. MRI coupled with clinically-applicable iron oxide nanoparticles reveals choroid plexus involvement in a murine model of neuroinflammation
  2883. MRI monitoring of neuroinflammation in mouse focal ischemia
  2884. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO
  2885. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
  2886. MRI/MRS in neuroinflammation: methodology and applications
  2887. MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury
  2888. MSP-dependent activation of CNS Ron Receptor Tyrosine Kinase signaling attenuates neuroinflammation through the physiological regulation of IL1B and NLRP3 …
  2889. mTOR and neuroinflammation
  2890. mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy
  2891. mTOR Pathway Inhibition Prevents neuroinflammation and Neuronal Death in a Mouse Model of Spinal Cord Injury
  2892. mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia
  2893. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation
  2894. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity
  2895. Mucuna pruriens protects against MPTP Intoxicated neuroinflammation in Parkinson’s disease through NF-κB/pAKT signaling pathways
  2896. Müller Cell–Microglia Cross Talk Drives neuroinflammation in Diabetic Retinopathy
  2897. Multi-functional diarylurea small molecule inhibitors of TRPV1 with therapeutic potential for neuroinflammation
  2898. Multi-scale analyses of molecular network dynamics underlying neuronal excitability, neuroinflammation, and organismal homeostasis
  2899. Multifaces of neuropeptide Y in the brain–neuroprotection, neurogenesis and neuroinflammation
  2900. Multimodal approach to the evaluation of diffuse neuroinflammation in multiple sclerosis using positron emission tomography and diffusion tensor imaging
  2901. Multimodal evaluation of neuroinflammation-associated changes during epileptogenesis using small animal PET and MRI.
  2902. Multimodal molecular imaging demonstrates myeloperoxidase regulation of matrix metalloproteinase activity in neuroinflammation
  2903. Multiple loci comprising immune-related genes regulate experimental neuroinflammation
  2904. Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies
  2905. Multiple Sclerosis is a Primary System of Neurodegeneration Permissive for neuroinflammation and Demyelination
  2906. Multiple sclerosis: Coagulation factors could mediate neuroinflammation in multiple sclerosis
  2907. Multiple sclerosis: implications of obesity in neuroinflammation
  2908. Multitarget Profiling of a Strigolactone Analog for Early Events of Alzheimer’s Disease: in Vitro Therapeutic Activities against neuroinflammation
  2909. Mumefural Ameliorates Cognitive Impairment in Chronic Cerebral Hypoperfusion via Regulating the Septohippocampal Cholinergic System and neuroinflammation
  2910. Murine K2P5. 1 deficiency has no impact on autoimmune neuroinflammation due to compensatory K2P3. 1-and KV1. 3-dependent mechanisms
  2911. Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice
  2912. Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
  2913. Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis
  2914. Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
  2915. MyD88 is dispensable for cerebral amyloid pathology and neuroinflammation in PSAPP transgenic mice
  2916. MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice
  2917. Myelin loss associated with neuroinflammation in hypertensive rats
  2918. Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice
  2919. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions
  2920. Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis
  2921. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
  2922. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation
  2923. Myeloid-derived suppressor cells infiltrate the brain and suppress neuroinflammation in a mouse model of focal traumatic brain injury
  2924. Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune neuroinflammation
  2925. Myocardial infarction is associated with neuroinflammation-a systemic analysis using TSPO-targeted molecular imaging.
  2926. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction
  2927. Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice
  2928. Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model
  2929. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis
  2930. n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and neuroinflammation
  2931. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer’s disease
  2932. N-3 Polyunsaturated Fatty Acid and neuroinflammation in Aging: Role in Cognition
  2933. N-3 Polyunsaturated Fatty Acids and neuroinflammation in Alzheimer’s Disease
  2934. N-3 polyunsaturated fatty acids and the resolution of neuroinflammation
  2935. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation
  2936. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update
  2937. N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice
  2938. N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
  2939. N-acetylcysteine Prevents Alcohol Related neuroinflammation in Rats
  2940. N-Palmitoylethanolamine and neuroinflammation: a Novel Therapeutic Strategy of Resolution
  2941. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation and oxidative stress associated to vascular dementia
  2942. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an …
  2943. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord …
  2944. N, N-disubstituted azines attenuate LPS-mediated neuroinflammation in microglia and neuronal apoptosis via inhibiting MAPK signaling pathways
  2945. Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats
  2946. NAFLD induces neuroinflammation and accelerates Alzheimer’s disease
  2947. Naja sputatrix venom preconditioning attenuates neuroinflammation in a rat model of surgical brain injury via PLA2/5-LOX/LTB4 cascade activation
  2948. Nalmefene prevents alcohol‐induced neuroinflammation and alcohol drinking preference in adolescent female mice: role of TLR4
  2949. NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation
  2950. Nano-size Particles Of Probiotics For Preventing And Treating neuroinflammation
  2951. Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
  2952. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation
  2953. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
  2954. NanoString analysis of neuroinflammation in multiple system atrophy
  2955. Nanotherapeutics for gene modulation that prevents apoptosis in the brain and fatal neuroinflammation
  2956. Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice
  2957. Naringenin protects against 1-methyl-4-phenylpyridinium-induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line …
  2958. Naringin attenuates autophagic stress and neuroinflammation in kainic acid-treated hippocampus in vivo
  2959. Narrative Review Article: neuroinflammation and Perioperative Neurocognitive Disorders
  2960. Natural AD-Like neuropathology in Octodon degus: impaired burrowing and neuroinflammation
  2961. Natural compound 2 provides neuroprotection and anti-neuroinflammation via Nrf2/AREdependent HO-1 expression through activation of the PI3K/AKT …
  2962. Natural compounds isolated from wild Alaska bog blueberries intervene with molecular targets of neuroinflammation
  2963. Natural flavone jaceosidin is a neuroinflammation inhibitor
  2964. Naturally occurring beta-secretase inhibitors mitigate behavioral impairment, cerebral amyloidosis and neuroinflammation in transgenic mice
  2965. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease
  2966. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral …
  2967. Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation …
  2968. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
  2969. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation
  2970. NEIL1 stimulates neurogenesis and suppresses neuroinflammation after stress
  2971. NEK7 regulates NLRP3 inflammasome activation and neuroinflammation post-TBI
  2972. Neonatal Bacillus Calmette-Guerin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice
  2973. Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice
  2974. Neonatal lipopolysaccharide treatment alters hippocampal neuroinflammation, microglia morphology and anxiety-like behavior in rats selectively bred for an infantile …
  2975. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF-κB
  2976. Nesfatin-1 Ameliorate Learning and Memory Deficit via Inhibiting Apoptosis and neuroinflammation Following Ethanol-Induced Neurotoxicity in Early Postnatal Rats
  2977. Netrin 1 regulates blood–brain barrier function and neuroinflammation
  2978. Netrin‐1 and multiple sclerosis: a new biomarker for neuroinflammation?
  2979. Network medicine in drug design: implications for neuroinflammation
  2980. Neural stem cell small extracellular vesicle-based delivery of 14-3-3t reduces apoptosis and neuroinflammation following traumatic spinal cord injury by …
  2981. Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  2982. Neural Stem Cell Treatment Prevents neuroinflammation and Increases Hippocampal BDNF Levels in Genetic Absence Epileptic WAG/Rij Rats
  2983. Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy
  2984. Neural stem cells respond to extracellular succinate via SUCNR1/GPR91 to ameliorate chronic neuroinflammation
  2985. Neuraminidase-induced neuroinflammation is largely dependent on microglial TLR4 receptor
  2986. Neuregulin upregulates microglial α7 nicotinic acetylcholine receptor expression in immortalized cell lines: implications for regulating neuroinflammation
  2987. Neuregulin-1 protects mouse cerebellum against oxidative stress and neuroinflammation
  2988. Neuroactive Steroids and neuroinflammation
  2989. Neuroactive steroids, their metabolites, and neuroinflammation
  2990. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex
  2991. Neurocysticercosis and hippocampal damage: a causal link favored by epileptogenesis or neuroinflammation?
  2992. Neurodegeneration and neuroinflammation in a Mouse Model of Sarin Exposure
  2993. Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration
  2994. Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss
  2995. Neurodegeneration and neuroinflammation in Parkinson’s disease: reasearch of blood circulating biomarkers.
  2996. Neurodegeneration and neuroinflammation: two processes, one target
  2997. Neurodegeneration in Chronic Kidney Disease: role of neuroinflammation and uremic toxins
  2998. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.
  2999. Neurogenesis and neuroinflammation: the role of Wnt proteins
  3000. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome
  3001. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
  3002. Neuroglial activation and neuroinflammation in the brain of patients with autism
  3003. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
  3004. Neuroimaging in Autoimmune and neuroinflammation-Related Epilepsies
  3005. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia
  3006. Neuroimmune and Systemic Manifestations of neuroinflammation in the Temporomandibular Joint and Related Disorders
  3007. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
  3008. Neuroimmunity and neuroinflammation
  3009. Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation
  3010. Neuroimmunology and neuroinflammation in autoimmune, neurodegenerative and psychiatric disease
  3011. Neuroimmunology: What Role for Autoimmunity, neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events …
  3012. neuroinflammation
  3013. neuroinflammation
  3014. neuroinflammation
  3015. neuroinflammation
  3016. neuroinflammation
  3017. neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy
  3018. neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders
  3019. neuroinflammation activates Mdr1b efflux transport through NFκB: promoter analysis in BBB endothelia
  3020. neuroinflammation after acute brain injury: the role of interleukin-1 actions on non-neuronal cells
  3021. neuroinflammation after intracerebral hemorrhage
  3022. neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
  3023. neuroinflammation after neonatal hypoxia–ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most …
  3024. neuroinflammation after Subarachnoid Hemorrhage: The Role of Microglia
  3025. neuroinflammation after traumatic brain injury is enhanced in activating transcription factor 3 mutant mice
  3026. neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention
  3027. neuroinflammation after traumatic injury to the developing brain
  3028. neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation
  3029. neuroinflammation alters integrative properties of rat hippocampal pyramidal cells
  3030. neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression
  3031. neuroinflammation alters voltage-dependent conductance in striatal astrocytes
  3032. neuroinflammation AND 18F-AV-1451 PET FINDINGS IN SEMANTIC DEMENTIA
  3033. neuroinflammation and aberrant hippocampal plasticity in a mouse model of emotional stress evoked by exposure to ultrasound of alternating frequencies
  3034. neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor …
  3035. neuroinflammation and adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment in aged mice
  3036. neuroinflammation and ageing: current theories and an overview of the data
  3037. neuroinflammation and aging: influence of dietary n-3 polyunsaturated fatty acid
  3038. neuroinflammation and aging: significance of declining circadian functions and melatonin
  3039. neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets
  3040. neuroinflammation and Alzheimer’s Disease
  3041. neuroinflammation and Alzheimer’s disease: implications for microglial activation
  3042. neuroinflammation and Alzheimer’s disease: implications of Abeta immunotherapy
  3043. neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
  3044. neuroinflammation and amyloid deposition: Concurrent [11C] PBR28 and [11C] PIB PET imaging in patients with Alzheimer’s disease, mild cognitive impairment, and …
  3045. neuroinflammation AND AMYLOID PATHOLOGY AFTER TBI
  3046. neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s …
  3047. neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
  3048. neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood–brain barrier (BBB) opening
  3049. neuroinflammation and autism spectrum disorder: a review
  3050. neuroinflammation and autism: toward mechanisms and treatments
  3051. neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation
  3052. neuroinflammation and B-Cell Phenotypes in Cervical and Lumbosacral Regions of the Spinal Cord in Experimental Autoimmune Encephalomyelitis in the Absence …
  3053. neuroinflammation and behavior
  3054. neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress
  3055. neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism
  3056. neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy
  3057. neuroinflammation and blood–brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets
  3058. neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection
  3059. neuroinflammation and brain antioxidant levels in ethanol leaf extract of Nauclea latifolia and Artemisinin-combination therapy in Swiss mice infected with …
  3060. neuroinflammation and brain atrophy in former NFL players: an in vivo multimodal imaging pilot study
  3061. neuroinflammation and brain functional disconnection in Alzheimer’s disease
  3062. neuroinflammation and brain infections: historical context and current perspectives
  3063. neuroinflammation and Cannabinoid CB2 Receptor Expression in the Human Huntington’s Disease Brain and R6/1 Transgenic Mouse Model
  3064. neuroinflammation and cell therapy for Parkinson’s disease
  3065. neuroinflammation and central nervous system regeneration in vertebrates
  3066. neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain
  3067. neuroinflammation and central sensitization in chronic and widespread pain
  3068. neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective
  3069. neuroinflammation and Circuitry Changes in the Dorsal Raphe Nucleus with Depressive Phenotype after Spinal Cord Injury
  3070. neuroinflammation and CNS disorders
  3071. neuroinflammation AND COGNITION
  3072. neuroinflammation and Cognition
  3073. neuroinflammation and cognitive aging
  3074. neuroinflammation and cognitive dysfunction in chronic disease and aging
  3075. neuroinflammation and cognitive function in aged mice following minor surgery
  3076. neuroinflammation and cognitive impairment in the aged: implications for nutritional intervention
  3077. neuroinflammation and cognitive plasticity following experimental stroke
  3078. neuroinflammation and common mechanism in Alzheimer’s disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary …
  3079. neuroinflammation and comorbid depression: a role for interleukin-1 beta converting enzyme and indoleamine 2, 3-dioxygenase
  3080. neuroinflammation and comorbidities are frequently ignored factors in CNS pathology
  3081. neuroinflammation and comorbidity of pain and depression
  3082. neuroinflammation and Complexes of 17β-Hydroxysteroid Dehydrogenase type 10-Amyloid β in Alzheimer’s Disease
  3083. neuroinflammation and copper in Alzheimer’s disease
  3084. neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?
  3085. neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods
  3086. neuroinflammation AND DEFECTIVE MYELINATION IN POLYMICROGYRIA
  3087. neuroinflammation and defining gene therapy approaches for ovine CLN6 Batten disease
  3088. neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection
  3089. neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation
  3090. neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation
  3091. neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system
  3092. neuroinflammation and EIF2 signaling persist in an HiPSC tri-culture model of HIV infection despite antiretroviral treatment
  3093. neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration
  3094. neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo (His-Pro) to prevent LPS neurotoxicity
  3095. neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model
  3096. neuroinflammation and excitatory symptoms in bipolar disorder
  3097. neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection
  3098. neuroinflammation and fatty acids
  3099. neuroinflammation and Fragile X syndrome: regulation by glycogen synthase kinase-3
  3100. neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance
  3101. neuroinflammation And Glial Cell Activation In Mental Disorders
  3102. neuroinflammation and glial cell activation in pathogenesis of chronic pain
  3103. neuroinflammation and glial phenotypic changes in alpha-synucleinopathies
  3104. neuroinflammation and Immune Regulation in Ischemic Stroke: Identification of New Pharmacological Targets
  3105. neuroinflammation and immunity: a new pharmacological target in depression
  3106. neuroinflammation and impairment of hippocampal neurogenesis underlies depressive-like behaviors of obese rats: Role of TNF-alpha inhibition
  3107. neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit
  3108. neuroinflammation and inhibitory synaptic control of cultured premotor circuits
  3109. neuroinflammation and iron handling in animal models with brain iron overload
  3110. neuroinflammation and its modulation by flavonoids
  3111. neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis
  3112. neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration
  3113. neuroinflammation and mechanisms of neuropathic pain development
  3114. neuroinflammation and memory: the role of prostaglandins
  3115. neuroinflammation and microglia in glaucoma: time for a paradigm shift
  3116. neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
  3117. neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome
  3118. neuroinflammation and mitochondrial dysfunction in Alzheimer’s and prion’s diseases
  3119. neuroinflammation and mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease: modulation by Coriolus Versicolor (Yun-Zhi) nutritional …
  3120. neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury
  3121. neuroinflammation and myelin status in Alzheimer’s disease, Parkinson’s disease, and normal aging brains: A small sample study
  3122. neuroinflammation and neuroaxonal damage in multiple sclerosis: a cross-sectional cerebrospinal fluid-based proteomic study
  3123. neuroinflammation and neurodegeneration
  3124. neuroinflammation and neurodegeneration as mechanisms for worsened outcomes in elderly traumatic brain injury
  3125. neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid
  3126. neuroinflammation and neurodegeneration in human brain at single-cell resolution
  3127. neuroinflammation and neurodegeneration in overnutrition-induced diseases
  3128. neuroinflammation and neurodegeneration: pinpointing pathological and pharmacological targets
  3129. neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets
  3130. neuroinflammation and neurodegenerative diseases: a single subject analysis
  3131. neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
  3132. neuroinflammation and neurogenesis in the choroid plexus
  3133. neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
  3134. neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain
  3135. neuroinflammation and Neuroimmunomodulation in Alzheimer’s Disease
  3136. neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
  3137. neuroinflammation and neurological alterations in chronic liver diseases
  3138. neuroinflammation and Neuromodulation in Neurological Diseases
  3139. neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral …
  3140. neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer’s disease
  3141. neuroinflammation and neuroplasticity in pain
  3142. neuroinflammation and neuroprotection in schizophrenia and autism spectrum disorder
  3143. neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment
  3144. neuroinflammation and neuroprotective strategies in acute ischaemic stroke-from bench to bedside
  3145. neuroinflammation and neurosteroidogenesis: Reciprocal modulation during injury to the adult zebra finch brain
  3146. neuroinflammation and neurotoxicity contribute to neuroprogression in neurological and psychiatric disorders
  3147. neuroinflammation and neurotrophic actions of chemokines during a cerebral ischemic process
  3148. neuroinflammation AND NEUROVASCULAR DYSFUNCTION IN CVN MICE AFTER ORTHOPEDIC SURGERY
  3149. neuroinflammation and non-motor symptoms: the dark passenger of Parkinson’s disease?
  3150. neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome
  3151. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
  3152. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
  3153. neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
  3154. neuroinflammation and oxidative injury in developmental neurotoxicity
  3155. neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation
  3156. neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets
  3157. neuroinflammation and oxidative stress in psychosis and psychosis risk
  3158. neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation
  3159. neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson’s disease
  3160. neuroinflammation and pain
  3161. neuroinflammation and Parkinson disease: the silent battleground
  3162. neuroinflammation and Parkinson’s disease
  3163. neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in …
  3164. neuroinflammation and Pediatric Lupus
  3165. neuroinflammation and peripheral immune infiltration in Parkinson’s disease: an autoimmune hypothesis
  3166. neuroinflammation and physical exercise as modulators of adult hippocampal neural precursor cell behavior
  3167. neuroinflammation and postoperative cognitive dysfunction: what do we know?
  3168. neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
  3169. neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1
  3170. neuroinflammation and Psychiatric Illness
  3171. neuroinflammation and psychosis; antipsychotic medication.
  3172. neuroinflammation and regeneration in the early stages of Alzheimer’s disease pathology
  3173. neuroinflammation and regulation of glial glutamate uptake in neurological disorders
  3174. neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivomodel of Alzheimer’s disease
  3175. neuroinflammation and schizophrenia
  3176. neuroinflammation and Schizophrenia
  3177. neuroinflammation and Seizures After Pediatric Brain Injury: What a Headache!
  3178. neuroinflammation and sickness induced by lipopolysaccharide in adult and aged mice are not mitigated by dietary broccoli (134.4)
  3179. neuroinflammation and Sjogren’s Syndrome
  3180. neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension
  3181. neuroinflammation and synaptic loss
  3182. neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
  3183. neuroinflammation and tau interact with amyloid in predicting sleep problems in aging independently of atrophy
  3184. neuroinflammation and the APOε genotype: Implications for Alzheimer’s disease and modulation by dietary flavonoids and n-3 polyunsaturated fatty acids
  3185. neuroinflammation and the Behavioral Consequences of Air Pollution Over the Life Course
  3186. neuroinflammation and the blood‐brain‐interface: new findings in brain pathology
  3187. neuroinflammation and the blood–brain interface: New findings in brain pathology
  3188. neuroinflammation and the cGAS-STING pathway
  3189. neuroinflammation and the dynamic lesion in traumatic brain injury
  3190. neuroinflammation and the generation of neuropathic pain
  3191. neuroinflammation and the genetics of Alzheimer’s disease: the search for a pro-inflammatory phenotype
  3192. neuroinflammation and the glial endocannabinoid system
  3193. neuroinflammation and the Glial Response Contribute to Both Beneficial and Pathological Outcomes in Multiple Disease Models
  3194. neuroinflammation and the gut microbiota: possible alternative therapeutic targets to counteract Alzheimer’s disease?
  3195. neuroinflammation and the immune-kynurenine pathway in anxiety disorders
  3196. neuroinflammation and the plasticity-related immediate-early gene Arc
  3197. neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson’s disease.
  3198. neuroinflammation and the role of glia: relevance for neurodegenerative and neurosupportive roles
  3199. neuroinflammation and Toll-Like Receptors in the Skin
  3200. neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
  3201. neuroinflammation and Virus Replication in the Spinal Cord of Simian Immunodeficiency Virus–Infected Macaques
  3202. neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging
  3203. neuroinflammation and white matter pathology in schizophrenia: systematic review
  3204. neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
  3205. neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other Driving Chronic Progression of Parkinson’s Disease
  3206. neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease
  3207. neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging
  3208. neuroinflammation appears early on PET imaging and then plateaus in a mouse model of Alzheimer disease
  3209. neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease
  3210. neuroinflammation as a cause of chronic pain
  3211. neuroinflammation as a common feature of neurodegenerative disorders
  3212. neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases
  3213. neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments
  3214. neuroinflammation as a mechanism for cardiovascular diseases
  3215. neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on” Increased MCP-1 and microglia in various regions of human alcoholic brain”.
  3216. neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
  3217. neuroinflammation as a potential therapeutic target in dementia with Lewy bodies
  3218. neuroinflammation as a risk factor for attention deficit hyperactivity disorder
  3219. neuroinflammation as a target for glaucoma therapy
  3220. neuroinflammation as a target for intervention in subarachnoid hemorrhage
  3221. neuroinflammation as a therapeutic target in neurodegenerative diseases
  3222. neuroinflammation as an Early Event and Prime Mover in Alzheimer’s Pathobiology
  3223. neuroinflammation as an important pathogenic mechanism in spinal cord injury
  3224. neuroinflammation as fuel for axonal regeneration in the injured vertebrate central nervous system
  3225. neuroinflammation as fuel for axonal regeneration: unravelling the underlying players
  3226. neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: understanding pathogenesis and chances for treatment
  3227. neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis
  3228. neuroinflammation assessment of a mouse model of multiple sclerosis
  3229. neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress
  3230. neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress
  3231. neuroinflammation biomarkers
  3232. neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse
  3233. neuroinflammation caused by mental stress: the effect of chronic restraint stress and acute repeated social defeat stress in mice
  3234. neuroinflammation contributes to high salt intake-augmented neuronal activation and active coping responses to acute stress
  3235. neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity
  3236. neuroinflammation disorders exacerbated by environmental stressors
  3237. neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
  3238. neuroinflammation during Parkinson’s disease: key cells and molecules involved in it
  3239. neuroinflammation during RNA viral infections
  3240. neuroinflammation explains aspects of chronic pain and opens new avenues for therapeutic interventions
  3241. neuroinflammation Extends Brain Tissue at Risk to Vital Peri-Infarct Tissue: A Double Tracer [11C]PK11195- and [18F]FDG-PET Study
  3242. neuroinflammation facilitates LIF entry into brain: role of TNF
  3243. neuroinflammation follow-up in a quinolinic acid rat model of excitotoxicity by translocator protein (18 kDa) mapping with CLINDE
  3244. neuroinflammation following disease modifying therapy in multiple sclerosis: a pilot positron emission tomography study
  3245. neuroinflammation Following Sleep Fragmentation In A Pediatric Model
  3246. neuroinflammation functionally regulates CNS lymphatic vasculature and drainage
  3247. neuroinflammation imaging markers for epileptogenesis
  3248. neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
  3249. neuroinflammation in a Forceps Compression Model of Spinal Cord Injury
  3250. neuroinflammation IN A T-CELL TGF-β RECEPTOR DISRUPTED P301S MOUSE
  3251. neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11C-PK11195 and 18F-DPA-714 micro-positron …
  3252. neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets
  3253. neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies
  3254. neuroinflammation in advanced canine glaucoma
  3255. neuroinflammation in Age-Related Neurodegenerative Diseases
  3256. neuroinflammation in Aging
  3257. neuroinflammation in alcoholism using [11C] PBR28: from rat to human
  3258. neuroinflammation in Alzheimer’s
  3259. neuroinflammation in Alzheimer’s disease
  3260. neuroinflammation in Alzheimer’s disease
  3261. neuroinflammation in Alzheimer’s disease
  3262. neuroinflammation in Alzheimer’s disease and Down syndrome
  3263. neuroinflammation in Alzheimer’s disease and involvement of interleukin-1: a mechanistic view
  3264. neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancy
  3265. neuroinflammation in Alzheimer’s disease and obesity
  3266. neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder?
  3267. neuroinflammation in Alzheimer’s disease and prion disease
  3268. neuroinflammation in Alzheimer’s Disease and Prion Disease
  3269. neuroinflammation in Alzheimer’s Disease and Vascular Cognitive Impairment
  3270. neuroinflammation IN ALZHEIMER’S DISEASE PATHOLOGY DECREASES WITH AGE
  3271. neuroinflammation in Alzheimer’s disease wanes with age
  3272. neuroinflammation in Alzheimer’s disease; a source of heterogeneity and target for personalized therapy
  3273. neuroinflammation in Alzheimer’s disease: an understanding of physiology and pathology
  3274. neuroinflammation in Alzheimer’s disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
  3275. neuroinflammation in Alzheimer’s disease: Characterization and modification of the response of transgenic mice to intrahippocampal lipopolysaccharide …
  3276. neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors
  3277. neuroinflammation in Alzheimer’s disease: current evidence and future directions
  3278. neuroinflammation in Alzheimer’s disease: different molecular targets and potential therapeutic agents including curcumin
  3279. neuroinflammation in Alzheimer’s disease: focus on NF-κB and C/EBP transcription factors
  3280. neuroinflammation in Alzheimer’s disease: from pathogenesis to a therapeutic target
  3281. neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation
  3282. neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
  3283. neuroinflammation in Alzheimer’s disease: pleiotropic roles for cytokines and neuronal pentraxins
  3284. neuroinflammation in Alzheimer’s Disease: Potential Targets for Disease-Modifying Drugs
  3285. neuroinflammation in Alzheimer’s disease: protector or promoter?
  3286. neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
  3287. neuroinflammation in Alzheimer’s, Parkinson’s and Huntington’s Diseases
  3288. neuroinflammation in amyotrophic lateral sclerosis
  3289. neuroinflammation in amyotrophic lateral sclerosis: new targets for the treatment?
  3290. neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
  3291. neuroinflammation in amyotrophic lateral sclerosis: role of redox (dys) regulation
  3292. neuroinflammation in an Alzheimer’s disease animal model andthe effectiveness of selective suppression of glial activation
  3293. neuroinflammation in animal models of autism
  3294. neuroinflammation in animal models of fatigue
  3295. neuroinflammation in animal models of traumatic brain injury
  3296. neuroinflammation in autism spectrum disorders
  3297. neuroinflammation in autism spectrum disorders: Role of high mobility group box 1 protein
  3298. neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota
  3299. neuroinflammation in Bacterial Meningitis
  3300. neuroinflammation in bipolar disorder–A [11C]-(R)-PK11195 positron emission tomography study
  3301. neuroinflammation in bipolar disorders
  3302. neuroinflammation in CNS diseases: molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
  3303. neuroinflammation in delirium: a postmortem case-control study
  3304. neuroinflammation in Demyelinating Diseases: Oxidative Stress as a Modulator of Glial Cross-Talk
  3305. neuroinflammation in depression
  3306. neuroinflammation in early and late onset Alzheimer´ s disease: a multimodal analysis
  3307. neuroinflammation in Early Stages of Alzheimer’s Disease and Parkinson’s Disease
  3308. neuroinflammation in epilepsy: an analysis of patients’ sera and its effect on microglia-like cells (S55. 007)
  3309. neuroinflammation in epileptogenesis: insights and translational perspectives from new models of epilepsy
  3310. neuroinflammation in fibromyalgia and CRPS is multifactorial
  3311. neuroinflammation in fibromyalgia and CRPS: top-down or bottom-up?
  3312. neuroinflammation in first episodes of psychosis
  3313. neuroinflammation in frontotemporal dementia
  3314. neuroinflammation in frontotemporal lobar degeneration revealed by 11C‐PBR28 PET
  3315. neuroinflammation in glaucoma and optic nerve damage
  3316. neuroinflammation in glaucoma: a new opportunity
  3317. neuroinflammation in glaucoma: soluble tumor necrosis factor alpha and the connection with excitotoxic damage
  3318. neuroinflammation in Gulf War Illness is linked with HMGB1 and complement activation, which can be discerned from brain-derived extracellular vesicles in the blood
  3319. neuroinflammation in hAPPSL transgenic mice
  3320. neuroinflammation in HCV-infection–Peril or protection?
  3321. neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand,[18F]-FEPPA
  3322. neuroinflammation in heart failure: new insights for an old disease
  3323. neuroinflammation in hepatic encephalopathy: mechanistic aspects
  3324. neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
  3325. neuroinflammation in Huntington’s disease
  3326. neuroinflammation in Huntington’s disease
  3327. neuroinflammation in Huntington’s disease-effects of fractalkine on microglia in a mouse model R6/2 of Huntington’s disease
  3328. neuroinflammation in Huntington’s Disease: New Insights with 11C-PBR28 PET/MRI
  3329. neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
  3330. neuroinflammation in inflammatory bowel disease
  3331. neuroinflammation in intrauterine growth restriction
  3332. neuroinflammation in Ischaemic Stroke: Utilizing the Biphasic Niche of Neuroprotection and Neurotoxicity for Clinic
  3333. neuroinflammation in ischemic brain injury as an adaptive process
  3334. neuroinflammation in ischemic pediatric stroke
  3335. neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
  3336. neuroinflammation in Lewy body dementia
  3337. neuroinflammation in liver disease: sessional talks from ISHEN
  3338. neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
  3339. neuroinflammation in Major Depressive Disorder and Schizophrenia: A PET Study
  3340. neuroinflammation in manganese neurotoxicity
  3341. neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis
  3342. neuroinflammation in mood disorders: Mechanisms and drug targets
  3343. neuroinflammation in motor neuron disease
  3344. neuroinflammation in motor neuron disease
  3345. neuroinflammation in mouse models of Alzheimer’s disease
  3346. neuroinflammation in Movement Disorders
  3347. neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction
  3348. neuroinflammation in multiple system atrophy: response to and cause of α-synuclein aggregation
  3349. neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant
  3350. neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein
  3351. neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives
  3352. neuroinflammation in neurodegenerative diseases: Current multi-modal imaging studies and future opportunities for hybrid PET/MRI
  3353. neuroinflammation in neurodegenerative disorders—a review
  3354. neuroinflammation in Neurodegenerative Disorders: Harmful or Helpful?
  3355. neuroinflammation in neurological disorders
  3356. neuroinflammation in Neurological Dysfunction and Degeneration
  3357. neuroinflammation in neuronal degeneration and repair
  3358. neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance
  3359. neuroinflammation in organophosphate-induced neurotoxicity
  3360. neuroinflammation in overnutrition-induced diseases
  3361. neuroinflammation in Parkinson’s disease
  3362. neuroinflammation in Parkinson’s disease
  3363. neuroinflammation in Parkinson’s disease and its potential as therapeutic target
  3364. neuroinflammation in Parkinson’s disease and related disorders: a lesson from genetically manipulated mouse models of-synucleinopathies
  3365. neuroinflammation in Parkinson’s disease animal models: a cell stress response or a step in neurodegeneration?
  3366. neuroinflammation in Parkinson’s disease: a target for neuroprotection?
  3367. neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention
  3368. neuroinflammation in Parkinson’s disease: role in neurodegeneration and tissue repair
  3369. neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 …
  3370. neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study
  3371. neuroinflammation in plaque and vascular β-amyloid disorders: clinical and therapeutic implications
  3372. neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
  3373. neuroinflammation in preclinical Alzheimer’s disease is associated with parahippocampal pathology and memory deficits
  3374. neuroinflammation in preclinical Alzheimer’s disease: a review of current evidence
  3375. neuroinflammation in preterm babies and autism spectrum disorders
  3376. neuroinflammation in primary blast neurotrauma: Time course and prevention by torso shielding
  3377. neuroinflammation in prion diseases: concepts and targets for therapeutic intervention
  3378. neuroinflammation in pulmonary hypertension: concept, facts, and relevance
  3379. neuroinflammation in response to intracerebral injections of different HMGB1 redox isoforms
  3380. neuroinflammation in retinitis pigmentosa, diabetic retinopathy, and age-related macular degeneration: a minireview
  3381. neuroinflammation in schizophrenia and effects of antipsychotic medication-a PET study.
  3382. neuroinflammation in schizophrenia especially focused on the role of microglia
  3383. neuroinflammation in schizophrenia-related psychosis: a PET study
  3384. neuroinflammation in schizophrenia: a critical review and the future
  3385. neuroinflammation in schizophrenia: meta-analysis of in-vivo microglial imaging studies
  3386. neuroinflammation in schizophrenic patients: a positron emission tomography study with [11C]-(R)-PK11195
  3387. neuroinflammation in sepsis: sepsis associated delirium
  3388. neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration
  3389. neuroinflammation in suicide
  3390. neuroinflammation in suicide: too little may be just as bad as too much
  3391. neuroinflammation in suicide: Toward a comprehensive model
  3392. neuroinflammation in Survivors of Murine Pneumosepsis
  3393. neuroinflammation in synucleinopathies
  3394. neuroinflammation in systemic lupus erythematosus–a review
  3395. neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein
  3396. neuroinflammation in the aging down syndrome brain; lessons from Alzheimer’s disease
  3397. neuroinflammation in the Brain of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  3398. neuroinflammation in the C1q/TNF-related over-expression mouse model of chronic ethanol exposure
  3399. neuroinflammation in the central nervous system: symphony of glial cells
  3400. neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia
  3401. neuroinflammation in the fetus exposed to maternal obsessive–compulsive disorder during pregnancy: A comparative study on cord blood tumor necrosis factor-alpha …
  3402. neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson’s disease
  3403. neuroinflammation in the living brain of Parkinson’s disease
  3404. neuroinflammation in the metabolic disorder X-adrenoleukodystrophy
  3405. neuroinflammation in the normal aging hippocampus
  3406. neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
  3407. neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1
  3408. neuroinflammation in the Pathogenesis of Hepatic Encephalopathy
  3409. neuroinflammation in the pathophysiology of Parkinson’s disease and therapeutic evidence of anti-inflammatory drugs
  3410. neuroinflammation in the pathophysiology of Parkinson’s disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET
  3411. neuroinflammation in the peripheral nerve: cause, modulator, or bystander in peripheral neuropathies?
  3412. neuroinflammation in the rat–CNS cells and their role in the regulation of immune reactions
  3413. neuroinflammation in traumatic brain injury: A chronic response to an acute injury
  3414. neuroinflammation in treated HIV-positive individuals: a TSPO PET study
  3415. neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury
  3416. neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression …
  3417. neuroinflammation induced by amyloid β25–35 modifies mucin-type O-glycosylation in the rat’s hippocampus
  3418. neuroinflammation induced by intracerebroventricular injection of microbial neuraminidase
  3419. neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice
  3420. neuroinflammation induced by lipopolysaccharide leads to memory impairment and alterations in hippocampal leptin signaling
  3421. neuroinflammation induced by secretion of acetylated HMGB1 from activated microglia in hippocampi of mice following chronic cold exposure
  3422. neuroinflammation induced by surgery does not impair the reference memory of young adult mice
  3423. neuroinflammation induced by the peptide amyloid-β (25–35) increase the presence of galectin-3 in astrocytes and microglia and impairs spatial memory
  3424. neuroinflammation induces glial aromatase expression in the uninjured songbird brain
  3425. neuroinflammation induces neurodegeneration
  3426. neuroinflammation induces time-dependant behavioral, cellular and molecular changes that resemble characteristics of Alzheimer’s and Parkinson’s diseases and …
  3427. neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy
  3428. neuroinflammation is a putative target for the prevention and treatment of perioperative neurocognitive disorders
  3429. neuroinflammation is associated with brain extracellular TAU-protein release after spontaneous subarachnoid hemorrhage
  3430. neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions
  3431. neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease
  3432. neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca 2+-dependent NF-κB and MAPK pathways
  3433. neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca2+-dependent NF-κB and MAPK pathways.
  3434. neuroinflammation is not a prerequisite for diabetes-induced tau phosphorylation
  3435. neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity
  3436. neuroinflammation markers and methyl alcohol induced toxic brain damage
  3437. neuroinflammation mediated by NF-kappaB activation in astrocytes induces non-cell-autonomous Purkinje cell degeneration
  3438. neuroinflammation mediates noise-induced synaptic imbalance and tinnitus in rodent models
  3439. neuroinflammation mediates synergy between cerebral ischemia and Amyloid-β to cause synaptic depression
  3440. neuroinflammation MODIFYING APPROACHES IN PARKINSON’S DISEASE
  3441. neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
  3442. neuroinflammation negatively affects adult hippocampal neurogenesis and cognition: can exercise compensate?
  3443. neuroinflammation not associated with cholinergic degeneration in aged-impaired brain
  3444. neuroinflammation of the central and peripheral nervous system: an update
  3445. neuroinflammation of the nigrostriatal pathway during progressive 6‐OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
  3446. neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients
  3447. neuroinflammation pathways: a general review
  3448. neuroinflammation preceding and accompanying primary central nervous system lymphoma: case study and literature review
  3449. neuroinflammation produced by heavy alcohol intake is due to loops of interactions between Toll-like 4 and TNF receptors, peroxisome proliferator-activated receptors …
  3450. neuroinflammation Promotes Reduced Neurogenesis in Patients with Amyotrophic Lateral Sclerosis (ALS)(P6. 227)
  3451. neuroinflammation quantification for spinal cord injury
  3452. neuroinflammation rapidly triggers long-term modulation of synaptic transmission
  3453. neuroinflammation regulates cognitive impairment in socially defeated mice
  3454. neuroinflammation responses after subarachnoid hemorrhage: a review
  3455. neuroinflammation responses and neurodegeneration in multiple sclerosis
  3456. neuroinflammation resulting from covert brain invasion by common viruses–a potential role in local and global neurodegeneration
  3457. neuroinflammation screening in immunotherapy trials against Alzheimer’s disease
  3458. neuroinflammation signaling modulated by ASS234, a multitarget small molecule for Alzheimer’s disease therapy
  3459. neuroinflammation trajectories precede cognitive impairment after experimental meningitis—evidence from an in vivo PET study
  3460. neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration
  3461. neuroinflammation Update: New Insights and Future Directions
  3462. neuroinflammation versus decreased Zif268 mRNA expression as causal mediators of decreased GAD67 mRNA expression within dorsolateral prefrontal cortex in …
  3463. neuroinflammation–Mechanisms and Management
  3464. neuroinflammation-A major cause for striatal dopaminergic degeneration in Parkinson’s disease
  3465. neuroinflammation-Associated Aspecific Manipulation of Mouse Predator Fear by Toxoplasma gondii
  3466. neuroinflammation-associated modulation of regulators of G protein signaling in models of neuropathic pain
  3467. neuroinflammation-induced downregulation of hippocampacal neuregulin 1-ErbB4 signaling in the parvalbumin interneurons might contribute to cognitive impairment …
  3468. neuroinflammation-induced interactions between protease-activated receptor 1 and proprotein convertases in HIV-associated neurocognitive disorder
  3469. neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells
  3470. neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with d-Cycloserine
  3471. neuroinflammation-mediated neurotoxin production in neurodegenerative diseases
  3472. neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidosis
  3473. neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
  3474. neuroinflammation–an early event in both the history and pathogenesis of Alzheimer’s disease
  3475. neuroinflammation—a co-occurring phenomenon linking chronic pain and opioid dependence
  3476. neuroinflammation—using big data to inform clinical practice
  3477. neuroinflammation, AD, and dementia
  3478. neuroinflammation, AD, and Dementia
  3479. neuroinflammation, Alzheimer Disease, and Other Aging Disorders
  3480. neuroinflammation, Alzheimers disease and periodontal disease: is there an association between the two processes
  3481. neuroinflammation, bone marrow stem cells, and chronic pain
  3482. neuroinflammation, cortical activity, and fatiguing behaviour during self-paced exercise
  3483. neuroinflammation, COX-2, and ALS—a dual role?
  3484. neuroinflammation, cytokines and neuropathic pain
  3485. neuroinflammation, depression and Alzheimer’s disease: Insights from the Kynurenine pathway
  3486. neuroinflammation, Finding A Marine Natural Product that Targets Microglia in Brain
  3487. neuroinflammation, Glutamate Regulation and Memory
  3488. neuroinflammation, gut microbiome, and Alzheimer’s Disease
  3489. neuroinflammation, gut-brain axis and depression
  3490. neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young …
  3491. neuroinflammation, immune system and Alzheimer disease: searching for the missing link
  3492. neuroinflammation, mast cells, and glia: dangerous liaisons
  3493. neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer’s disease
  3494. neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review
  3495. neuroinflammation, microglia, and cell-association during prion disease
  3496. neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model
  3497. neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice.
  3498. neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome
  3499. neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response
  3500. neuroinflammation, neurodegeneration, and depression
  3501. neuroinflammation, oxidative stress and the pathogenesis of Alzheimer’s disease
  3502. neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator …
  3503. neuroinflammation, Oxidative Stress, and Neurogenesis in a Mouse Model of Chronic Fatigue Syndrome, and the Treatment with Kampo Medicine
  3504. neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
  3505. neuroinflammation, the thread connecting neurological disease
  3506. neuroinflammation, TNF, and ceramide signaling: putative pathways for neurotoxicity in Parkinson’s disease
  3507. neuroinflammation, Type 2 Diabetes, and Dementia
  3508. neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier
  3509. neuroinflammation: a contributing factor to the pathogenesis of cancer cachexia
  3510. neuroinflammation: a need to understand microglia as resident cells of the developing brain
  3511. neuroinflammation: a potential therapeutic target
  3512. neuroinflammation: a precursor and promoter of oncogenesis
  3513. neuroinflammation: a therapeutic target of cotinine for the treatment of psychiatric disorders?
  3514. neuroinflammation: beneficial and detrimental effects after traumatic brain injury
  3515. neuroinflammation: Brain on Fire?
  3516. neuroinflammation: effect of surgical stress compared to anaesthesia and effect of physostigmine
  3517. neuroinflammation: Friend or Foe, Itsa Matter of Time?
  3518. neuroinflammation: Friend or foe?
  3519. neuroinflammation: good, bad, or indifferent?
  3520. neuroinflammation: identifying approaches to protect neurons from inflammation-related death
  3521. neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer’s disease
  3522. neuroinflammation: mechanisms and management
  3523. neuroinflammation: mechanisms and management
  3524. neuroinflammation: Mechanisms and Management
  3525. neuroinflammation: Mechanisms and Management: edited by Paul L. Wood
  3526. neuroinflammation: MECHANISMS AND MANAGEMENT.
  3527. neuroinflammation: microglia and T cells get ready to tango
  3528. neuroinflammation: microglial activation during sepsis
  3529. neuroinflammation: Modulating mighty microglia
  3530. neuroinflammation: modulation by flavonoids and mechanisms of action
  3531. neuroinflammation: NEUROPATHOLOGICAL AND CLINICAL CORRELATES
  3532. neuroinflammation: new vistas for neuropsychiatric research
  3533. neuroinflammation: Peripheral and Neurogenic Underlying Processes
  3534. neuroinflammation: surprises from the sanitary engineers
  3535. neuroinflammation: synapses pruned in lupus
  3536. neuroinflammation: the devil is in the details
  3537. neuroinflammation: The parasympathetic anti-inflammatory pathway
  3538. neuroinflammation: the role and consequences
  3539. neuroinflammation: ways in which the immune system affects the brain
  3540. neuroinflammation‘differs categorically from inflammation: transcriptomes of Alzheimer’s disease, Parkinson’s disease, schizophrenia and inflammatory diseases …
  3541. Neurological disease as a failure of brain–immune crosstalk: the multiple faces of neuroinflammation
  3542. Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK/CREB signaling
  3543. Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-κB-dependent neuroinflammation and activating PI3K/Akt survival signaling …
  3544. Neuron-glia interaction in neuroinflammation
  3545. Neuron-microglia co-cultures as in vitro model of neuroinflammation. Anti-inflammatory but not neuroprotective effect of IL-10
  3546. Neuron-microglia interaction in neuroinflammation
  3547. Neuron–astrocyte interactions in neurodegenerative diseases: role of neuroinflammation
  3548. Neuron–Astrocyte Interactions in neuroinflammation
  3549. Neuron–microglia interactions in neuroinflammation
  3550. Neuron–oligodendrocyte interaction in neuroinflammation
  3551. Neuron–Oligodendrocyte Interactions in neuroinflammation
  3552. Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain
  3553. Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis
  3554. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL
  3555. Neuronal effects of progranulin deficiency contribute to frontotemporal dementia independent of neuroinflammation
  3556. Neuronal mitochondria modulation of LPS-induced neuroinflammation
  3557. Neuropathological evaluation of four Danish cases of CLIPPERS: Evidence of generalized neuroinflammation but no pre-lymphoma
  3558. Neuropathology and the neuroinflammation idea
  3559. Neuroprotection by adenosine receptors in aged rats-role of neuroinflammation
  3560. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation
  3561. Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation
  3562. Neuroprotection by Insulin-like Growth Factor-1 in Rats with Ischemic Stroke is Associated with Microglial Changes and a Reduction in neuroinflammation
  3563. Neuroprotection by Paeoniflorin against Nuclear Factor Kappa B-Induced neuroinflammation on Spinal Cord Injury
  3564. Neuroprotection by regulation of neuroinflammation and histone acetylation in the genetic mice models of Parkinson’s disease
  3565. Neuroprotection by vitamin C against ethanol-induced neuroinflammation associated neurodegeneration in developing rat brain
  3566. Neuroprotective activity of sitagliptin via reduction of neuroinflammation beyond the incretin effect: Focus on Alzheimer’s disease
  3567. Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation
  3568. Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β-amyloid deposition, and neuroinflammation in the SAMP8 mice
  3569. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson’s disease
  3570. Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone
  3571. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo
  3572. Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation
  3573. Neuroprotective Effect of Curcumin against Cholesterol Induced neuroinflammation in In-Vitro and In-Vivo Models
  3574. Neuroprotective effect of Estrogen Receptor α against neuroinflammation induced by hypoxia/ischemia via SIRT1-dependent AMPK pathway ZZ, He WQ2, Cao …
  3575. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice
  3576. Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and neuroinflammation by
  3577. Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal …
  3578. Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and neuroinflammation by Inhibiting the Activation of NF-κB and STAT3 in Transient Focal Stroke
  3579. Neuroprotective effect of mogrol against Aβ1–42‐induced memory impairment neuroinflammation and apoptosis in mice
  3580. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone
  3581. Neuroprotective effect of quercetin in neurotoxicity induced rats: role of neuroinflammation in neurodegeneration
  3582. Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on Aβ25-35-induced neuroinflammation
  3583. NEUROPROTECTIVE EFFECT OF THYMOHYDROQUINONE IN LIPOPOLYSACCHARIDE-INDUCED neuroinflammation AND COGNITIVE IMPAIRMENT IN …
  3584. Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: involvement of brain-derived neurotrophic factor
  3585. Neuroprotective effects of aged garlic extract on cognitive dysfunction and neuroinflammation induced by β-amyloid in rats
  3586. Neuroprotective effects of dl-3-n-Butylphthalide against doxorubicin-induced neuroinflammation, oxidative stress, endoplasmic reticulum stress, and behavioral …
  3587. Neuroprotective Effects of Endurance Exercise Against High‐Fat Diet‐Induced Hippocampal neuroinflammation
  3588. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson’s disease mice
  3589. Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson’s disease model by inhibition of NF-κB and STAT3
  3590. Neuroprotective effects of INT-777 against Aβ1–42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
  3591. Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with …
  3592. Neuroprotective effects of pifithrin-α against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and …
  3593. Neuroprotective effects of xylopic acid on lipopolysaccharide-induced neuroinflammation
  3594. Neuropsychiatric symptoms in dementia—A role for neuroinflammation?
  3595. Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia
  3596. Neurosteroids as regulators of neuroinflammation
  3597. Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy
  3598. Neurotoxicity and neuroinflammation in the enteric nervous system.
  3599. Neurotoxicity of air pollution: Role of neuroinflammation
  3600. Neurotransmitters and microglial-mediated neuroinflammation
  3601. Neurotrophic and immune regulatory factors in neuroinflammation
  3602. Neurotrophin Peptidomimetics Activate TrkA/B Signaling and Display Neuroprotective Effects in neuroinflammation and Neurodegeneration (P07. 091)
  3603. Neurotrophins and neuroinflammation in fetuses exposed to maternal depression and anxiety disorders during pregnancy: a comparative study on cord blood
  3604. Neurotropin inhibits neuroinflammation via suppressing NF-κB and MAPKs signaling pathways in lipopolysaccharide-stimulated BV2 cells
  3605. Neurotropin reduces memory impairment and neuroinflammation via BDNF/NF-κB in a transgenic mouse model of Alzheimer’s disease
  3606. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke
  3607. Neutral sphingomyelinase behaviour in hippocampus neuroinflammation of MPTP-induced mouse model of Parkinson’s disease and in embryonic hippocampal cells
  3608. Neutral sphingomyelinase inhibition alleviates LPS-induced microglia activation and neuroinflammation after experimental traumatic brain injury
  3609. Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment
  3610. Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation
  3611. Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation
  3612. NEW ASPECTS OF neuroinflammation AND NEURODEGENERATION: INVOLVEMENT OF THE CHOLINERGIC SYSTEM
  3613. New aspects of neuroinflammation and neuroimmune crosstalk in the airways
  3614. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis
  3615. New developments in understanding and treating neuroinflammation
  3616. New insights into adaptive immunity in chronic neuroinflammation
  3617. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
  3618. New insights on Parkinson’s disease genes: the link between mitochondria impairment and neuroinflammation
  3619. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis
  3620. New mechanism of neuroinflammation in Alzheimer’s disease: The activation of NLRP3 inflammasome mediated by gut microbiota
  3621. New potential strategies for treatment of neuroinflammation in rodents
  3622. NEWS FROM THE AAN ANNUAL MEETING: Toll-Like Receptor 3, a Mediator of neuroinflammation, Linked to Epileptogenesis
  3623. NEWS FROM THE SOCIETY FOR NEUROSCIENCE ANNUAL MEETING: New PET Tracer Visualizes neuroinflammation and Response to Experimental Therapy in …
  3624. Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats
  3625. NF-kappaB in neuroinflammation
  3626. NF-κB-mediated inhibition of neuroinflammation by formononetin: role of ERβ.
  3627. NF-κB-Mediated neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols
  3628. NG2 plays a role in neuroinflammation but is not expressed by immune cells
  3629. NG2, a common denominator for neuroinflammation, blood–brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic …
  3630. Nicotinic mitigation of neuroinflammation and oxidative stress after chronic sleep deprivation
  3631. Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration
  3632. Nitric Oxide Influences HSV-1-Induced neuroinflammation
  3633. Nitric oxide inhibits CXCL12 expression in neuroinflammation
  3634. Nitric oxide protects against infection-induced neuroinflammation by preserving the stability of the blood-brain barrier
  3635. NITRO-PROTEOMICS TO DISCOVER SYNAPTOSOMAL BIOMARKERS OF neuroinflammation IN ALZHEIMER’S DISEASE
  3636. Nitrogen-doped carbon nanocages and human umbilical cord mesenchymal stem cells cooperatively inhibit neuroinflammation and protect against ischemic stroke
  3637. NK cells promote neutrophil recruitment in the brain during sepsis-induced neuroinflammation
  3638. NLRP3 inflammasome activation is involved in trimethyltin-induced neuroinflammation
  3639. NLRP3 inflammasome activation mediates fatigue-like behaviors in mice via neuroinflammation
  3640. NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation
  3641. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis
  3642. NMDA receptor is involved in neuroinflammation in intracerebroventricular colchicine-injected rats
  3643. NMR and pattern recognition can distinguish neuroinflammation and peripheral inflammation
  3644. Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury
  3645. NON-AMNESTIC ALZHEIMER’S DISEASE: A POSSIBLE ROLE FOR neuroinflammation?
  3646. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and neuroinflammation
  3647. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and neuroinflammation.
  3648. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia
  3649. Non-coding RNA and neuroinflammation: implications for the therapy of stroke
  3650. Non-neuronal cells are required to mediate the effects of neuroinflammation: results from a neuron-enriched culture system
  3651. Non-steroidal anti-inflammatory drugs in Alzheimer’s disease and Parkinson’s disease: reconsidering the role of neuroinflammation
  3652. Noninvasive molecular imaging of neuroinflammation
  3653. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and …
  3654. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge…
  3655. Noradrenaline, Astroglia, and neuroinflammation
  3656. Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation
  3657. NOSH‐aspirin (NBS‐1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A …
  3658. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer’s disease mice by attenuating amyloid-beta, tau, and neuroinflammation …
  3659. Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation
  3660. Novel approaches in the field of cancer and neuroinflammation: design, synthesis and biological evaluation of new modulators of the endocannabinoid system and …
  3661. Novel Approaches to PET Imaging neuroinflammation
  3662. Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug development
  3663. Novel Flow-Based Multiplex Assay Panel for Quantifying Human neuroinflammation Biomarkers
  3664. Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
  3665. Novel insights into the role of hippocampal TLX in neurogenesis, neuroinflammation and behaviour in adolescence and adulthood
  3666. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer’s disease
  3667. NOVEL NAMPT ACTIVATORS ATTENUATE NEUROTOXICITY AND neuroinflammation ASSOCIATED WITH NEURODEGENERATION
  3668. Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the camp/PKA/CREB signaling pathway and …
  3669. Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET
  3670. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease
  3671. Novel Role of Mannose Binding Lectin in neuroinflammation and Neurocognitive Consequences in HIV-1 Infected Brain
  3672. Novel role of TGF‐β in differential astrocyte‐TIMP‐1 regulation: Implications for HIV‐1‐dementia and neuroinflammation
  3673. Novel Roles of RelB in neuroinflammation
  3674. Novel targets for positron emission tomography (PET) radiopharmaceutical tracers for visualization of neuroinflammation
  3675. Novel therapeutic targets in neuroinflammation and neuropathic pain
  3676. Nox2-dependent neuroinflammation in an EAE model of multiple sclerosis
  3677. NR4A1 regulates cerebral ischemia-induced brain injury by regulating neuroinflammation through interaction with NF-κB/p65
  3678. Nrdp1 is associated with neuronal apoptosis in lipopolysaccharide-induced neuroinflammation
  3679. Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model
  3680. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease
  3681. Nrf2–ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
  3682. Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism
  3683. Nuclear factor κB activation impairs ependymal ciliogenesis and links neuroinflammation to hydrocephalus formation
  3684. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
  3685. Nuclear receptors and neuroinflammation in schizophrenia
  3686. Nucleoside reverse transcriptase inhibitors (NRTIs) induce pathological pain through Wnt5a-mediated neuroinflammation in aging mice
  3687. Nutraceutical Apigenin regulates DC function in a RelB-dependent manner during neuroinflammation
  3688. Nutrient-sensing mechanisms in hypothalamic cell models: neuropeptide regulation and neuroinflammation in male-and female-derived cell lines
  3689. Nutrition, neuroinflammation and Cognition
  3690. Nutritional modulation of immune and central nervous system homeostasis: the role of diet in development of neuroinflammation and neurological disease
  3691. Nutritional Mushroom Treatment in Meniere’s Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in neuroinflammation and …
  3692. Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation
  3693. O 20: The Role of neuroinflammation in Epilepsy: A New Target for Treatment
  3694. O 3: Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune neuroinflammation
  3695. O 6: Kininogen Deficiency Ameliorates neuroinflammation by Reducing Immune Cell Trafficking
  3696. O016 Inhibition of the JAK/STAT pathway protects against neuroinflammation
  3697. O11: Novel Approaches to Prevent neuroinflammation by Targeting the Coagulation System
  3698. O4-01-08: Neurodegeneration and neuroinflammation in cdk5/p25 inducible mice: A model for hippocampal sclerosis and neocortical degeneration
  3699. Obesity and gut’s dysbiosis promote neuroinflammation, cognitive impairment, and vulnerability to Alzheimer’s disease: new directions and therapeutic …
  3700. Obesity and neuroinflammation
  3701. Obesity and neuroinflammation: a pathway to cognitive impairment
  3702. Obesity in Aging Exacerbates Blood Brain Barrier Disruption and neuroinflammation Leading to Synaptic Plasticity Deficit and Cognitive Decline in Mice
  3703. Obesity in aging exacerbates blood brain barrier disruption, neuroinflammation and oxidative stress in the mouse hippocampus: effects on expression of genes …
  3704. Obesity in aging exacerbates blood–brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes …
  3705. Obesity in aging exacerbates neuroinflammation and alters eicosanoid profiles in the mouse hippocampus: potential role in impaired synaptic plasticity and cognitive …
  3706. Obesity in aging exacerbates neuroinflammation, dysregulating synaptic function-related genes and altering eicosanoid synthesis in the mouse hippocampus …
  3707. Obesity induces neuroinflammation mediated by altered expression of the renin–angiotensin system in mouse forebrain nuclei
  3708. Obesity-induced neuroinflammation: beyond the hypothalamus
  3709. Obesity‐and neuroinflammation‐Associated Mood and Cognitive Disorders
  3710. Obesity, adipokines and neuroinflammation
  3711. Obesity, neuroinflammation, and Reproductive Function
  3712. Obestatin improve spatial memory impairment in a rat model of fetal alcohol spectrum disorders via inhibiting apoptosis and neuroinflammation
  3713. Obovatol attenuates microglia‐mediated neuroinflammation by modulating redox regulation
  3714. Observations on the evolving fields of neuroimmunology and neuroinflammation
  3715. Obsessive-Compulsive Disorder: Autoimmunity and neuroinflammation
  3716. Obstructive Sleep Apnea Induced Hypertension Involves Gut Dysbiosis and neuroinflammation
  3717. Ocimum basilicum attenuates ethidium bromide-induced cognitive deficits and pre-frontal cortical neuroinflammation, astrogliosis and mitochondrial dysfunction in …
  3718. of neuroinflammation
  3719. of Project: neuroinflammation in the Peripheral and Central Nervous System
  3720. Old age increases microglial senescence, exacerbates secondary neuroinflammation, and worsens neurological outcomes after acute traumatic brain injury in mice
  3721. Old drugs in a new light: investigating the gold Rheumatoid Arthritis medications as novel inhibitors of neuroinflammation
  3722. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals
  3723. Oleoylethanolamide, neuroinflammation, and alcohol abuse
  3724. Olfactory dysfunction in autoimmune central nervous system neuroinflammation
  3725. Oligodendrocyte death, neuroinflammation, and the effects of minocycline in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)
  3726. Oligodendrocytes as active modulators of neuroinflammation
  3727. Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis
  3728. Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
  3729. Oligostilbenes from the leaves of Gnetum latifolium and their biological potential to inhibit neuroinflammation
  3730. Omega-3 fatty acids and neuroinflammation in Alzheimer’s disease: the unraveling of neurorestorative cell signaling
  3731. Omega-3 fatty acids revert high-fat diet-induced neuroinflammation but not recognition memory impairment in rats
  3732. Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia
  3733. Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease
  3734. On neuroinflammation in psychotic disorders
  3735. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis
  3736. On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation
  3737. Opening of microglial KATP channels inhibits rotenone‐induced neuroinflammation
  3738. Opposing roles of interferon-gamma on cells of the central nervous system in autoimmune neuroinflammation
  3739. Opposite modulation of peripheral inflammation and neuroinflammation by adenosine A2A receptors
  3740. Optical imaging spectroscopy of early haemodynamic changes in a rat model of neuroinflammation
  3741. Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation
  3742. Optimization of non-invasive [18F] fluoromethyl-PBR28 PET study for quantification of neuroinflammation using alternative reference compartments in rat Parkinson’s …
  3743. Optimization of S1P1-specific PET radioligands for imaging neuroinflammation
  3744. OR-012 The Regulation of NF-κB-TNF-α/IDO/5-HT Axis by Aerobic Exercise against Hippocampal neuroinflammation in CUMS Depressive Mice
  3745. Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model
  3746. Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune …
  3747. Orexin-A prevents lipopolysaccharide-induced neuroinflammation at the level of the intestinal barrier
  3748. Oridonin attenuates Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway
  3749. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway
  3750. Osteopontin as a two-sided mediator in acute neuroinflammation in rat models
  3751. Ouabain attenuates oxidative stress and modulates lipid composition in hippocampus of rats in lipopolysaccharide‐induced hypocampal neuroinflammation in rats
  3752. Ouabain modulates the lipid composition of hippocampal plasma membranes from rats with LPS-induced neuroinflammation
  3753. Outbred ICR/CD1 mice display more severe neuroinflammation mediated by microglial TLR4/CD14 activation than inbred C57Bl/6 mice
  3754. Outdoor ambient air pollution and neurodegenerative diseases: the neuroinflammation hypothesis
  3755. Outside in: unraveling the role of neuroinflammation in the progression of Parkinson’s disease
  3756. Over-activated proteasome mediates neuroinflammation on acute intracerebral hemorrhage in rats
  3757. Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Inhibits the neuroinflammation in Hypertensive Rats
  3758. Overexpression of human apolipoprotein AI preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of …
  3759. Overexpression of phosphodiesterase-4 subtypes involved in surgery-induced neuroinflammation and cognitive dysfunction in mice
  3760. Overexpression of SIRT2 alleviates neuropathic pain and neuroinflammation through deacetylation of transcription factor nuclear factor-kappa B
  3761. Overnight S100B in Parkinson’s Disease: A glimpse into sleep-related neuroinflammation
  3762. Overpressure blast injury-induced oxidative stress and neuroinflammation response in rat frontal cortex and cerebellum
  3763. Overview of Innovative Mouse Models for Imaging neuroinflammation
  3764. Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation
  3765. Oxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets
  3766. Oxidative stress and neuroinflammation in the story of Parkinson’s disease: could targeting these pathways write a good ending?
  3767. Oxidative stress and neuroinflammation should be both considered in the occurrence of fatigue and depression in multiple sclerosis
  3768. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation
  3769. Oxidative stress is associated with neuroinflammation in animal models of HIV-1 Tat neurotoxicity
  3770. Oxidative Stress, Epigenetic, neuroinflammation and Alzheimer’s Disease
  3771. Oxidative stress, neuroinflammation, and neurodegeneration
  3772. Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain
  3773. Oxycodone suppresses the lipopolysaccharide-induced neuroinflammation by downregulating nuclear factor-κB in hippocampal astrocytes of Sprague–Dawley rats
  3774. Oxymatrine can attenuate pathological deficits of Alzheimer’s disease mice through regulation of neuroinflammation
  3775. Oxymatrine reduces neuroinflammation in rat brain: A signaling pathway★
  3776. Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models
  3777. Oxysterols promote encephalitogenic CD4+ T cell migration during neuroinflammation
  3778. Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation
  3779. P 101: Ginger and Honey Mixture as an Anti-Inflammatory Drug in neuroinflammation: Alzheimer Disease
  3780. P 102: The Study of Some Factors Which Effect on Beta-Amyloid Signaling in neuroinflammation
  3781. P 103: Effects of Physical Exercise on neuroinflammation
  3782. P 104: Effects of Human Neural Stem Cells in Cure neuroinflammation of Traumatic Brain Injury
  3783. P 107: P2x7 Receptors: as a Novel Targets for the Treatment of neuroinflammation
  3784. P 110: Evaluating the Role of Histone Hyper Acetylation in Induction of neuroinflammation
  3785. P 115: Potential Therapeutic Targets Related to neuroinflammation in Treatment and Prevention of Autism
  3786. P 118: Osteopontin: An Early Player in neuroinflammation Disease
  3787. P 121: neuroinflammation and Diabetes
  3788. P 133: neuroinflammation in Alzheimer’s Disease
  3789. P 134: Use of Zinc in Drugs to Improve neuroinflammation Disease
  3790. P 138: Improving Neuroplasticity Through neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism
  3791. P 153: neuroinflammation in Multiple Sclerosis
  3792. P 28: Bone Marrow-Derived Mesenchymal Stem Cells Reduces neuroinflammation and Splenic Cytolytic CD8+ T Cells in Mice with Experimental Autoimmune …
  3793. P 47: Occupational Toxins and neuroinflammation
  3794. P 49: Exercise Effects on Cognitive Impairments Through Altering neuroinflammation
  3795. P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in neuroinflammation
  3796. P 62: Markers of neuroinflammation Related to Alzheimer’s Disease Pathology in the Elderly
  3797. P 63: Role of neuroinflammation in Depression
  3798. P 66: A Review of Novel Biomarkers Involved in the neuroinflammation Caused by Human T Lymphotropic Virus-1
  3799. P 67: The Role of neuroinflammation in Dysfunction of Adult Hippocampal Neurogenesis
  3800. P 68: The Role of neuroinflammation in Post-Traumatic Stress Disorder (PTSD)
  3801. P 79: neuroinflammation: A Common Phenomenon between Chronic Pain and Opioids
  3802. P 88: Matrix Metalloproteinases in neuroinflammation
  3803. P 89: Reduction of neuroinflammation in Epilepsy by Using Stem Cells Derived Astrocytes
  3804. P 92: A Critical Balance between Repair and Demolish of Proinflammatory Factors to Improve Effects of neuroinflammation
  3805. P 93: The Role of Marine Compounds in neuroinflammation
  3806. P 98: neuroinflammation and Nanomedicine, How about Cerebral Palsy
  3807. P-01 MicroRNA PROFILING IDETIFY NEW REGULATORY GENES IN ETHANOL-INDUCED neuroinflammation AND BRAIN DAMAGE THROUGH TLR4 …
  3808. P-010: Chronic lithium administration attenuates upregulated brain arachidonic acid metabolism in a rat model of neuroinflammation
  3809. P-107: neuroinflammation and neuronal networks activation involved in learning and memory
  3810. P-glycoprotein activity in the blood–brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment
  3811. P-glycoprotein activity in the rat brain is affected by HSV-1 induced neuroinflammation and antipsychotic treatment: implication in treatment resistant …
  3812. P-glycoprotein acts as an immunomodulator during neuroinflammation
  3813. P02DYSFUNCTIONS IN PROTEIN DEGRADATION IN ALCOHOL-INDUCED neuroinflammation AND BRAIN DAMAGE
  3814. P100: A Review of Postoperative Cognitive Dysfunction and neuroinflammation Processes Induced by Anaesthesia
  3815. P101: neuroinflammation and Cognitive Dysfunction as a Side Effect of Abdominal Surgery
  3816. P104: Obesity-Induced neuroinflammation: Focus on Hypothalamic Inflammation
  3817. P109: neuroinflammation and Forgotten Dimensions of Persian Medicine: from the Basic Concepts to Biopsychologic Interventions and Their Probable Mechanisms
  3818. P11: Assess the Electrophysiological Activity of Olfactory Bulb in the Animal Model of PTSD and its Relationship with neuroinflammation in the Olfactory Bulb
  3819. P110: Nitrous Oxide and neuroinflammation
  3820. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens neuroinflammation, and Prevents Cognitive Decline in an …
  3821. P116: The Relationship between Spinal Cord Injury and neuroinflammation and Treatment Methods
  3822. P121: The Effect of Stress on neuroinflammation in Multiple Sclerosis
  3823. P147: Postoperative Cognitive Dysfunction and neuroinflammation Associated with Cardiac Surgery
  3824. P2 Receptors for Extracellular Nucleotides in the Central Nervous System: Role of P2X7 and P2Y2 Receptor Interactions in neuroinflammation
  3825. P2-149: Procalcitonin in cerebrospinal fluid is elevated in patients with dementia and acute neuroinflammation
  3826. P2-398: Role Of endocannabinoids on neuroinflammation, memory and neurogenesis in aged rats
  3827. P24 Matrine ameliorates cognitive deficits and neuroinflammation via inhibition of microglial activation in an Alzheimer’s disease mouse model
  3828. P29: The Role of Platelet Granules in neuroinflammation
  3829. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus
  3830. P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH
  3831. P2Y receptors in microglia and neuroinflammation
  3832. P3-354: Role of IL-6–mediated chronic neuroinflammation on amyloid pathology
  3833. P3-359: The role of MFG-E8 in glial-neuronal interactions and neuroinflammation
  3834. P3-367: Alterations in the subcellular localization of calcineurin/NFAT isoforms in Alzheimer’s disease: Implications for neuroinflammation
  3835. P4-420: Anti-inflammatory actions of the endocannabinoid system in a rodent model of chronic neuroinflammation
  3836. P60: Mesenchymal Stem Cells Encapsulated in a Self-Assembling Nanopeptide Scaffold Attenuate neuroinflammation and Behavioral Function in a Model of …
  3837. P6262Midregional proenkephalin A, a marker of neuroinflammation predicts incident vascular dementia: Population-based prospective study
  3838. P7 Extract of Ligusticum chuanxiong Hort attenuates LPS-induced neuroinflammation in BV2 microglia via down-regulation of TLR4/MyD88 pathway
  3839. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection‐induced neuroinflammation
  3840. P77: NADPH Oxidase Type 4 Inhibits Immune Cell Trafficking into The Central Nervous System During neuroinflammation
  3841. P7C3 suppresses neuroinflammation and protects retinal ganglion cells of rats from optic nerve crush
  3842. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1 (G93A) mouse model of amyotrophic …
  3843. PACAP27 mitigates an age‐dependent hippocampal vulnerability to PGJ2‐induced spatial learning deficits and neuroinflammation in mice
  3844. Paeoniflorin ameliorates interferon-alpha-induced neuroinflammation and depressive-like behaviors in mice
  3845. Paeoniflorin ameliorates neuroinflammation in MPTP-induced mice Parkinson’s disease model through inhibiting TLR4/NF-κB/MAPK pathway
  3846. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease by activation of adenosine A1 receptor
  3847. Pain in gynecology and neuroinflammation: the evil twin
  3848. Pain, sex and neuroinflammation: toward gender bias?
  3849. Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress
  3850. Palmitate induces neuroinflammation, ER stress, and Pomc mRNA expression in hypothalamic mHypoA-POMC/GFP neurons through novel mechanisms that are …
  3851. Palmitoylethanolamid and Other Lipid Autacoids Against neuroinflammation, Pain, and Spasms in Multiple Sclerosis
  3852. Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia …
  3853. Parallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammation
  3854. Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects
  3855. Parametric mapping using spectral analysis for11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects
  3856. Parasite-induced alterations of sensorimotor pathways in gammarids: collateral damage of neuroinflammation?
  3857. Parasitic manipulation and neuroinflammation: Evidence from the system Microphallus papillorobustus (Trematoda) – Gammarus (Crustacea)
  3858. Parasuicidal behavior and neuroinflammation: A genetics and gene expression approach
  3859. Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control
  3860. Parenchymal neuroinflammation in Familial Hemiplegic Migraine Type 1 Transgenic Mouse Model After Cortical Spreading Depression
  3861. Paricalcitol alleviates lipopolysaccharide-induced depressive-like behavior by suppressing hypothalamic microglia activation and neuroinflammation
  3862. Parkinson’s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.
  3863. Parkinson’s disease in the nuclear age of neuroinflammation
  3864. Parkinson’s disease: autoimmunity and neuroinflammation
  3865. Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation
  3866. PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy
  3867. Parthenolide inhibits neuroinflammation and promotes neurogenesis in the ischemic striatum following transient middle cerebral artery occlusion in the adult rat brain
  3868. Parthenolide, an NF-κB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model
  3869. Participation of dendritic cells in neuroinflammation: factors regulating adhesion to human cerebral endothelium
  3870. Participation of Glial Cells in the Pathogenesis of AD: A Different View on neuroinflammation
  3871. Patchouli alcohol protects against ischemia/reperfusion-induced brain injury via inhibiting neuroinflammation in normal and obese mice
  3872. Patent application title: PET VISUALIZATION OF AMYLOID-ASSOCIATED neuroinflammation IN THE BRAIN Inventors: Tetsuya Suhara (Chiba-Shi, JP) …
  3873. Pathobiology of neuroinflammation and basal ganglia circuitry in Parkinson’s Disease
  3874. Pathogenesis and progression of multiple sclerosis: the role of arachidonic acid–mediated neuroinflammation
  3875. Pathogenesis and Progression of Multiple Sclerosis: The Role of Arachidonic Acid–Mediated neuroinflammation–Multiple Sclerosis: Perspectives in Treatment and …
  3876. Pathogenesis of Neurodegenerative Diseases: Contribution of Oxidative Stress and neuroinflammation
  3877. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells
  3878. Pathogenic role of CD4+ T cells in the progression of neurotropic mouse hepatitis virus induced neuroinflammation
  3879. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats
  3880. Pathological and biochemical consequences of chronic neuroinflammation in the basal forebrain: An investigation of the mechanisms underlying neuroprotection
  3881. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimer’s disease
  3882. Pathomechanism involving neuroinflammation in SCA17 transgenic mice
  3883. Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders
  3884. Pattern recognition receptors and inflammasome activation in the blood-brain barrier: new players in neuroinflammation
  3885. PDE4B as a microglia target to reduce neuroinflammation
  3886. PECAM-1 stabilizes blood-brain barrier integrity and favors paracellular T-cell diapedesis across the blood-brain barrier during neuroinflammation
  3887. PECAM‐1, a key player in neuroinflammation
  3888. Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation
  3889. Peli1 controls the survival of dopaminergic neurons through modulating microglia-mediated neuroinflammation
  3890. Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection
  3891. Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection
  3892. Pembrolizumab-related neuroinflammation: a case report and review of the literature
  3893. Pentraxin 3 regulates neutrophil infiltration to the brain during neuroinflammation
  3894. Peptide derivatives of erythropoietin in the treatment of neuroinflammation and neurodegeneration
  3895. Perfluorooctanesulfonate induces neuroinflammation through the secretion of TNF-α mediated by the JAK2/STAT3 pathway
  3896. Perinatal Micro-Bleeds and neuroinflammation in E19 Rat Fetuses Exposed to Utero-Placental Ischemia
  3897. Periodontitis and Alzheimer’s disease: a possible comorbidity between oral chronic inflammatory condition and neuroinflammation
  3898. Perioral dermatitis after dental filling in a 12-year-old girl: involvement of cholinergic system in skin neuroinflammation?
  3899. Peripheral administration of tumor necrosis factor-alpha induces neuroinflammation and sickness but not depressive-like behavior in mice
  3900. Peripheral blood monocyte tolerance alleviates intraperitoneal lipopolysaccharides-induced neuroinflammation in rats via upregulating the CD200R expression
  3901. Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB−/− mouse model of neurodegeneration
  3902. Peripheral immunity, immunoaging and neuroinflammation in Parkinson’s disease
  3903. Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats
  3904. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus
  3905. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying …
  3906. Peripheral Nerve Injury Triggers neuroinflammation in the Medial Prefrontal Cortex and Ventral Hippocampus in a Subgroup of Rats with Coincident Affective …
  3907. Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation
  3908. Peripheral neuroinflammation and novel potential therapeutic targets in familial amyloidotic polyneuropathy
  3909. Peripheral surgical wounding and age-dependent neuroinflammation in mice
  3910. Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation
  3911. Perivascular Macrophages in neuroinflammation, the role of the Scavenger Receptor CD163
  3912. Perivascular spaces and the two steps to neuroinflammation
  3913. Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation
  3914. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
  3915. Peroxisome proliferator-activated receptors:“key” regulators of neuroinflammation after traumatic brain injury
  3916. Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication
  3917. Persistent behavioral impairments and neuroinflammation following global ischemia in the rat
  3918. Persistent cognitive deficits and neuroinflammation in a rat model of cardiopulmonary bypass
  3919. Persistent neuroinflammation and Brain Specific Immune Priming in A Novel Survival Model of Murine Pneumosepsis.
  3920. Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication
  3921. Persistent neuroinflammation may be involved in the pathogenesis of traumatic brain injury (TBI)-induced hypopituitarism: potential genetic and autoimmune factors
  3922. Persistent region-dependent neuroinflammation, NMDA receptor loss and atrophy in an animal model of penetrating brain injury
  3923. Personalized genetics of the cholinergic blockade of neuroinflammation
  3924. Perspectives in pain research 2014: neuroinflammation and glial cell activation: the cause of transition from acute to chronic pain?
  3925. Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy?
  3926. PET and MR imaging of neuroinflammation in hepatic encephalopathy
  3927. PET and MRI as yardstick for neuroinflammation, a pathological trademark of Multiple Sclerosis (MS) 2 Glob J Neurol, 2018; Volume 1, Issue 1 9. Politis M …
  3928. PET and MRI measurements of neuroinflammation and brain plasticity after a stroke
  3929. PET Imaging in neuroinflammation
  3930. PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats
  3931. PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis
  3932. PET imaging of microglial activation using a novel peripheral benzodiazepine receptor ligand,[18F] FEPPA, in a rat neuroinflammation model
  3933. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714
  3934. PET imaging of neuroinflammation targeting TSPO and P2X7 receptor
  3935. PET Imaging of Stroke-Induced neuroinflammation in Mice Using [18F]PBR06
  3936. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of neuroinflammation
  3937. PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide
  3938. PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and neuroinflammation
  3939. PET markers of tau and neuroinflammation are co-localized in progressive supranuclear palsy
  3940. PET radioligands for in vivo visualization of neuroinflammation
  3941. PET/CT for neuroinflammation
  3942. Peucedani Japonici Radix ameliorates lipopolysaccharide-induced neuroinflammation by regulating microglial responses
  3943. Pharmacokinetics of a thermally responsive curcumin conjugate for local antagonism of neuroinflammation in disc herniation
  3944. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
  3945. Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: an effect partially mediated by central TRPV1
  3946. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset …
  3947. Pharmacological inhibition of TLR4 reduces mast cell activation, neuroinflammation and hyperalgesia in sickle mice
  3948. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging
  3949. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging
  3950. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation
  3951. Phenolic compounds characteristic of the mediterranean diet in mitigating microglia-mediated neuroinflammation
  3952. Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation
  3953. Phenotypic Screening Using Mouse and Human Stem Cell-Based Models of neuroinflammation and Gene Expression Analysis to Study Drug Responses
  3954. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo
  3955. Phlorizin administration ameliorates cognitive deficits by reducing oxidative stress, tau hyper‐phosphorylation, and neuroinflammation in a rat model of Alzheimer’s …
  3956. Phloroglucinol derivative compound 21 attenuates cuprizone-induced multiple sclerosis mice through promoting remyelination and inhibiting neuroinflammation
  3957. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice
  3958. Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition
  3959. Phosphoinositide 3-kinase gamma contributes to neuroinflammation in a rat model of surgical brain injury
  3960. Phospholipase C-related catalytically inactive pro-tein is involved in the neuroinflammation-induced anorexia
  3961. Phospholipids: a neuroinflammation emerging target
  3962. Phosphorus-Based Dendrimer ABP Treats neuroinflammation by Promoting IL-10-Producing CD4+ T Cells
  3963. Physical activity and exercise attenuate neuroinflammation in neurological diseases
  3964. Physical exercise and neuroinflammation in major depressive disorder
  3965. Phytoestrogen Analogues Targeting neuroinflammation
  3966. PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model
  3967. Picroside II attenuates CCI-induced neuropathic pain in rats by inhibiting spinal reactive astrocyte-mediated neuroinflammation through the NF-κB pathway
  3968. Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
  3969. Pioglitazone attenuates neuroinflammation and promotes dopaminergic neuronal survival in the nigrostriatal system of rats after diffuse brain injury
  3970. Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex
  3971. Pioglitazone prevents sevoflurane‑induced neuroinflammation and cognitive decline in a rat model of chronic intermittent hypoxia by upregulating hippocampal PPAR …
  3972. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in …
  3973. Piperlongumine inhibits neuroinflammation via regulating NF-κB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells
  3974. Piracetam attenuates LPS-induced neuroinflammation and cognitive impairment in rats
  3975. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
  3976. PKCε induces astrocyte stellation by modulating multiple cytoskeletal proteins and interacting with Rho a signalling pathways: implications for neuroinflammation
  3977. Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release
  3978. Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury
  3979. Platelet‐activating factor receptor antagonism targets neuroinflammation in experimental epilepsy
  3980. Platelets mediate protective neuroinflammation and promote neuronal plasticity at the site of neuronal injury
  3981. Platelets play differential role during the initiation and progression of autoimmune neuroinflammation
  3982. Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation
  3983. Pleiotrophin regulates microglia-mediated neuroinflammation
  3984. Pleiotrophin regulates microglia-mediated neuroinflammation/R. Fernández-Calle…[et al.].
  3985. Pleiotropic molecules in axon regeneration and neuroinflammation
  3986. PM345. Resveratrol Suppresses neuroinflammation in the Experimental Paradigm of Autism Spectrum Disorders
  3987. PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid-Induced Cognitive Deficits through Modulation of neuroinflammation
  3988. PN401 decreases neurodegeneration in models of Alzheimer’s, Huntington’s and Parkinson’s disease, neuroinflammation, excitotoxicity and has antiepileptic activity
  3989. Poly-arginine peptide R18D reduces neuroinflammation and functional deficits following traumatic brain injury in the long-Evans rat
  3990. Polydatin attenuates neuronal loss via reducing neuroinflammation and oxidative stress in rat MCAO models
  3991. Polygonum aviculare L. extract reduces fatigue by inhibiting neuroinflammation in restraint-stressed mice
  3992. POLYMICROBIAL INFECTION EXACERBATES neuroinflammation AND WORSENS ALZHEIMER’S-ASSOCIATED MEMORY LOSS IN A FEMALE …
  3993. Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation
  3994. Polyphenol metabolites and new molecules for attenuation of neuroinflammation
  3995. Polyphenols derived from lychee seed suppress Aβ (1-42)-induced neuroinflammation
  3996. Polyphenols from Toona sinensis seeds alleviate neuroinflammation in rats with Parkinson’s disease via inhibiting p38MAPK signaling pathway
  3997. Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural …
  3998. Polyspecific IgG against mumps, rubella and measles in paediatric population with neuroinflammation process in vaccine failure conditions
  3999. Polyunsaturated fatty acids, neuroinflammation and well being
  4000. Pomegranate ellagitannin-gut microbial-derived metabolites, urolithins, inhibit neuroinflammation in vitro
  4001. Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β stimulated SK-N-SH cells
  4002. Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells
  4003. Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice
  4004. Positive allosteric modulation of indoleamine 2, 3-dioxygenase 1 restrains neuroinflammation
  4005. Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer’s disease
  4006. Positron emission tomography imaging of neuroinflammation
  4007. Positron emission tomography imaging of neuroinflammation
  4008. Positron emission tomography studies with [11C] PBR28 in the healthy rodent brain: validating SUV as an outcome measure of neuroinflammation
  4009. Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
  4010. Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
  4011. Positron emissiontomography imaging of neuroinflammation in Multiple Sclerosis with a second generation translocator protein PET radioligand
  4012. Possible involvement of glucocorticoids in mycotoxin-induced neuroinflammation
  4013. Possible involvement of metformin in downregulation of neuroinflammation and associated behavioural changes in mice
  4014. Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders
  4015. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of …
  4016. Post-injury alcohol exposure exacerbates neuroinflammation and impairs neurological recovery following traumatic brain injury (859.6)
  4017. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different …
  4018. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
  4019. Post-seizure α-tocopherol treatment decreases neuroinflammation and neuronal degeneration induced by status epilepticus in rat hippocampus
  4020. Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol A NOVEL MECHANISM OF INHIBITING neuroinflammation IN VITRO
  4021. Postconditioning with inhaled carbon monoxide counteracts apoptosis and neuroinflammation in the ischemic rat retina
  4022. Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of neuroinflammation
  4023. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats
  4024. Postoperative cognitive dysfunction and neuroinflammation; cardiac surgery and abdominal surgery are not the same
  4025. Postoperative cognitive dysfunction in the aged: the collision of neuroinflammaging with perioperative neuroinflammation
  4026. Postoperative cognitive dysfunction: Involvement of neuroinflammation
  4027. Postoperative cognitive dysfunction: involvement of neuroinflammation and neuronal functioning
  4028. Postoperative impairment of cognitive function in old mice: a possible role for neuroinflammation mediated by HMGB1, S100B, and RAGE
  4029. Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of autoimmune neuroinflammation (P6273)
  4030. Potassium 2-(1-hydroxypentyl)-benzoate attenuates neuronal apoptosis in neuron–astrocyte co-culture system through neurotrophy and neuroinflammation …
  4031. Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders
  4032. Potential biomarkers for neuroinflammation and neurodegeneration at short and long term after neonatal hypoxic-ischemic insult in rat
  4033. Potential new therapies against a toxic relationship: neuroinflammation and Parkinson’s disease
  4034. Potential of sodium MRI as a biomarker for neurodegeneration and neuroinflammation in multiple sclerosis
  4035. Potential of the Flavonoid Apigenin in Regulating Immune Cell Functions During neuroinflammation in a RelB-dependent Manner
  4036. Potential role of heme oxygenase-1 in neuroinflammation caused by manganese
  4037. Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
  4038. PPARs in neuroinflammation
  4039. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
  4040. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson’s disease
  4041. PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice
  4042. PPARγ coactivator-1α (PGC-1α) protects neuroblastoma cells against amyloid-beta (Aβ) induced cell death and neuroinflammation via NF-κB pathway
  4043. Pre-and Neonatal Exposure to Lead (Pb) Induces neuroinflammation in the Forebrain Cortex, Hippocampus and Cerebellum of Rat Pups
  4044. Pre-conditioning with transcranial low-level light therapy reduces neuroinflammation and protects blood-brain barrier after focal cerebral ischemia in mice
  4045. Preclinical comparison study between [18F] fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation
  4046. Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation
  4047. Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders
  4048. Predicting neuroinflammation in morphine tolerance for tolerance therapy from immunostaining images of rat spinal cord
  4049. Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo
  4050. Pregnant serum induces neuroinflammation and seizure activity via TNFα
  4051. Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model
  4052. Prenatal air pollution exposure induces neuroinflammation and predisposes offspring to weight gain in adulthood in a sex-specific manner
  4053. Preoperative pain aggravates postoperative cognitive deficits and hippocampal neuroinflammation in rats
  4054. Preoperative Sleep Disturbance Exaggerates Surgery-Induced neuroinflammation and Neuronal Damage in Aged Mice
  4055. Preparation and Characterization of Polymersomes for Nose-to-Brain Delivery of Combination Therapeutics in neuroinflammation Treatment
  4056. Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain
  4057. Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression
  4058. Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage
  4059. PREVENTING STRESS SIGNALING AND INCREASED neuroinflammation ALLEVIATES ALZHEIMER’S-LIKE PATHOLOGY IN MICE OVEREXPRESSING THE …
  4060. Prevention by Curcumin of neuroinflammation in Intracerebral Hemorrhage
  4061. Prevention of neuroinflammation by Resveratrol
  4062. Primary Neuron-glia Culture from Rat Cortex as a Model to Study neuroinflammation in CNS Injuries or Diseases
  4063. Primary neuron-glia culture from rat cortex as a model to study neuroinflammation in CNS injuries or diseases
  4064. Prion and neuroinflammation: Creutzfeldt-Jakob disease
  4065. Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction
  4066. Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation
  4067. Prior stressor exposure delays the recovery of surgery-induced cognitive impairment and prolongs neuroinflammation in aged rats
  4068. Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: a natural model of neuroinflammation during systemic parasitic …
  4069. Probiotics alleviate cognitive dysfunction associated with neuroinflammation in cardiac surgery
  4070. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation
  4071. Production and roles of glial tissue inhibitor of metalloproteinases-1 in human immunodeficiency virus-1-associated dementia neuroinflammation: a review
  4072. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors α and β
  4073. Progesterone exerts neuroprotective effects against Aβ-induced neuroinflammation by attenuating ER stress in astrocytes
  4074. Progesterone protective effects in neurodegeneration and neuroinflammation
  4075. Progesterone suppresses Aβ42-induced neuroinflammation by enhancing autophagy in astrocytes
  4076. Prognostic factors of neuroinflammation and oxidative stress in brain injury patients at Cipto Mangunkusumo Hospital Jakarta
  4077. Progranulin and Inflammation/neuroinflammation
  4078. Progranulin deficiency leads to altered microglial function and neuroinflammation
  4079. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury
  4080. Progranulin Function in Spinal Cord Injury and neuroinflammation
  4081. Progranulin in frontotemporal lobar degeneration and neuroinflammation
  4082. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid
  4083. Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation
  4084. Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior
  4085. Prolonged expression of IL-1β in hippocampusal astrocytes bridges acute and chronic neuroinflammation in aged rats
  4086. Prolonged mechanical ventilation–induced neuroinflammation affects postoperative memory dysfunction in surgical mice
  4087. Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats
  4088. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
  4089. Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research
  4090. Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 …
  4091. Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis
  4092. Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of streptococcal meningitis (161.7)
  4093. Prophylactic chronic zinc administration increases neuroinflammation in a hypoxia-ischemia model
  4094. Propofol partially attenuates complete freund’s adjuvant‐induced neuroinflammation through inhibition of the ERK1/2/NF‐κB pathway
  4095. Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
  4096. Prostaglandin D-2 is a strong mediator of neuroinflammation in genetic demyelinating mouse model
  4097. Prostaglandin E2 EP4 receptor activation attenuates neuroinflammation and early brain injury induced by subarachnoid hemorrhage in rats
  4098. Prostaglandin J2-regulated pathways critical for aggregation of ubiquitinated proteins and neurodegeneration in a cellular model of neuroinflammation
  4099. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation
  4100. Protection Against neuroinflammation by Promoting Co-activation of G Protein–Growth Factor Signaling and Metabolic Flexibility in the Brain
  4101. Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol
  4102. Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres
  4103. Protection of PMS777, a New AChE Inhibitor with PAF Antagonism, Against Amyloid-β-Induced Neuronal Apoptosis and neuroinflammation
  4104. Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin
  4105. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1–42-induced Alzheimer’s disease model rats
  4106. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis
  4107. Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on neuroinflammation by LPS-Induced BV2 …
  4108. PROTECTIVE EFFECT OF CARVACROL AGAINST LIPOPOLYSACCHARIDE-INDUCED neuroinflammation, APOPTOSIS AND MEMORY DEFICIT IN MICE
  4109. Protective effect of Convolvulus pluricaulis against neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
  4110. Protective effect of COX inhibitors on lipopolysaccharide-induced sickness behaviour or neuroinflammation and oxidative stress in male Wistar rat
  4111. Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain
  4112. Protective effect of hydrogen sulfide against neuronal apoptosis via inhibiting neuroinflammation in Parkinson rats
  4113. Protective effect of lupeol against lipopolysaccharide-induced neuroinflammation via the p38/c-Jun N-terminal kinase pathway in the adult mouse brain
  4114. Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord
  4115. Protective effect of quercetin on weight drop injury model-induced neuroinflammation alterations in brain of mice
  4116. Protective Effects of 1-Methylnicotinamide on Aβ1–42-Induced Cognitive Deficits, neuroinflammation and Apoptosis in Mice
  4117. Protective effects of a phosphatidylcholine-enriched diet in lipopolysaccharide-induced experimental neuroinflammation in the rat
  4118. Protective effects of AGE and its components on neuroinflammation and neurodegeneration
  4119. Protective effects of Phyllanthus amarus against lipopolysaccharide-induced neuroinflammation and cognitive impairment in rats
  4120. Protective effects of resveratrol on social stress-induced neuroinflammation and depressive-like behavior
  4121. Protective effects of telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuroinflammation, and amyloidogenesis: possible role of brain …
  4122. Protective effects of wogonoside against β-amyloid-induced neurotoxicity and neuroinflammation
  4123. Protective role of apigenin on rotenone induced rat model of Parkinson’s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis
  4124. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson’s disease: Involvement of neuroinflammation and …
  4125. Protective role of fentanyl in lipopolysaccharide‑induced neuroinflammation in BV‑2 cells
  4126. Protective role of β-carotene against oxidative stress and neuroinflammation in a rat model of spinal cord injury
  4127. PROTEIN AGGREGATION AND neuroinflammation ARE INTERRELATED IN ALZHEIMER’S DISEASE
  4128. Protein kinase C delta and prokineticin-2 signaling in experimental models of neuroinflammation and Parkinson’s disease
  4129. Protein-energy malnutrition exacerbates stroke-induced forelimb abnormalities and dampens neuroinflammation
  4130. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
  4131. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection
  4132. Proteolytic Opening of the Blood-Brain Barrier During neuroinflammation
  4133. Proteomic signatures of neuroinflammation in Alzheimer’s disease, multiple sclerosis and ischemic stroke
  4134. Proteomics-based discovery of biomarkers and therapeutic targets in neurodegenerative diseases: perspective of microglia and neuroinflammation
  4135. PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation
  4136. PS216. Preclinical and clinical assessment of tryptophan catabolites (TRYCATS) as a measure of neuroinflammation and utility in compound screening.
  4137. PS218. Phospholipase C-related catalytically inactive protein is involved in the neuroinflammation-induced anorexia
  4138. Pseudane-VII Regulates LPS-Induced neuroinflammation in Brain Microglia Cells through the Inhibition of iNOS Expression
  4139. Pseudoginsenoside-F11 attenuates cognitive impairment by ameliorating oxidative stress and neuroinflammation in d‑galactose-treated mice
  4140. Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, neuroinflammation and Cardiovascular Disease …
  4141. Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer’s disease: the emerging role for microglia?
  4142. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection
  4143. Pterostilbene inhibits amyloid‐β‐induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase‐1 inflammasome pathway
  4144. Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord
  4145. Pulmonary Hypertension in Rats is Associated with VascularRemodeling and neuroinflammation in the Brain
  4146. Punicalagin inhibits neuroinflammation in LPS‐activated rat primary microglia
  4147. Purine nucleoside analogs in the therapy of cancer and neuroinflammation
  4148. Purinergic control of neuroinflammation and neuroprotection by the blockade of P2 receptors under excitotoxic conditions in the hippocampus
  4149. Purinergic mechanisms in neuroinflammation: an update from molecules to behavior
  4150. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
  4151. Purinergic signaling-induced neuroinflammation and status epilepticus
  4152. Purines control neuron-glia interaction during neuroinflammation
  4153. Purple sweet potato color attenuates high fat-induced neuroinflammation in mouse brain by inhibiting MAPK and NF-κB activation
  4154. Pyrethroid bifenthrin induces oxidative stress, neuroinflammation, and neuronal damage, associated with cognitive and memory impairment in murine hippocampus
  4155. Pyrrolidine dithiocarbamate attenuates surgery-induced neuroinflammation and cognitive dysfunction possibly via inhibition of nuclear factor κB
  4156. Pyrrolidine dithiocarbamate prevents neuroinflammation and cognitive dysfunction after endotoxemia in rats
  4157. Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced neuroinflammation
  4158. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F]DPA-714 PET
  4159. Quantifying CSF Biomarkers of Neuronal Injury, neuroinflammation and Synaptic Integrity in Antibody-Mediated Encephalitis (P2. 2-001)
  4160. Quantitative analysis of synaptic pathology and neuroinflammation: an initial study in a female rhesus monkey model of the” synaptic” phase of Alzheimer’s Disease
  4161. Quantitative characterization of amyloid plaque coverage in the 5XFAD mouse model phenotype and correlation with development of neuroinflammation
  4162. Quantitative imaging of neuroinflammation in human white matter: A positron emission tomography study with translocator protein 18 kDa radioligand, [18F]‐FEPPA
  4163. Quantitative phosphoproteomic analysis identifies the critical role of JNK1 in neuroinflammation induced by Japanese encephalitis virus
  4164. Quantitative proteomics analysis for effect of Acanthopanax senticosus extract on neuroinflammation.
  4165. Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation
  4166. Quercetin attenuates AZT-induced neuroinflammation in the CNS
  4167. Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS/NF-κB and HO-1/Nrf2 pathways
  4168. Questions and perspectives on involvement of S1PR1 in cancer-induced bone pain and neuroinflammation
  4169. Quetiapine attenuates the neuroinflammation and executive function deficit in streptozotocin-induced diabetic mice
  4170. Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week
  4171. Quinolinic Acid Accumulation During neuroinflammation: Does it Imply Excitotoxicity?
  4172. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson’s disease model
  4173. Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis
  4174. Radiation dosimetry of [18F] DPA-714, a potential PET biomarker for neuroinflammation
  4175. Radiation-induced neuroinflammation and radiation somnolence syndrome
  4176. Radio electric asymmetric conveyer technology modulates neuroinflammation in a mouse model of neurodegeneration
  4177. Radioisotopic imaging of neuroinflammation
  4178. Radiopharmaceuticals for PET imaging of neuroinflammation
  4179. Radiosurgery-Induced neuroinflammation in the Spinal Cord
  4180. RADIOSYNTHESIS OF [18F] F-DPA WITH VARIOUS MOLAR ACTIVITIES FOR THE IMAGING OF neuroinflammation
  4181. Raf kinase inhibitor protein protects microglial cells against 1-methyl-4-phenylpyridinium-induced neuroinflammation in vitro
  4182. RAGE antagonism by FPS‑ZM1 attenuates postoperative cognitive dysfunction through inhibition of neuroinflammation in mice
  4183. RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis
  4184. Rage signal transduction and implications for neuroinflammation in Alzheimer’s disease
  4185. RAGE signaling contributes to neuroinflammation in infantile neuronal ceroid lipofuscinosis
  4186. RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease
  4187. RAGE-specific inhibitor FPS-ZM1 attenuates AGEs-induced neuroinflammation and oxidative stress in rat primary microglia
  4188. Raman Spectroscopy Analysis of the Retina Reveals Changes in Glutamate, N-Acetyl-Aspartate, NADH and Phosphatidylcholine in neuroinflammation (P01. 166)
  4189. Randomized, Placebo-Controlled Trial of Targeting neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
  4190. Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo
  4191. Ratio measure of 11C-PBR28 binding allows noninvasive quantification of neuroinflammation in Alzheimer’s disease
  4192. Ratio of Alpha 2-Macroglobulin Levels in Cerebrospinal Fluid and Serum: An Expression of neuroinflammation in Acute Disseminated Encephalomyelitis
  4193. Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA …
  4194. REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
  4195. Reactive carbonyl compounds, carbonyl stress, and neuroinflammation in methyl alcohol intoxication
  4196. Reactive Glia-Derived neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age
  4197. Reactive gliosis and neuroinflammation in rats with communicating hydrocephalus
  4198. Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer’s disease: The NF-κB connection
  4199. Realgar is active ingredient of Angong Niuhuang pill in protection against LPS-induced neuroinflammation
  4200. Reboxetine Treatment Reduces neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer’s Disease: Role of CCL2
  4201. Recent advances in neuroinflammation therapeutics: PPARs/LXR as neuroinflammatory modulators
  4202. Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
  4203. Recent developments in targeting neuroinflammation in disease
  4204. Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target
  4205. Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders
  4206. Recent progress in the development of TSPO PET ligands for neuroinflammation imaging in neurological diseases
  4207. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies
  4208. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress
  4209. Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent neuroinflammation during Graft Versus Host Disease
  4210. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10
  4211. Recombinant netrin-1 binding UNC5B receptor attenuates neuroinflammation and brain injury via PPARγ/NFκB signaling pathway after subarachnoid hemorrhage in …
  4212. Recombinant Slit2 attenuates neuroinflammation after surgical brain injury by inhibiting peripheral immune cell infiltration via Robo1-srGAP1 pathway in a rat model
  4213. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
  4214. Red wine retards Abeta deposition and neuroinflammation in Alzheimer’s disease
  4215. Redirecting adult mesenchymal stromal cells to the brain: a new approach for treating CNS autoimmunity and neuroinflammation?
  4216. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a “central hub” in schizophrenia pathophysiology?
  4217. Redox signaling, neuroinflammation, and neurodegeneration
  4218. Reduced acute neuroinflammation and improved functional recovery after traumatic brain injury by α-linolenic acid supplementation in mice
  4219. Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation
  4220. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives
  4221. Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression
  4222. Reduced immune cells infiltration and increased neuroinflammation in type 2 diabetic mice infected with West Nile virus (P6038)
  4223. Reduced neuroinflammation and Improved Functional Recovery after Traumatic Brain Injury by Prophylactic Diet Supplementation in Mice
  4224. Reduced Nicotinamide Adenine Dinucleotide Phosphate inhibits MPTP-induced neuroinflammation and neurotoxicity
  4225. Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for …
  4226. Reducing cerebral microvascular amyloid-β protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic …
  4227. Reducing neuroinflammation
  4228. Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel
  4229. Reducing neuroinflammation by delivery of IL‐10 encoding lentivirus from multiple‐channel bridges
  4230. Reducing peripheral inflammation with infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy
  4231. Reduction in hypoxia-derived neuroinflammation and dysfunctional glutamate transporters by minocycline may restore hypoxia-injured cognition of neonatal rat
  4232. Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation
  4233. Reductions in amyloid-β-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation
  4234. Reductive Reprogramming: A Not-So-Radical Hypothesis of Neurodegeneration Linking Redox Perturbations to neuroinflammation and Excitotoxicity
  4235. Regenerative medicine therapies for targeting neuroinflammation after stroke
  4236. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion …
  4237. Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice
  4238. Region‐selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain
  4239. Regional distribution of CNS antigens differentially determines T-cell mediated neuroinflammation in a CX3CR1-dependent manner
  4240. Regional myelin and axon damage and neuroinflammation in the adult mouse brain after long-term postnatal vanadium exposure
  4241. Regional sensitivity to neuroinflammation: in vivo and in vitro studies
  4242. Regulation of autoimmune neuroinflammation by Hv1 proton channels
  4243. Regulation of autoimmune neuroinflammation by stress-responsive genes
  4244. Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation
  4245. Regulation of haeme oxygenase‐1 for treatment of neuroinflammation and brain disorders
  4246. Regulation of LPS-Induced neuroinflammation by Targeting Microglia in vivo Using Chemogenetics
  4247. Regulation of lymphocyte adhesion and migration into the CNS by phospholipase D1 in autoimmune neuroinflammation
  4248. Regulation of microglia activity by glaucocalyxin-A: Attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling …
  4249. Regulation of neuroinflammation by cGMP-mediated pathways
  4250. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases
  4251. Regulation of neuroinflammation by matrix metalloproteinase-8 inhibitor derivatives in activated microglia and astrocytes
  4252. REGULATION OF neuroinflammation THROUGH CONTROL OF MACROPHAGE AND MICROGLIAL POLARIZATION DYNAMICS
  4253. Regulation of neuroinflammation through programed death-1/programed death ligand signaling in neurological disorders
  4254. Regulation of neuroinflammation: the role of CXCL10 in lymphocyte infiltration during autoimmune encephalomyelitis
  4255. Regulation of neuroinflammation: what Role for the Tumor necrosis Factor-Like weak inducer of Apoptosis/Fn14 Pathway?
  4256. Regulation of Oxidative Stress and neuroinflammation by LRRK2 and Discovery of Biomarker in Parkinson’s Disease
  4257. Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells
  4258. Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
  4259. Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway
  4260. Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation
  4261. Regulatory B cells induce formation of IL-10-expressing T cells in mice with autoimmune neuroinflammation
  4262. Regulatory effects of caffeic acid phenethyl ester on neuroinflammation in microglial cells
  4263. Regulatory role of B cell-derived transforming growth factor-β1 expression in autoimmune neuroinflammation
  4264. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation
  4265. Regulatory role of Ifit2 in mouse hepatitis virus induced neuroinflammation
  4266. Regulatory role of the cannabinoid CB2 receptor in stress‐induced neuroinflammation in mice
  4267. Regulatory T cells in autoimmune neuroinflammation
  4268. Relationship between central cholinergic system and neuroinflammation a molecular pharmacological approach
  4269. Relationship between tau pathology and neuroinflammation in Alzheimer’s disease
  4270. Relationships between mitochondria and neuroinflammation: implications for Alzheimer’s disease
  4271. Relevance of neuroinflammation and encephalitis in autism
  4272. Relevance of spinal neuroinflammation to neuropathic pain: an exploratory clinical study evaluated by 11C-DPA-713 PET and TSPO-related biomarkers.
  4273. Relevant molecular and functional g-protein coupled receptor interactions in neuroinflammation and addiction
  4274. Reparixin attenuates neuronal injury in experimental Klebsiella pneumoniae meningoencephalitis through dual effects on neuroprotection and neuroinflammation
  4275. Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
  4276. Repeated injury to the lumbar nerve roots produces enhanced mechanical allodynia and persistent spinal neuroinflammation
  4277. Repeated mild lateral fluid percussion brain injury in the rat causes cumulative long-term behavioral impairments, neuroinflammation, and cortical loss in an animal …
  4278. Repeated mild traumatic brain injury causes chronic neuroinflammation, changes in hippocampal synaptic plasticity, and associated cognitive deficits
  4279. Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice
  4280. Repeated social defeat stress induces neuroinflammation and impairs hippocampal neurogenesis that differentially regulate mood and cognition
  4281. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist …
  4282. Repeated Social Defeat-Induced neuroinflammation, Anxiety-like behavior and Resistance to Fear Extinction were Attenuated by the Cannabinoid Receptor Agonist …
  4283. Repeated social defeat, neuroinflammation, and behavior: monocytes carry the signal
  4284. Reperfusion therapy for acute stroke improves outcome by decreasing neuroinflammation
  4285. Repetitive hyperbaric oxygen treatment attenuates complete Freund’s adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord
  4286. Repetitive mild traumatic brain injury with impact acceleration in the mouse: multifocal axonopathy, neuroinflammation, and neurodegeneration in the visual system
  4287. Reply to: High-Fat Diet–Induced Dysbiosis as a Cause of neuroinflammation
  4288. Reply: Increased olfactory bulb volume due to treatment of chronic rhinosinusitis: neuroinflammation and adult neurogenesis
  4289. Reprint of: neuroinflammation in acute liver failure: Mechanisms and novel therapeutic targets
  4290. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes
  4291. Research Advances in the neuroinflammation in Alzheimer’s Disease.
  4292. Research model of neurodegenerative diseases based on neuroinflammation and its traditional Chinese medicine treatment strategies
  4293. Research report 2: The effect of copper nanoparticle exposure on neuroinflammation
  4294. Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation
  4295. Resolution of neuroinflammation by Cytochrome P4504f: Implication in Alzheimer’s disease
  4296. Resolution of neuroinflammation: mechanisms and potential therapeutic option
  4297. Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX/FPR2 receptor-regulated microRNAs
  4298. Resolving neuroinflammation, the therapeutic potential of the anti-malaria drug family of artemisinin
  4299. Resolving postoperative neuroinflammation and cognitive decline
  4300. Restraining neuroinflammation during antigen delivery as an immunosuppressive approach to prevent and treat contact dermatitis
  4301. Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic mice
  4302. Resveratrol alleviates ethanol-induced neuroinflammation in vivo and in vitro: Involvement of TLR2-MyD88-NF-κB pathway
  4303. Resveratrol alleviates nuclear factor‐κB‐mediated neuroinflammation in vasculitic peripheral neuropathy induced by ischaemia–reperfusion via suppressing …
  4304. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation
  4305. Resveratrol as a protective molecule for neuroinflammation: a review of mechanisms
  4306. Resveratrol attenuates neuroinflammation after deep hypothermia with circulatory arrest in rats
  4307. Resveratrol attenuates neuroinflammation-mediated cognitive deficits in rats
  4308. Resveratrol attenuates neuroinflammation, maintains hippocampal BDNF levels and alleviates depressive-like behavior in aged rats
  4309. Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage
  4310. Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK/mTOR …
  4311. Resveratrol promoted the M2 polarization of microglia and reduced neuroinflammation after cerebral ischemia by inhibiting miR-155
  4312. Resveratrol protects cortical neurons against microglia‐mediated neuroinflammation
  4313. Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats
  4314. Resveratrol reverses morphine-induced neuroinflammation in morphine-tolerant rats by reversal HDAC1 expression
  4315. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders
  4316. Rethinking the role of cyclooxygenase-1 in neuroinflammation: more than homeostasis
  4317. Retinal ganglion cell death in glaucoma: exploring the role of neuroinflammation
  4318. Retinal microglia initiate neuroinflammation in ocular autoimmunity
  4319. Retracted: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs‐mediated neuroinflammation in bone cancer rats
  4320. Retraction Note: Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling
  4321. Review on Cross Talk between Neurotransmitters and neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour
  4322. Review on the Third International neuroinflammation Congress and Student Festival of Neuroscience in Mashhad University of Medical Sciences
  4323. Revisiting the systemic lipopolysaccharide mediated neuroinflammation: Appraising the effect of L-cysteine mediated hydrogen sulphide on it
  4324. Rh-IFN-α attenuates neuroinflammation and improves neurological function by inhibiting NF-κB through JAK1-STAT1/TRAF3 pathway in an experimental GMH rat …
  4325. rhEPO attenuates neuropathology and restrains neuroinflammation and apoptosis in rats with intracerebral hemorrhage
  4326. Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age
  4327. Rhinacanthin C Alleviates Amyloid-β Fibrils’ Toxicity on Neurons and Attenuates neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial …
  4328. Rhynchophyllin attenuates neuroinflammation in Tourette syndrome rats via JAK2/STAT3 and NF‐κB pathways
  4329. RIPK3 restricts viral pathogenesis via cell death-independent neuroinflammation
  4330. RIPped for neuroinflammation
  4331. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
  4332. Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats
  4333. Rodent models of neuroinflammation for Alzheimer’s disease
  4334. Role and function of adenosine and its receptors in inflammation, neuroinflammation, IBS, autoimmune inflammatory disorders, rheumatoid arthritis and psoriasis
  4335. Role for the Peripheral Benzodiazepine Receptor in neuroinflammation of Neurodegenerative disorders
  4336. Role of 26S Proteasome and Regulator of G-Protein Signaling 10 in Regulating neuroinflammation in the Central Nervous System
  4337. Role of 3-Acetyl-11-Keto-Beta-Boswellic acid in counteracting LPS-induced neuroinflammation via modulation of miRNA-155
  4338. Role of adenosine A2A receptor in controlling neuroinflammation mediated by retinal microglial cells
  4339. Role of Adenosine A2A Receptors in the Control of neuroinflammation—Relevance for Parkinson’s Disease
  4340. Role of Astrocyte-Derived Extracellular Vesicles in neuroinflammation Mediated by Drug Abuse
  4341. Role of astrocytic IL-6 and IL-6R in normal physiology and neuroinflammation
  4342. Role of Astroglial α7 Nicotinic Acetylcholine Receptorsin neuroinflammation and Oxidative Stress
  4343. Role of CC chemokine receptor type 7 and its ligands during neuroinflammation
  4344. Role of chondroitin sulfate proteoglycan signaling in regulating neuroinflammation following spinal cord injury
  4345. Role of Complement Factor H Polymorphism and Diet in neuroinflammation
  4346. Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer’s disease
  4347. Role of diet and gut microbiota in multiple sclerosis: New findings on the role of high‐salt intake in induction of neuroinflammation
  4348. Role of dietary phenols in mitigating microglia-mediated neuroinflammation
  4349. Role of dopamine receptors in the control of neuroinflammation
  4350. Role of endocannabinoids on neuroinflammation in autism spectrum disorder prevention
  4351. role of estradiol on fatty acid induced neuroinflammation
  4352. Role of extracellular signal-related kinase (Erk) 1 in the regulation of neuroinflammation
  4353. Role of flavonoid and polyunsaturated fatty acid in glial cell functions and neuroinflammation
  4354. Role of gasotransmitters in oxidative stresses, neuroinflammation, and neuronal repair
  4355. Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis
  4356. Role of GSK-3β in isoflurane-induced neuroinflammation and cognitive dysfunction in aged rats
  4357. Role of infiltrating macrophage in neuroinflammation following infection and obesity in mice (392.1)
  4358. Role of infiltrating monocytes/macrophages in acute and chronic neuroinflammation: effects on cognition, learning and affective behaviour
  4359. Role of Interleukin-1β and neuroinflammation in the Persistence of Neuropathic Pain
  4360. Role of JMJD3 and histone modifications in intermittent hypoxia-induced neuroinflammation (1120.6)
  4361. Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy
  4362. Role of macrophage dopamine receptors in mediating cytokine production: implications for neuroinflammation in the context of HIV-associated neurocognitive …
  4363. Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain
  4364. ROLE OF MICROGLIA-MEDIATED neuroinflammation IN DYSFUNCTION OF BLOOD-BRAIN BARRIER IN GLIOBLASTOMA
  4365. Role of microglial activation and neuroinflammation in neurotoxicity of acrylamide in vivo and in vitro
  4366. Role of microglial NMDA receptor-initiated PARP-1/TRPM2 signaling in driving chronic neuroinflammation
  4367. Role of Microglial Proton Channel Hv1 in Paraquat-Induced neuroinflammation
  4368. Role of microglial redox balance in modulation of neuroinflammation
  4369. Role of microRNA‐155 in modifying neuroinflammation and γ‐aminobutyric acid transporters in specific central regions after post‐ischaemic seizures
  4370. Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, neuroinflammation, and Pro-apoptosis—A Review
  4371. Role of Myocardial Infarction-Induced neuroinflammation for Depression-Like Behavior and Heart Failure in Ovariectomized Female Rats
  4372. Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson’s disease
  4373. Role of neuroinflammation and sex hormones in war-related PTSD
  4374. Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches
  4375. Role of neuroinflammation in Alzheimer’s and parkinson’s disease:[11C] PK11195 PET study
  4376. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications
  4377. Role of neuroinflammation in ethanol neurotoxicity
  4378. Role of neuroinflammation in evolution of childhood epilepsy
  4379. Role of neuroinflammation in hypertension-induced brain amyloid pathology
  4380. Role of neuroinflammation in ischemic stroke
  4381. Role of neuroinflammation in morphine tolerance: Effect of tumor necrosis factor-α
  4382. Role of neuroinflammation in neurodegeneration: new insights
  4383. Role of neuroinflammation in neurodegenerative diseases
  4384. Role of neuroinflammation in Opioid Tolerance: Translational Evidence from Human-to-Rodent Studies
  4385. Role of neuroinflammation in parkinson disease: the enigma continues
  4386. Role of neuroinflammation in pathogenesis of Alzheimer’s disease
  4387. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity
  4388. Role of neuroinflammation in the Pathophysiology of Traumatic Brain Injury
  4389. Role of neuroinflammation in the Trajectory of Alzheimer’s Disease and in vivo Quantification Using PET
  4390. Role of NOX2 Enzyme Activity In neuroinflammation: Preliminary Results In Amyotrophic Lateral Sclerosis And Parkinson’s Disease (P1. 080)
  4391. Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of β-amyloid animal model of Alzheimer’s disease
  4392. Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model
  4393. ROLE OF PLA2-DERIVED BIOACTIVE LIPIDS IN neuroinflammation
  4394. Role of pleiotrophin and midkine in LPS-induced astrocytosis: implications in neuroinflammation
  4395. Role of Reactive Gliosis and neuroinflammation in Experimental Glaucoma
  4396. ROLE OF REACTIVE OXIGEN SPECIES IN THE REGULATION OF neuroinflammation INDUCED BY EXCITOTOXIC DAMAGE IN CEREBELLAR …
  4397. Role of redox signaling in neuroinflammation and neurodegenerative diseases
  4398. Role of sortilin in models of autoimmune neuroinflammation
  4399. Role of TFH cells in promoting T helper 17-induced neuroinflammation
  4400. ROLE OF THE BONE MARROW AND neuroinflammation IN HYPERTENSION
  4401. Role of the CD200-CD200R axis during homeostasis and neuroinflammation
  4402. Role of the cell adhesion molecule L1 during neuroinflammation in the central nervous system
  4403. Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesis
  4404. Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy
  4405. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications
  4406. Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders
  4407. ROLE OF THE INFLAMMASOMES IN neuroinflammation ASSOCIATED WITH ALZHEIMER’S DISEASE
  4408. Role of the NLR gene family members in neuroinflammation and demyelination in the CNS
  4409. Role of the NLRP3 inflammasome in stress-induced neuroinflammation and anxiety-like behavior
  4410. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease
  4411. Role of TNF in mast cell neuroinflammation and pain
  4412. Role of toll-like receptor 4 in alcohol-induced neuroinflammation and behavioral dysfunctions
  4413. Role of toll-like receptor 4 in the regulation of the cell death pathway and neuroinflammation
  4414. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes
  4415. Role of triggering receptor expressed on myeloid cells 2 in neuroinflammation and neurodegeneration of the central nervous system
  4416. Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity
  4417. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina
  4418. ROLES OF ANTI-neuroinflammation AND ANTI-OXIDATIVE PROPERTIES OF A STANDARDISED Andrographis paniculata BURM. NEES AQUEOUS …
  4419. Roles of chemokines and their receptors in neuroinflammation
  4420. Roles of glial cells in neuroinflammation and neurodegeneration
  4421. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain
  4422. ROLES OF ORNITHINE DECARBOXYLASE (ODC) IN REGULATION OF AMYLOID β-INDUCED MICROGLIAL neuroinflammation
  4423. Roles of Th17 and Treg Cells in neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson’s Disease
  4424. Roles of Treg and Th17 cells in neuroinflammation and Neurodegeneration of Parkinson’s Disease
  4425. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
  4426. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
  4427. ROSMARINIC ACID ATTENUATES OXIDATIVE STRESS, neuroinflammation AND NEURODEGENERATION AGAINST LIPOPOLYSACCHARIDE …
  4428. Rosuvastatin attenuates high-salt and cholesterol diet induced neuroinflammation and cognitive impairment via preventing nuclear factor KappaB pathway
  4429. Rosuvastatin reduces neuroinflammation in the hemorrhagic transformation after rt-PA treatment in a mouse model of experimental stroke
  4430. Running for REST: physical activity attenuates neuroinflammation in the hippocampus of aged mice
  4431. Rutin attenuates neuroinflammation in spinal cord injury rats
  4432. Rutin improves spatial memory in Alzheimer’s disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation
  4433. Rutin inhibits neuroinflammation and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage, possibly through suppressing the RAGE …
  4434. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type
  4435. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
  4436. S-100β Reflects the Extent of Injury and Outcome, Whereas Neuronal Specific Enolase Is a Better Indicator of neuroinflammation in Patients With Severe Traumatic …
  4437. S-Adenosylmethionine attenuates oxidative stress and neuroinflammation induced by amyloid-β through modulation of glutathione metabolism
  4438. S1 PR 3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen‐glucose deprivation‐induced neuroinflammation via inhibiting TLR 2/4‐NF κB …
  4439. S14. 3CAN PERIPHERAL MARKERS INDICATE neuroinflammation?
  4440. S14IDENTIFICATION OF neuroinflammation IN THE BRAIN IN VIVO AND IN VITRO AND THERAPEUTIC STRATEGIES TO COMBAT ITS PROGRESSIONS14 …
  4441. S20. 3CHRONIC ALCOHOL INTAKE CAUSES neuroinflammation AND MYELIN ALTERATIONS IN MOUSE BRAIN
  4442. S4-02-06: Integrative approach targeting neuroinflammation
  4443. SA86. neuroinflammation in puerperal psychosis: the relationship between myelin content and peripheral inflammatory markers
  4444. Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation
  4445. Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression
  4446. Salidroside ameliorates diabetic neuropathic pain in rats by inhibiting neuroinflammation
  4447. Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation
  4448. Salt-sensitive alterations in gut microbiota impact Th17 cells and neuroinflammation (P3. 391)
  4449. Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury
  4450. Saponins from Panax japonicus attenuate age-related neuroinflammation via regulation of the mitogen-activated protein kinase and nuclear factor kappa B …
  4451. Sarcandra glabra Extract Protects against Scopolamine Induced Cognitive Deficits by Modulating neuroinflammation and the Cholinergic System
  4452. Scavenger receptor on astrocytes and its relationship with neuroinflammation.
  4453. Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation
  4454. Schisantherin A attenuates neuroinflammation in activated microglia: Role of Nrf2 activation through ERK phosphorylation
  4455. Schizophrenia: A disease mediated by neuroinflammation, neurotransmitters, or both?
  4456. Schizophrenia: neuroinflammation, neurodegeneration or neurodevelopment? A genetic overview
  4457. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice
  4458. SCO-Spondin Defects and neuroinflammation Identified as Conserved Mechanisms Driving Severe Spine Deformity Across Genetic Models of Idiopathic Scoliosis
  4459. SCOPOLETIN ATTENUATES MITOCHONDRIAL-OXIDATIVE STRESS, neuroinflammation AND NEURODEGENERATION IN BETA AMYLOID–AND OKADIAC …
  4460. Screening for inhibitors of microglia to reduce neuroinflammation
  4461. Scutellarin as a potential therapeutic agent for microglia-mediated neuroinflammation in cerebral ischemia
  4462. Scutellarin attenuates microglia-mediated neuroinflammation and promotes astrogliosis in cerebral ischemia-a therapeutic consideration
  4463. Scutellarin suppresses neuroinflammation via the inhibition of the AKT/NF-κB and p38/JNK pathway in LPS-induced BV-2 microglial cells
  4464. Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
  4465. Secondary neuroinflammation in a rat sepsis model
  4466. Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of α-synuclein and neuroinflammation
  4467. Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
  4468. Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure–induced transient …
  4469. Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
  4470. Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment
  4471. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma
  4472. Selective inhibition of microglia-mediated neuroinflammation mitigates radiation-induced cognitive impairment
  4473. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury
  4474. Selective PCAF inhibitor ameliorates cognitive and behavioral deficits by suppressing NF-κB-mediated neuroinflammation induced by Aβ in a model of …
  4475. Seleno-polymannuronate attenuates neuroinflammation by suppressing microglial and astrocytic activation
  4476. Sensors of succinate: neural stem cell grafts fight neuroinflammation
  4477. Serial Imaging with [11C] PBR28 Suggests Increased neuroinflammation During the Progression of Alzheimer’s Disease (P6. 173)
  4478. Sericin alleviates restraint stress induced depressive-and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal …
  4479. Serotonergic system and its interaction with neuroinflammation
  4480. SerpinB1 controls encephalitogenic T helper cells in neuroinflammation
  4481. Sertoli cells avert neuroinflammation-induced cell death and improve motor function and striatal atrophy in rat model of Huntington disease
  4482. Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood–brain barrier impairment
  4483. Sesquiterpene coumarins from Ferula sinkiangensis act as neuroinflammation inhibitors
  4484. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 …
  4485. Severe recurrent neuroinflammation associated with cytotoxic T-lymphocyte antigen-4 (CTLA4) haploinsufficiency (P1. 330)
  4486. Sevoflurane Exacerbates Cognitive Impairment Induced by Aβ1–40 in Rats through Initiating Neurotoxicity, neuroinflammation, and Neuronal Apoptosis in Rat …
  4487. Sevoflurane exaggerates cognitive decline in a rat model of chronic intermittent hypoxia by aggravating microglia-mediated neuroinflammation via downregulation of …
  4488. Sevoflurane Post-treatment Upregulated miR-203 Expression to Attenuate Cerebral Ischemia-Reperfusion-Induced neuroinflammation by Targeting MyD88
  4489. Sex Bias in Pathogenesis of Autoimmune neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action
  4490. Sex bias in pathogenesis of autoimmune neuroinflammation: relevance for dimethyl fumarate immunomodulatory/anti-oxidant action
  4491. Sex differences in acute neuroinflammation after experimental traumatic brain injury are mediated by infiltrating myeloid cells
  4492. Sex differences in depression-like behavior and neuroinflammation in rats post-MI: role of estrogens
  4493. Sex Differences in Microgial Activation and neuroinflammation On a High Fat Diet in Mice
  4494. Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development
  4495. Sex differences in neuroinflammation and neuroprotection in ischemic stroke
  4496. Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice
  4497. Sex-dependent effects of developmental exposure to different pesticides on spatial learning. The role of induced neuroinflammation in the hippocampus
  4498. Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: Relevance for susceptibility and resilience in autism
  4499. Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation
  4500. Sex‐dependent long‐term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats
  4501. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging
  4502. Sfrp1 promotes neuroinflammation through the modulation of ADAM10 proteolytic activity
  4503. Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation
  4504. Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis
  4505. Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition
  4506. Short-term Feeding Effects of High-Fat Diet on Hippocampal neuroinflammation: Differences among C57BL/6J, C3H/HeN, and C3H/HeJ mice
  4507. Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice
  4508. Should we stop saying ‘glia’and ‘neuroinflammation‘?
  4509. Sialoadhesin promotes neuroinflammation‐related disease progression in two mouse models of CLN disease
  4510. Sickness Behavior Score Is Associated with neuroinflammation and Late Behavioral Changes in Polymicrobial Sepsis Animal Model
  4511. Siegesbeckia Orientalis L. extract attenuates postoperative cognitive dysfunction, systemic inflammation, and neuroinflammation
  4512. Sifting through the surfeit of neuroinflammation tracers
  4513. Sigma-1 receptor modulates neuroinflammation after traumatic brain injury
  4514. Sigma-1 receptor-modulated neuroinflammation in neurological diseases
  4515. Sigma‐1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain
  4516. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation
  4517. Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation
  4518. Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
  4519. Signs of persistent neuroinflammation after myocardial infarction of mice (730.3)
  4520. Sildenafil (Viagra) protective effects on neuroinflammation: the role of iNOS/NO system in an inflammatory demyelination model
  4521. Sildenafil reduces neuroinflammation in cerebellum, restores GABA ergic tone, and improves motor in‐coordination in rats with hepatic encephalopathy
  4522. Silencing alpha synuclein in mature nigral neurons results in rapid neuroinflammation and subsequent toxicity
  4523. Silencing of Long Noncoding RNA Nespas Aggravates Microglial Cell Death and neuroinflammation in Ischemic Stroke
  4524. Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress
  4525. Simvastatin prevents neuroinflammation by inhibiting N‐methyl‐D‐aspartic acid receptor 1 in 6‐hydroxydopamine‐treated PC12 cells
  4526. Simvastatin therapy in adolescent mice attenuates HFD-induced depression-like behavior by reducing hippocampal neuroinflammation
  4527. Single administration of soluble epoxide hydrolase inhibitor suppresses neuroinflammation and improves neuronal damage after cardiac arrest in mice
  4528. Single episode of mild murine malaria induces neuroinflammation, alters microglial profile, impairs adult neurogenesis, and causes deficits in social and anxiety-like …
  4529. Single inflammatory trigger leads to neuroinflammation in LRRK2 rodent model without degeneration of dopaminergic neurons
  4530. Single mild traumatic brain injury induces persistent disruption of the blood-brain barrier, neuroinflammation and cognitive decline in hypertensive rats
  4531. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models
  4532. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
  4533. Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation
  4534. Sinularin from indigenous soft coral attenuates nociceptive responses and spinal neuroinflammation in carrageenan-induced inflammatory rat model
  4535. SIRT 2 inhibition exacerbates neuroinflammation and blood–brain barrier disruption in experimental traumatic brain injury by enhancing NF‐κB p65 acetylation and …
  4536. SIRT1 dependent modulation of neuroinflammation led neuroexcitotoxicity in aging rats.
  4537. SIRT2 plays significant roles in lipopolysaccharides-induced neuroinflammation and brain injury in mice
  4538. Sirtuin 3 attenuates neuroinflammation-induced apoptosis in BV-2 microglia
  4539. Skull fractures induce neuroinflammation and worsen outcomes after closed head injury in mice
  4540. SLEEP DEPRIVATION INDUCES COGNITIVE DYSFUNCTION THROUGH MECHANISM INVOLVED IN neuroinflammation AND OXIDATIVE STRESS
  4541. Sleep disturbance induces neuroinflammation and impairment of learning and memory
  4542. Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration
  4543. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer’s disease
  4544. SMALL MOLECULES TARGETING TAU AGGREGATION DECREASE TAU PATHOLOGY AND neuroinflammation IN VIVO
  4545. Smallanthus sonchifolius leaf attenuates neuroinflammation
  4546. SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal neuroinflammation and Vascular Leakage in Experimental Diabetes
  4547. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral …
  4548. SOD1G93A Mutant Mice Develop a neuroinflammation-Independent Dendropathy in Excitatory Neuronal Subsets of the Olfactory Bulb and Retina
  4549. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration
  4550. Sodium hydrosulfide attenuates beta-amyloid-induced cognitive deficits and neuroinflammation via modulation of MAPK/NF-κB pathway in rats
  4551. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s …
  4552. Sodium P-aminosalicylic acid inhibits sub-chronic manganese-induced neuroinflammation in rats by modulating MAPK and COX-2
  4553. Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
  4554. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction
  4555. Soybean isoflavone ameliorates cognitive impairment, neuroinflammation, and amyloid β accumulation in a rat model of Alzheimer’s disease
  4556. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease
  4557. Spatio-temporal overview of neuroinflammation in an experimental mouse stroke model
  4558. Spatio-temporal overview of neuroinflammation in an experimental mouse stroke model
  4559. Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat
  4560. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters
  4561. Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology
  4562. Sphingolipids in neuroinflammation
  4563. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
  4564. Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation
  4565. Sphingosine kinase 1 mediates neuroinflammation following cerebral ischemia
  4566. Sphk1 mediates neuroinflammation and neuronal injury via TRAF2/NF-κB pathways in activated microglia in cerebral ischemia reperfusion
  4567. Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal …
  4568. Spirocyclic iodonium ylide-based synthesis of [18F] FDPA and preliminary PET studies in neuroinflammation
  4569. Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke
  4570. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small …
  4571. Stabilization of brain mast cells alleviates LPS-induced neuroinflammation by inhibiting microglia activation and migration
  4572. STAT1 drives M1 microglia activation and neuroinflammation under hypoxia
  4573. STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression
  4574. STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression
  4575. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation
  4576. Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice
  4577. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria
  4578. Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction
  4579. Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms
  4580. Stem cell therapy for sequestering neuroinflammation in traumatic brain injury: an update on exosome-targeting to the spleen.
  4581. Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor
  4582. Sterile neuroinflammation and strategies for therapeutic intervention
  4583. Steroid-Enriched Fraction of Achyranthes bidentata Protects Amyloid β Peptide 1–40-Induced Cognitive Dysfunction and neuroinflammation in Rats
  4584. Stimulation of endocannabinoid receptors is required for reduction of neuroinflammation and restoration of neurogenesis in the aged brain
  4585. Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice
  4586. Stimulation of Toll-like receptor 9 by chronic intraventricular unmethylated cytosine-guanine DNA infusion causes neuroinflammation and impaired spatial memory
  4587. Stimuli-responsive star poly (ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation
  4588. Strategies to drive microglia towards pro-regenerative function in neuroinflammation: implications for the treatment of neurological disorders
  4589. Stress and neuroinflammation
  4590. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness
  4591. Stress Hormone Enhancement of OP-Induced neuroinflammation as an Animal Model of GWI: The Role of Toll-like Receptors and Plasticity
  4592. Stress Hormone Enhancement of OP-induced neuroinflammation as an Animal Model of GWI: The Role of Toll-like Receptors and Plasticity
  4593. Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior
  4594. Stress-induced neuroinflammation: mechanisms and new pharmacological targets
  4595. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway
  4596. Striatal neuroinflammation promotes Parkinsonism in rats
  4597. Striatal neuroinflammation promotes parkinsonism in rats
  4598. Stromelysin-1 (MMP-3) affects blood-brain barrier permeability during lipopolysaccharide-induced neuroinflammation
  4599. Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation
  4600. Structure− activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections
  4601. Studies on 16, 17-pyrazoline substituted heterosteroids as anti-Alzheimer and anti-Parkinsonian agents using LPS induced neuroinflammation models of mice and …
  4602. Studies on structural and functional changes of mouse choroid plexus in the initiation of neuroinflammation
  4603. Studies on the Development and Consequences of neuroinflammation in Obesity
  4604. Study of Anti-Inflammatory Activity of Crizotinib in Microglia Model of neuroinflammation
  4605. Study of neuroinflammation markers in the hippocampus of adolescent rats after binge-like ethanol exposure
  4606. Study on the dynamic changes in synaptic vesicle-associated protein and axonal transport protein combined with LPS neuroinflammation model
  4607. Study on the role of Molecular and Cellular Mediators involved in neuroinflammation
  4608. SU68. Effect of Cannabis on neuroinflammation in Clinical High Risk for Psychosis: An In Vivo PET Study With [18F]-FEPPA
  4609. Sub-chronic exposure of non-observable adverse effect dose of terbufos sulfone: neuroinflammation in diabetic and non-diabetic rats
  4610. Sub-concussive brain injury in the Long-Evans rat induces acute neuroinflammation in the absence of behavioral impairments
  4611. Substance P and antagonists of the neurokinin-1 receptor in neuroinflammation associated with infectious and neurodegenerative diseases of the central …
  4612. Substance Use Exacerbates neuroinflammation And Neurocognitive Impairment In Hiv Infection
  4613. Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease
  4614. Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt–Jakob disease
  4615. Sulfasalazine attenuates chronic constriction injury-induced neuroinflammation and mechanical hypersensitivity in rats
  4616. Sulforaphane as a potential nutritional intervention to reduce neuroinflammation associated with aging and sickness behavior
  4617. Sulforaphane-enriched broccoli sprouts pretreated by pulsed electric fields reduces neuroinflammation and ameliorates scopolamine-induced amnesia in mouse …
  4618. Superparamagnetic iron oxide nanocolloids in MRI studies of neuroinflammation
  4619. Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging of neuroinflammation in a Rat Model of Radicular Pain
  4620. Supplementary data to: LONG-TERM ADMINISTRATION OF MELATONIN ATTENUATES neuroinflammation IN THE AGED MOUSE BRAIN
  4621. Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway
  4622. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation
  4623. Suppression of IL-17 and GM-CSF production in T cells by immunomodulator ameliorates the pathogenesis of autoimmune neuroinflammation (P5150)
  4624. Suppression of lipopolysaccharide-induced neuroinflammation by morin via MAPK, PI3K/Akt, and PKA/HO-1 signaling pathway modulation
  4625. Suppression of miR-193a alleviates neuroinflammation and improves neurological function recovery after traumatic brain injury (TBI) in mice
  4626. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine
  4627. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
  4628. Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson’s disease model mice challenged with …
  4629. Suppression of neuroinflammation by the dopamine receptor D2 via alphaB-crystallin
  4630. Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality
  4631. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic …
  4632. Suppressive effect of ginsenoside Rg3 against lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice
  4633. Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 …
  4634. Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine
  4635. Suppressors of cytokine signalling (SOCS)-1 inhibits neuroinflammation by regulating ROS and TLR4 in BV2 cells
  4636. Suprachiasmatic nucleus and subordinate brain oscillators: Clock gene desynchronization by neuroinflammation
  4637. Surgery, neuroinflammation and cognitive impairment
  4638. Surgery, neuroinflammation and long-term outcome
  4639. Surgical trauma exacerbates cognitive deficits and neuroinflammation in aged rats: The role of CX3CL1-CX3CR1 signaling
  4640. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of neuroinflammation and a Potential Outcome …
  4641. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
  4642. Sustained stimulation of β2-and β3-adrenergic receptors leads to persistent functional pain and neuroinflammation
  4643. Sutherlandia frutescens may exacerbate HIV-associated neuroinflammation
  4644. SV40T-MEDIATED NEURONAL CELL CYCLE DYSREGULATION IN MICE INDUCES Aβ AND TAU PATHOLOGIES AND neuroinflammation
  4645. Swine Barn Dust Exposure Activates Microglia through Induction of Oxidative Stress and the Resultant neuroinflammation Appears to Involve HMGB1 and RAGE …
  4646. SY10-5 INVESTIGATING ALCOHOL AND neuroinflammation
  4647. Symposium 10–Microglia, neuroinflammation and psychiatric disease: biomarkers and therapeutic potential
  4648. Synaptic scaffolding protein neuroligin 1 links amyloid deposition, neuroinflammation and impaired memory
  4649. Synergy Between Plasminogen Activator Inhibitor-1, α-Synuclein, and neuroinflammation in Parkinson’s Disease
  4650. Synthesis and evaluation of a novel TSPO radiotracer [18F] FM-PBR28 in a rat model of neuroinflammation: A PET study in comparison with [11C] PBR28
  4651. Synthesis and in vitro characterization of a P2X7 radioligand [123I] TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease
  4652. Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A‐740003 as a novel tracer of neuroinflammation
  4653. Synthesis of [18F] fluoromethyl-PBR28-d2 and its preclinical comparison with [18F] fluoromethyl-PBR28 in a rat model of neuroinflammation
  4654. Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor
  4655. Synthesis of fluorine-18-labelled TSPO ligands for imaging neuroinflammation with positron emission tomography
  4656. Synthesis of MC1 for Toxicology Study, Preceding Evaluation of [11C] MC1 as a PET Radioligandfor Imaging neuroinflammation in Humans
  4657. Synthesis of PET radioligands as potential probes for imaging COX-2 in neuroinflammation
  4658. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats
  4659. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
  4660. systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis
  4661. Systemic immune activation leads to neuroinflammation and sickness behavior in mice
  4662. Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis
  4663. Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain
  4664. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
  4665. Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway
  4666. T cell production of cytokines, neurotrophins and MHC regulation in autoimmune neuroinflammation
  4667. T cell-selective deletion of Oct1 protects animals from autoimmune neuroinflammation while maintaining neurotropic pathogen response
  4668. T lymphocytes impair P-glycoprotein function during neuroinflammation
  4669. T-14: IN VIVO IMAGING OF neuroinflammation IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION.
  4670. T-bet expression in NK cells is critical in the pathogenicity of Th17-induced neuroinflammation
  4671. T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation
  4672. T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring …
  4673. T1R1/T1R3 Taste Receptor Suppresses Granulocyte-Mediated neuroinflammation after Spinal Cord Injury
  4674. T256. Differential Effects of Antipsychotics on neuroinflammation and Energy Sensing in a Hypothalamic Cell Line
  4675. T80. Novel PET Radioligands Show That COX-2, but not COX-1, is Induced by neuroinflammation in Rhesus Macaque
  4676. TAARgeting Astrocyte Mitochondrial Dysfunction during HIV-associated neuroinflammation and METH Exposure.
  4677. TAARgeting Astrogliosis and Mitochondrial Dysfunction during METH Exposure and HIV-relevant neuroinflammation
  4678. Tackling neuroinflammation and cholinergic deficit in Alzheimer’s disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase
  4679. TAM Receptor Pathways at the Crossroads of neuroinflammation and Neurodegeneration
  4680. Tannic Acid Ameliorates STZ-Induced Alzheimer’s Disease-Like Impairment of Memory, neuroinflammation, Neuronal Death and Modulates Akt Expression
  4681. Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice
  4682. Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice
  4683. Targeting CXCL13 during neuroinflammation
  4684. Targeting cyclooxygenases-1 and-2 in neuroinflammation: Therapeutic implications
  4685. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS
  4686. Targeting extracellular cyclophilin A reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis
  4687. Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: opportunities, challenges and future directions for cerebral stroke management
  4688. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases
  4689. Targeting ion channels for the treatment of autoimmune neuroinflammation
  4690. Targeting key signaling factors as a way to control microglial activation and induction of neuroinflammation
  4691. Targeting leukotriene-mediated neuroinflammation in traumatic brain injury
  4692. Targeting metabotropic glutamate receptors for the treatment of neuroinflammation
  4693. Targeting microglia attenuates neuroinflammation‐related neural damage in mice carrying human PLP1 mutations
  4694. Targeting microglia necroptosis to arrest neuroinflammation
  4695. Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
  4696. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis
  4697. Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities
  4698. Targeting neuroinflammation by Vascular Versus Metabolic Acting Drugs, in a Preventive or Therapeutic Approach, Using an Experimental Model of Sporadic …
  4699. Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT)
  4700. Targeting neuroinflammation in Alzheimer’s disease
  4701. Targeting neuroinflammation in Alzheimer’s disease: An attractive strategy for the development of novel therapeutic approaches.
  4702. Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
  4703. TARGETING neuroinflammation IN THE CONTEXT OF ALZHEIMER’S DISEASE WITH COMORBID VASCULAR PATHOLOGY
  4704. Targeting neuroinflammation in the treatment and prevention of Alzheimer’s disease
  4705. Targeting neuroinflammation through inhibition of NLRP3
  4706. Targeting neuroinflammation to treat Alzheimer’s disease
  4707. Targeting neuroinflammation with human umbilical cord tissue-derived mesenchymal stromal cells
  4708. Targeting neuroinflammation with Human Umbilical Cord Tissue‐Derived Mesenchymal Stromal Cells
  4709. Targeting neuroinflammation with Human Umbilical Cord Tissue‐Derived Mesenchymal Stromal Cells
  4710. Targeting neuroinflammation with minocycline in heavy drinkers
  4711. Targeting neuroinflammation-a potential for anti-aging interventions.
  4712. Targeting of cell death and neuroinflammation with peptide-linked iron oxide nanoparticles and Gd-DTPA in a mouse model of Parkinson’s disease (accepted)
  4713. Targeting oxidative stress to attenuate seizure-induced neuroinflammation in temporal lobe epilepsy
  4714. Targeting radiation-induced neuroinflammation using ICAM-MPIO
  4715. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long‐term effects on neurological recovery
  4716. Targeting STATs in neuroinflammation: The road less traveled!
  4717. TARGETING THE NLRP3 INFLAMMASOME IN MECHANISMS OF SLEEP DEPRIVATION-INDUCED neuroinflammation
  4718. Targeting the NLRP3 Inflammasome in neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders
  4719. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation
  4720. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation
  4721. Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases
  4722. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders
  4723. Targeting Transcription Factor NF-kappa B by Dual Functional Oligodeoxynucleotide Complex for Inhibition of neuroinflammation
  4724. Tau and neuroinflammation: What impact for Alzheimer’s Disease and Tauopathies?
  4725. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment
  4726. Tau hyperphosphorylation: a downstream effector of isoflurane-induced neuroinflammation in aged rodents
  4727. Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer’s disease
  4728. Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation
  4729. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats
  4730. Tauroursodeoxycholic Acid Ameliorates Lipopolysaccharide-Induced Depression Like Behavior in Mice via the Inhibition of neuroinflammation and Oxido-Nitrosative …
  4731. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
  4732. TBK1: a new player in ALS linking autophagy and neuroinflammation
  4733. Telemedicine Reduces Barriers to Care for Patients with Multiple Sclerosis and neuroinflammation (P4. 378)
  4734. Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism
  4735. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS
  4736. Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy
  4737. Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations
  4738. Testosterone differentially affects T cells and neurons in murine and human models of neuroinflammation and neurodegeneration
  4739. Tetrahydroxystilbene glucoside attenuates neuroinflammation through the inhibition of microglia activation
  4740. Tetramethylpyrazine attenuates periorbital allodynia and neuroinflammation in a model of traumatic brain injury
  4741. Tetramethylpyrazine‑2′ O‑sodium ferulate provides neuroprotection against neuroinflammation and brain injury in MCAO/R rats by suppressing TLR-4/NF-κB …
  4742. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer’s disease induced …
  4743. TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation
  4744. TGF-β1 attenuates spinal neuroinflammation and the excitatory amino acid system in rats with neuropathic pain
  4745. TGF-β1 protection against Aβ1–42-induced neuroinflammation and neurodegeneration in rats
  4746. TGFβ contributes to the anti-inflammatory effects of tauroursodeoxycholic acid on an animal model of acute neuroinflammation
  4747. TGFβ regulates persistent neuroinflammation by controlling Th1 polarization and ROS production via monocyte‐derived dendritic cells
  4748. TGR 5 signaling reduces neuroinflammation during hepatic encephalopathy
  4749. Th17 cell-mediated neuroinflammation is involved in neurodegeneration of aβ1-42-induced Alzheimer’s disease model rats
  4750. Thalamic-evoked generalized convulsive seizures (GCS) result in apoptotis and neuroinflammation in remote areas
  4751. Thalidomide derivatives for the treatment of neuroinflammation
  4752. The 18 kDa translocator protein, microglia and neuroinflammation
  4753. The 18-kDa translocator protein as a CNS drug target: finding our way through the neuroinflammation fog
  4754. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4755. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4756. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4757. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4758. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4759. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4760. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4761. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4762. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4763. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4764. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4765. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4766. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4767. The 1st International neuroinflammation Congress and 1st Student Festival of Neurosience
  4768. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4769. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4770. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4771. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4772. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4773. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4774. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4775. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4776. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4777. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4778. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4779. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4780. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4781. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4782. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4783. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4784. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4785. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4786. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4787. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4788. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4789. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4790. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4791. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4792. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4793. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4794. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4795. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4796. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4797. The 2nd International neuroinflammation Congress and 2nd Student Festival of Neurosience
  4798. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice
  4799. The Action of Maternal Separation on and Glutamate Receptors and neuroinflammation: Role in Anxiety and Cocaine-Reinforced Behavior
  4800. The active contribution of OPCs to neuroinflammation is mediated by LRP1
  4801. The activity of antiparkinsonian drug hemantane in models of peripheral inflammation and lipopolysaccharide-induced neuroinflammation
  4802. The additive effect of aging on sepsis-induced cognitive impairment and neuroinflammation
  4803. The ameliorative effect of fluoxetine on neuroinflammation induced by sleep deprivation
  4804. The Amyloid-Tau-neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
  4805. The anti-amyloid compound DO1 decreases plaque pathology and neuroinflammation-related expression changes in 5xFAD transgenic mice
  4806. The anti-parkinsonian drug zonisamide reduces neuroinflammation: role of microglial Nav 1.6
  4807. The anti-rheumatic gold drug auranofin could be beneficial in Alzheimer’s disease by inhibiting astrocyte-mediated neuroinflammation
  4808. The aqueous extract from Toona sinensis leaves inhibits microglia-mediated neuroinflammation
  4809. The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson’s disease model
  4810. The Attenuative Effects of Immunoglobulin G (IgG) for neuroinflammation in the Rats Model of Spinal Cord Injury
  4811. The benefits of neuroinflammation for the repair of the injured central nervous system
  4812. The Blood–Brain Barrier in neuroinflammation
  4813. The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwDI mice
  4814. The brain barriers as therapeutic targets in neuroinflammation
  4815. The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer’s disease mouse model
  4816. The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and neuroinflammation
  4817. The CD200R1 microglial inhibitory receptor as potential target to control neuroinflammation and resulting neuronal damage in the MPTP mouse model of Parkinson’s …
  4818. The Cellular and Molecular Mechanisms of ASC-dependent Inflammasomes in neuroinflammation
  4819. The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival
  4820. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy
  4821. The chemokine (CC motif) ligand 2 in neuroinflammation and neurodegeneration
  4822. The chemokine system in neuroinflammation: an update
  4823. The choice of general anesthetics may not affect neuroinflammation and impairment of learning and memory after surgery in elderly rats
  4824. The choreography of neuroinflammation in Huntington’s disease
  4825. The choroid plexus in post-stroke neuroinflammation
  4826. The cognitive defects of neonatally irradiated mice are accompanied by changed synaptic plasticity, adult neurogenesis and neuroinflammation
  4827. The complement cascade: Yin–Yang in neuroinflammation–neuro‐protection and‐degeneration
  4828. The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects
  4829. The complex genetics of experimental autoimmune neuroinflammation
  4830. The complex role of neuroinflammation in glaucoma
  4831. The complexity of neuroinflammation at single-cell resolution
  4832. The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments
  4833. The Concept of In Vivo Imaging of neuroinflammation with [11C](R)-PK11195 PET
  4834. The contribution of formyl peptide receptor dysfunction to the course of neuroinflammation: A potential role in the brain pathology.
  4835. The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease
  4836. The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response
  4837. The correlation between accumulation of amyloid beta with enhanced neuroinflammation and cognitive impairment after intraventricular hemorrhage
  4838. The cox-2 inhibitor meloxicam ameliorates neuroinflammation and depressive behavior in adult mice after splenectomy
  4839. The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes
  4840. The cystathionine β-synthase/hydrogen sulfide pathway contributes to microglia-mediated neuroinflammation following cerebral ischemia
  4841. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 …
  4842. The detrimental effects of lipopolysaccharide-induced neuroinflammation on adult hippocampal neurogenesis depend on the duration of the pro-inflammatory …
  4843. The Development of Multimodal Imaging Probes for Visualizing neuroinflammation in Alzheimer’s Disease and Traumatic Brain Injury
  4844. The dietary flavonoid quercetin decreases neuroinflammation in a mouse model of Alzheimer’s disease
  4845. The disruption of mitochondrial axonal transport is an early event in neuroinflammation
  4846. The disruption of mitochondrial axonal transport is an early event in neuroinflammation
  4847. The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: implications for translational research
  4848. The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival
  4849. The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation
  4850. The Effect of Docosahexaenoic Acid in a Mouse Model of neuroinflammation
  4851. The effect of extracranial trauma and age on traumatic brain injury, and the role of neuroinflammation
  4852. The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6
  4853. The effect of HMGB1 on sub-toxic chlorpyrifos exposure-induced neuroinflammation in amygdala of neonatal rats
  4854. The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation
  4855. The effect of Intrahippocampal insulin infusion on spatial cognitive function and markers of neuroinflammation in diet-induced obesity
  4856. The effect of maternal and postnatal obesity on offspring anxiety and memory and the role of altered HPA axis function and neuroinflammation
  4857. The Effect of Minocycline on neuroinflammation After Brain Trauma
  4858. The Effect of Omega-3 Polyunsaturated Fatty Acids on neuroinflammation in the Hippocampus
  4859. The Effect of Omega-3 Polyunsaturated Fatty Acids on neuroinflammation in the Hippocampus
  4860. The effect of selective targeting of TNF-alpha and its receptors on depression and neuroinflammation after myocardial infarction
  4861. The effect of titanium dioxide nanoparticles on neuroinflammation response in rat brain
  4862. The effects of 8-OH-DPAT on neuroinflammation after sarin exposure in mice
  4863. The effects of a novel NSAID on chronic neuroinflammation are age dependent☆
  4864. The effects of a single acute and repeated intracerebroventricular infusions of propionic acid on locomotor activity and neuroinflammation in rats
  4865. The effects of acetyl-L-carnitine treatment on neuroinflammation: An in vitro study
  4866. The effects of Acorus calamus L. in preventing memory loss, anxiety, and oxidative stress on lipopolysaccharide-induced neuroinflammation rat models
  4867. The Effects of Aldose Reductase Inhibitor Quercetin and Monochloropivaloylquercetin in Amyloid β Peptide (1–42) Induced neuroinflammation in Microglial Cells
  4868. The effects of blocking amylin receptors on oxidative stress and neuroinflammation in APP/PS1 mice.
  4869. The Effects of Celecoxib on Rotenone-Induced Rat Model of Parkinson’s Disease: Suppression of neuroinflammation and Oxidative Stress-Mediated …
  4870. The Effects of Celecoxib on Rotenone-Induced Rat Model of Parkinson’s Disease: Suppression of neuroinflammation and Oxidative Stress-Mediated Apoptosis
  4871. The effects of Clopidogrel on neuroinflammation and learning impairment related to Alzheimer´ s disease
  4872. The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats
  4873. The effects of lipid lowering drugs on neuroinflammation in metabolic syndrome mice
  4874. The Effects of Lipopolysaccharide-induced neuroinflammation on Learning and Forgetting in Juvenile Rats
  4875. The Effects of Maternal Helminths on neuroinflammation in Offspring
  4876. The effects of N-acetyl-cysteine and acetyl-L-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury
  4877. The Effects of neuroinflammation on the Phagocytic Activity of Microglial Cells
  4878. The effects of neuroinflammation on the subventricular zone neurogenic compartment following Theiler’s Murine Encephalomyelitis virus infection and its regulation by …
  4879. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation
  4880. The Effects of TREM2 deficiency on Traumatic Brain Injury-induced neuroinflammation and Neurodegeneration
  4881. The Effects of Vagus Nerve Stimulation on neuroinflammation in Epilepsy
  4882. The emerging role of docosahexaenoic acid in neuroinflammation.
  4883. The emerging role of HMGB1 in neuropathic pain: a potential therapeutic target for neuroinflammation
  4884. The endocrine and metabolic factors influencing neuroinflammation and recovery following traumatic brain injury
  4885. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation
  4886. The endotoxin-induced neuroinflammation model of Parkinson’s disease
  4887. The enigma of neuroinflammation
  4888. The evolving landscape of neuroinflammation after neonatal hypoxia-ischemia
  4889. The Evolving Role of Specialized Pro-resolving Mediators in Modulating neuroinflammation in Perioperative Neurocognitive Disorders
  4890. The expression pattern of Nischarin after lipopolysaccharides (LPS)-induced neuroinflammation in rats brain cortex
  4891. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia
  4892. The Far-Reaching Effects of neuroinflammation
  4893. The far-reaching scope of neuroinflammation after traumatic brain injury
  4894. The Fas ligand/Fas death receptor pathways contribute to propofol-induced apoptosis and neuroinflammation in the brain of neonatal rats
  4895. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation
  4896. The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune …
  4897. The function of neuroinflammation in parkinson disease
  4898. The Fyn-dependent voltage-gated potassium channel Kv1. 3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease models
  4899. THE GENETIC RISK UNDERLYING SYNAPSE PLASTICITY AND neuroinflammation IN MAJOR DEPRESSIVE DISORDER (MDD): A JOINT WHOLE EXOME …
  4900. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
  4901. The glycosyltransferase EXTL2 and its regulation of remyelination and neuroinflammation
  4902. The good and the bad of neuroinflammation in multiple sclerosis
  4903. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for …
  4904. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation
  4905. The human microglia (HMC-3) as a cellular model of neuroinflammation
  4906. The imidazoline I2 receptor agonist 2-BFI attenuates hypersensitivity and spinal neuroinflammation in a rat model of neuropathic pain
  4907. The immune system and neuroinflammation as potential sources of blood-based biomarkers for Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease
  4908. The immunomodulatory effects of plant extracts and plant secondary metabolites on chronic neuroinflammation and cognitive aging: a mechanistic and …
  4909. The impact of HIV-1 Tat and morphine on microRNA-mediated neuroinflammation in HIV-associated neurocognitive disorders
  4910. The impact of matrix metalloproteinase-3 on neuroinflammation at the blood-retinal barrier: friend or foe?
  4911. The impact of neuroinflammation on tau pathology in healthy aging and neurodegeneration
  4912. The impact of nutrition on neuroinflammation in vitro and in vivo
  4913. The Impact of Prophylactic Lacosamide on LPS-Induced neuroinflammation in Aged Rats
  4914. The impact of systemic inflammation on neuroinflammation and tau phosphorylation in healthy ageing and pathology
  4915. The impact of Toll-like receptor activation on neuroinflammation and neurodegeneration in the central nervous system
  4916. THE IMPACT OF TSPO RS6971 POLYMORPHISM IN A CANADIAN NEUROIMAGING STUDY OF neuroinflammation
  4917. The implication of microglial sialic acid-binding immunoglobulin-like lectin-E (Siglec-E) in neuroinflammation
  4918. The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?
  4919. The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation
  4920. The influence of neuroinflammation in Autism Spectrum Disorder
  4921. The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder
  4922. The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain
  4923. The Interaction Between neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
  4924. The interaction effects of surgery and morphine treatment on neuroinflammation and cognitive function in aged rats
  4925. The INTUIT study: investigating neuroinflammation underlying postoperative cognitive dysfunction
  4926. The investigation of molecular mechanisms underlying anti-tumour and anti-neuroinflammation induced by Elephantopus scaber in in vitro and in vivo models/Chan …
  4927. The involvement of neuroinflammation and kynurenine pathway in Parkinson’s disease
  4928. The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia
  4929. The Involvement of neuroinflammation in Dengue Viral Disease: Importance of Innate and Adaptive Immunity
  4930. The involvement of renin-angiotensin system in lipopolysaccharide-induced behavioral changes, neuroinflammation and disturbed insulin signaling
  4931. The Kynurenine Pathway at the Interface Between neuroinflammation, Oxidative Stress, and Neurochemical Disturbances: Emphasis in Schizophrenia
  4932. The Legacy of Rita Levi-Montalcini: From Nerve Growth Factor to neuroinflammation
  4933. The liver–brain axis in liver failure: neuroinflammation and encephalopathy
  4934. The lys-EGFP-ki transgenic mouse: a novel model system for studying the cells involved in neuroinflammation in EAE
  4935. The many faces of EMMPRIN—roles in neuroinflammation
  4936. The ME7 prion model of neurodegeneration as a tool to understand and target neuroinflammation in Alzheimer’s disease
  4937. The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6
  4938. The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion
  4939. The Microbiome—Its Role in neuroinflammation: The Autism Spectrum Disorder Paradigm
  4940. The microbiome: a key regulator of stress and neuroinflammation
  4941. The MicroRNA Centrism in the Orchestration of neuroinflammation in Neurodegenerative Diseases
  4942. The modulatory role of dopamine receptors in brain neuroinflammation
  4943. The multifaceted potential of the lipid transmitter oleoylethanolamide to treat alcohol-induced neuroinflammation and alcohol use disorders
  4944. The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation
  4945. The mycobacterial adjuvant analogue TDB attenuates neuroinflammation via mincle-independent PLC-γ1/PKC/ERK signaling and microglial polarization
  4946. The neuro-immune-regulators (NIREGs) promote tissue resilience; a vital component of the host’s defense strategy against neuroinflammation
  4947. The neuroinflammation biobank in the Department of Neurology, University Hospital Muenster, Germany
  4948. The neuroinflammation hypothesis of psychiatric disorders
  4949. THE neuroinflammation HYPOTHESIS OF URBAN AIR POLLUTION EFFECTS IN THE BRAIN
  4950. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [11C] PBR28 PET study
  4951. The neuroinflammation perspective of depression: reuniting the outstanding mechanisms of the pathophysiology
  4952. The neurokinin-2 receptor antagonist GR 159897 protects against neuroinflammation in the mouse enteric nervous system during colitis
  4953. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus
  4954. The neurotropic parasite Toxoplasma gondii induces sustained neuroinflammation with microvascular dysfunction in infected mice
  4955. The new PDE4 inhibitor Roflupram ameliorated cognitive deficits and neuroinflammation in a rat model of Alzheimer’s disease
  4956. THE NIGELLA SATIVA (L.) SEEDS EXTRACT TREATMENT ON THE HIPPOCAMPAL GFAP IN 2VO-INDUCED CHRONIC neuroinflammation
  4957. The NLRP3 inflammasome: an important driver of neuroinflammation in hemorrhagic stroke
  4958. The Nogo/Nogo receptor (NgR) signal is involved in neuroinflammation through the regulation of microglial inflammatory activation
  4959. The novel and potent anti-depressive action of triptolide and its influences on hippocampal neuroinflammation in a rat model of depression comorbidity of chronic pain
  4960. The novel role of extracellular cardiolipin in microglial activation and neuroinflammation
  4961. The novel TH17-associated cytokine IL-26 mediates BBB breakdown and neuroinflammation
  4962. The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF‐α axonal transport in neuropathic pain
  4963. The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice
  4964. The oral pretreatment of glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer’s-related pathology …
  4965. The orphan nuclear receptor Nr4a1 mediates perinatal neuroinflammation in a murine model of preterm labor
  4966. The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
  4967. The p53 transcriptional network influences microglia behavior and neuroinflammation
  4968. The Pannexin-1 hemichannel and neuroinflammation in acute focal cerebral ischemia
  4969. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury
  4970. The PARF Antagonist AChE Inhibitor PMS777 Attenuates LPS-Induced Acute neuroinflammation
  4971. The PARF Antagonist AChE Inhibitor PMS777 Attenuates LPS-Induced Acute neuroinflammation
  4972. The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation
  4973. The PD-1/B7-H1 Pathway in a Transgenic Mouse Model for Spontaneous Autoimmune neuroinflammation: Immunological Studies on Devic B7-H1-/-Mice
  4974. The pharmacological research of Tek-1 relevance to anti-neuroinflammation, a candidate compound based on Telmisartan
  4975. The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
  4976. The phosphoinositide‐3 kinase signaling is involved in neuroinflammation in hypertensive rats
  4977. The plasminogen activation system in neuroinflammation
  4978. The pleiotropic effects of galectin-3 in neuroinflammation: a review
  4979. The potassium channel KCa3. 1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke
  4980. The potential neuroprotective role of mesenchymal stem cell-derived exosomes in cerebellar cortex lipopolysaccharide-induced neuroinflammation in rats: a …
  4981. The potential role of neuroinflammation and transcription factors in Parkinson disease
  4982. The potential role of the NLRP3 inflammasome activation as a link between mitochondria ROS generation and neuroinflammation in postoperative cognitive …
  4983. The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment …
  4984. The precursor to glutathione (GSH),g-glutamylcysteine (GGC), can Ameliorate Oxidative Damage and neuroinflammation Induced by Amyloid-beta Oligomers in …
  4985. The presence of the appswe mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation
  4986. THE R47H TREM2 VARIANT MODIFIES ALZHEIMER’S DISEASE PATHOLOGY AND neuroinflammation IN A NOVEL KNOCK-IN MOUSE MODEL
  4987. The Receptor for Advanced Glycation Endproducts (RAGE) in Microglia Exacerbates neuroinflammation during Alzheimer’s Disease (AD) and AD-like Murine Models …
  4988. The receptor-receptor interactions within the cytokine receptor superfamily. Role in neuroinflammation and beyond
  4989. The regulation of neuroinflammation by nuclear factor kappa B and apolipoprotein E
  4990. The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation
  4991. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus
  4992. The RNA-binding protein HuR contributes to neuroinflammation by promoting CC chemokine receptor 6 (CCR6) expression on Th17 cells
  4993. The role glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior: focus on microglia cells
  4994. The role of aluminum and copper on neuroinflammation and Alzheimer’s disease
  4995. The Role of AMPH1 During Tau-mediated neuroinflammation
  4996. The role of annexin A1 in the regulation of amyloid beta clearance, neuroinflammation, and blood-brain barrier functionality in Alzheimer’s disease
  4997. The role of apoptosis in neuroinflammation
  4998. THE ROLE OF ASTROCYTIC α7 NICOTINIC ACETYLCHOLINE RECEPTORS IN neuroinflammation-MEDIATED COGNITIVE IMPAIRMENT
  4999. The role of autophagy in modulation of neuroinflammation in microglia
  5000. The Role of Bhlhe40 in Autoimmune neuroinflammation and Mycobacterial Infection
  5001. The Role of Brain-Derived Neurotrophic Factor in Modulating neuroinflammation
  5002. The role of CAP37 and neutrophil serine proteases in neuroinflammation
  5003. The role of cell adhesion molecules in blood-brain barrier breakdown and neuroinflammation.
  5004. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation
  5005. The role of cofilin in age-related neuroinflammation
  5006. The Role of Complement Factors in Neurodegeneration, neuroinflammation and Neuroprotection: Friend or Foe?
  5007. The Role of Complement Factors in Neurodegeneration, neuroinflammation and Neuroprotection: Friend or Foe?
  5008. The role of cytosolic phospholipase A2 in microglial signaling pathways during neuroinflammation
  5009. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
  5010. The Role of ECS in Regulation of Neuronal Aging, neuroinflammation, Neurodegeneration and Cognitive Decline
  5011. The role of elevated prostaglandins in neuroinflammation-induced memory deficits: A complex picture
  5012. THE ROLE OF EPHA1 IN BLOOD-BRAIN BARRIER INTEGRITY AND neuroinflammation IN LATE-ONSET ALZHEIMER’S DISEASE
  5013. The role of estradiol on social stress induced depressive-like behavior and neuroinflammation in females
  5014. The Role of Flavonoids in Preventing neuroinflammation and Cognitive Decline
  5015. The role of fynt tyrosine kinase in astrocytes pertaining to neuroinflammation in Alzheimer’s disease
  5016. The role of glucagon-like peptide 1 (GLP1) in type 3 diabetes: GLP-1 controls insulin resistance, neuroinflammation and neurogenesis in the brain
  5017. The Role of Gluococorticoids and neuroinflammation in Mediating the Effects of Stress on Drug Abuse
  5018. The role of glycogen synthase kinase 3 beta in neuroinflammation and pain
  5019. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic …
  5020. The role of heat shock protein 70 in regulating neuroinflammation
  5021. The role of HMGB1 in neuroinflammation and tissue repair: A potential therapeutic target for depression?
  5022. The role of homer1b/c in neuronal apoptosis following LPS-induced neuroinflammation
  5023. The role of IL-12 cytokines in APC-T cell interactions during autoimmune neuroinflammation
  5024. The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat
  5025. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease
  5026. The role of indoleamine 2, 3-dioxygenase in a mouse model of neuroinflammation-induced depression
  5027. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer’s disease
  5028. The role of insulin and incretins in neuroinflammation and neurodegeneration
  5029. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
  5030. The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice
  5031. The Role of KV1. 3 Channels in neuroinflammation
  5032. The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
  5033. The role of manganese in neuroinflammation
  5034. The role of mast cells in neuroinflammation
  5035. The role of matrix metalloproteinase 3 and 9 in the pathogenesis of acute neuroinflammation. Implications for disease modifying therapy
  5036. The role of MFG-E8 in glial-neuronal interactions and neuroinflammation
  5037. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas
  5038. The role of microglia in neuroinflammation
  5039. The Role of Microglia in the Homeostasis of the Central Nervous System and neuroinflammation
  5040. The Role of Microglial Cells on neuroinflammation: Possible Therapeutic Applications
  5041. The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation
  5042. The role of natural killer cells in curbing neuroinflammation
  5043. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS 1 transgenic mouse model of Alzheimer’s disease
  5044. The role of neuroinflammation and neuroimmune activation in persistent pain
  5045. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
  5046. The role of neuroinflammation in age-related dementias
  5047. THE ROLE OF neuroinflammation IN ALZHEIMER’S DISEASE
  5048. The role of neuroinflammation in chronic traumatic encephalopathy
  5049. The role of neuroinflammation in dementias
  5050. The role of neuroinflammation in developmental neurotoxicity, tackling complexity in children’s exposures and outcomes
  5051. The role of neuroinflammation in glaucoma
  5052. The role of neuroinflammation in juvenile bipolar disorder
  5053. The role of neuroinflammation in L-DOPA-induced dyskinesia
  5054. The Role of neuroinflammation in Neurodegenerative Disorders
  5055. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets
  5056. The role of neuroinflammation in Parkinson’s disease
  5057. The role of neuroinflammation in pathogenesis of epilepsy and the possibility of neuroimmunomodulation
  5058. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment
  5059. The role of neuroinflammation in regulating the age-related decline in neurogenesis
  5060. The role of neuroinflammation in severe acquired brain injuries. Preliminary results on subacute and chronic patients
  5061. The role of neuroinflammation in stress & methamphetamine-induced damage
  5062. The role of neuroinflammation in the determination of regional and neuronal vulnerability in Alzheimer’s disease
  5063. The Role of neuroinflammation in the Pathogenesis of Amyotrophic Lateral Sclerosis
  5064. The Role of neuroinflammation in the Pathogenesis of Amyotrophic Lateral Sclerosis
  5065. The role of neuroinflammation in the release of aversive odor cues from footshock-stressed rats: Implications for the neural mechanism of alarm pheromone
  5066. The role of neuroinflammation in traumatic brain injury
  5067. The Role of neuroinflammation in Traumatic Brain Injury-Induced Anxiety Disorders: a possible therapeutic target
  5068. The Role of neuroinflammation in Tumor-Induced Fatigue
  5069. The role of neuroinflammation in α-synuclein-linked dopaminergic neurodegeneration in rat brain
  5070. The role of neuroinflammation on the pathogenesis of Parkinson’s disease
  5071. The role of neuroinflammation-related regulatory targets in the treatment for Parkinson’s disease
  5072. The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: bringing neurons into the neuroinflammation game
  5073. The role of NFATc2 in chronic autoimmune neuroinflammation
  5074. The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of …
  5075. The role of Nrf2 in experimental autoimmune encephalomyelitis—A mouse model of multiple sclerosis and neuroinflammation
  5076. The role of Nrf2 in neuroinflammation and the impact of botanicals
  5077. The role of oligodendrocyte gap junctions in neuroinflammation
  5078. The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation
  5079. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression
  5080. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
  5081. The Role of RIP3 in neuroinflammation in the Postnatal Mouse Brain
  5082. The role of S100a9 in the neuroinflammation of Alzheimer’s disease transgenic mouse model, Tg2576
  5083. The role of Scavenger receptor A in beta amyloid phagocytosis and neuroinflammation in Alzheimer’s disease
  5084. The role of SIRT1 in neuroinflammation and cognitive dysfunction in aged rats after anesthesia and surgery
  5085. The role of Smurf1 in neuronal necroptosis after lipopolysaccharide-induced neuroinflammation
  5086. The role of steroid hormones in the modulation of neuroinflammation by dietary interventions
  5087. The Role of Synaptopodin in neuroinflammation and Retinoic Acid-mediated Synaptic Plasticity in the Mouse Hippocampus
  5088. The role of tau and neuroinflammation in Progressive Supranuclear Palsy and Alzheimer’s Disease
  5089. The role of the cannabinoid receptor 2 in alcohol-induced neuroinflammation and alcohol addiction
  5090. The role of the complement system in neuroinflammation
  5091. The Role of the Fibrotic Scar in Repair Following neuroinflammation
  5092. The role of the heat shock response in protein aggregation and neuroinflammation associated with neurodegenerative diseases
  5093. The role of the immune system in driving neuroinflammation
  5094. The role of the noradrenergic system in cognition and neuroinflammation.
  5095. The role of TLR4 and HO‐1 in neuroinflammation after subarachnoid hemorrhage
  5096. The role of TLR4-mediated MyD88-dependent pathway in neuroinflammation in hippocampal neurons of rats
  5097. The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons
  5098. The role of TNF in controlling the spontaneous development of autoimmune neuroinflammation
  5099. The role of toll-like receptor 2 and 4 innate immunity pathways in intracortical microelectrode-induced neuroinflammation
  5100. The role of TSPO PET in assessing neuroinflammation
  5101. The role of vascular risk, beta-amyloid metabolism, and neuroinflammation in the genetics of late-onset Alzheimer’s disease
  5102. The role of α7 nicotinic acetylcholine receptors and α7-specific antibodies in neuroinflammation related to Alzheimer disease
  5103. The role that myeloid protein tyrosine phosphatase 1B (PTP1B) plays in obesity and type 2 diabetes with focus on neuroinflammation
  5104. The roles of Flavonoles/Flavonoids in Neurodegeneration and neuroinflammation.
  5105. The Roles of Matrix Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-2 in Microglia-Mediated neuroinflammation
  5106. The Roles of neuroinflammation and Orexin Signaling in Brain Radiation-Induced Fatigue
  5107. The selective glucocorticoid receptor modulator cort 113176 reduces neurodegeneration and neuroinflammation in wobbler mice spinal cord
  5108. The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation
  5109. The significance of neuroinflammation in understanding Alzheimer’s disease
  5110. The soluble guanylate cyclase stimulator IWP-550 inhibits neuroinflammation in vitro and in vivo
  5111. The specific protein kinase R (PKR) inhibitor C16 protects neonatal hypoxia-ischemia brain damages by inhibiting neuroinflammation in a neonatal rat model
  5112. The splenic response to ischemic stroke: neuroinflammation, immune cell migration, and experimental approaches to defining cellular mechanisms
  5113. The Study of neuroinflammation and Blood-Brain Barrier Disruption in Early Stage Alzheimer’s Disease Animal Model with Microarray Analysis
  5114. The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation
  5115. The synthetic peroxisome proliferator-activated receptor-γ agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain …
  5116. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging–guided PET study with 11C-PK11195 in acute subcortical stroke
  5117. The Temporal Relationship between Synucleinopathy, Nigrostriatal Degeneration, and neuroinflammation in the Alpha-Synuclein Preformed Fibril Model of …
  5118. The tiliroside derivative, 3-O-[(E)-(2-oxo-4-(p-tolyl) but–3–en–1–yl] kaempferol produced inhibition of neuroinflammation and activation of AMPK and Nrf2/HO-1 …
  5119. The toxic influence of dibromoacetic acid on the hippocampus and pre-frontal cortex of rat: involvement of neuroinflammation response and oxidative stress
  5120. The transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation
  5121. The triggering receptor expressed on myeloid cells 2: a molecular link of neuroinflammation and neurodegenerative diseases
  5122. The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain
  5123. Themes: Title: FTY720 attenuates beta amyloid-induced neuroinflammation in male Wistar rats by activation of sphingosine 1-phosphate receptor-1
  5124. Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson’s disease
  5125. Therapeutic developments targeting toll‐like receptor‐4‐mediated neuroinflammation
  5126. Therapeutic effects of dietary intervention on behavior, neuroinflammation and brain metabolism in a rat model of postoperative cognitive dysfunction
  5127. Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic stroke
  5128. Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic stroke.
  5129. Therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) on neuroinflammation and neuroplasticity in patients with Parkinson’s disease: a placebo …
  5130. Therapeutic efficacy of suppressing the JAK/STAT pathway in models of neuroinflammation (P5199)
  5131. Therapeutic Intervention of Glial-Mediated Enhancement of neuroinflammation in an Established Model of GWI
  5132. Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson’s disease
  5133. Therapeutic potential of inhibition of the neuroinflammation induced cathepsin X: in vivo evidence
  5134. Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases
  5135. Therapeutic role and drug delivery potential of neuroinflammation as a target in neurodegenerative disorders
  5136. Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy
  5137. Therapeutic strategy at the crossroad of neuroinflammation and oxidative stress in age-related neurodegenerative diseases
  5138. Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke
  5139. Therapies negating neuroinflammation after brain trauma
  5140. Thermal injury lowers the threshold for radiation-induced neuroinflammation and cognitive dysfunction
  5141. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction
  5142. Thrombosis, neuroinflammation, and poststroke infection: the multifaceted role of neutrophils in stroke
  5143. Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic neuroinflammation and …
  5144. Thymoquinone improves cognitive function and increases α-7nAChRs expression in a rat model of neuroinflammation
  5145. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington’s …
  5146. Thyroid hormone supplementation restores spatial memory, hippocampal markers of neuroinflammation, plasticity-related signaling molecules, and β-amyloid peptide …
  5147. Tibial fracture exacerbates traumatic brain injury outcomes and neuroinflammation in a novel mouse model of multitrauma
  5148. Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia
  5149. Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia
  5150. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson’s disease …
  5151. Time-dependent compensatory responses to chronic neuroinflammation in hippocampus and brainstem: the potential role of glutamate neurotransmission
  5152. Tinospora cordifolia Suppresses neuroinflammation in Parkinsonian Mouse Model
  5153. TiO2 nanoparticles induced hippocampal neuroinflammation in mice
  5154. TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation
  5155. TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation
  5156. TLR2 mediates neuroinflammation and neuronal damage
  5157. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model
  5158. TLR4-p38 pathway as a mechanism of APOE-modulated neuroinflammation in Alzheimer disease (1056.6)
  5159. TMIC-03. IMAGING BRAIN TUMOR-ASSOCIATED neuroinflammation IN ANIMAL MODELS USING FERUMOXYTOL
  5160. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
  5161. TNF-α-induced neuroregeneration through an NF-κB-dependent pathway: a new mechanism involving EphB2 in the context of HIV-1 neuroinflammation
  5162. TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature …
  5163. TNFα exposure induces neuroinflammation and insulin resistance in a rat-derived hypothalamic cell model, rHypoE-7
  5164. Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions
  5165. Toll-like receptor 2 and poly (ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
  5166. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation
  5167. Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to neuroinflammation in mice
  5168. Toll-like receptor 4 is involved in subacute stress–induced neuroinflammation and in the worsening of experimental stroke
  5169. Toll-like receptor 4 knockdown attenuates brain damage and neuroinflammation after traumatic brain injury via inhibiting neuronal autophagy and astrocyte activation
  5170. Toll-like receptor 4 knockout ameliorates neuroinflammation due to lung-brain interaction in mechanically ventilated mice
  5171. Toll-like receptor 4 mediates methamphetamine-induced neuroinflammation through caspase-11 signaling pathway in astrocytes
  5172. Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling
  5173. Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation
  5174. Toll-like receptor 7 tolerance in anti-neuroinflammation in murine experimental autoimmune encephalomyelitis
  5175. Toll-like receptor-4 antagonism mediates benefits during neuroinflammation
  5176. Toll-Like Receptors and neuroinflammation
  5177. Toll-like receptors as an innate immunity bridge to neuroinflammation in medulloblastoma
  5178. Toll-like receptors in the pathogenesis of neuroinflammation
  5179. Tonicity-responsive enhancer binding protein haplodeficiency attenuates seizure severity and NF-κ B-mediated neuroinflammation in kainic acid-induced …
  5180. Top ten discoveries of the year: neuroinflammation
  5181. Topical application of compound Ibuprofen suppresses pain by inhibiting sensory neuron hyperexcitability and neuroinflammation in a rat model of intervertebral …
  5182. Total isoflavones from soybean and tempeh reversed scopolamine-induced amnesia, improved cholinergic activities and reduced neuroinflammation in brain
  5183. Toward a new concept of Alzheimer’s disease models: a perspective from neuroinflammation
  5184. Towards a unifying hypothesis of Alzheimer’s disease: cholinergic system linked to plaques, tangles and neuroinflammation
  5185. Toxicity of inhaled particulate matter on the central nervous system: neuroinflammation, neuropsychological effects and neurodegenerative disease
  5186. Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation
  5187. Toxoplasma gondii Infection Promotes neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c Mice
  5188. Toxoplasma-induced Behavioral Changes: An Aspecific Consequence of neuroinflammation
  5189. TPL2 mediates IL-17R signaling in neuroinflammation
  5190. Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation
  5191. Traditional African Medicine as a source of biologically active substances inhibiting neuroinflammation
  5192. Trans-10-hydroxy-2-decenoic acid protects against LPS-induced neuroinflammation through FOXO1-mediated activation of autophagy
  5193. Trans-astaxanthin attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behavior in mice
  5194. Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells
  5195. Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-κB pathway in presenilin1/2 …
  5196. trans-Cinnamaldehyde Inhibits Microglial Activation and Improves Neuronal Survival against neuroinflammation in BV2 Microglial Cells with Lipopolysaccharide …
  5197. Trans-cinnamaldehyde Modulates Hippocampal Nrf2 Factor and Inhibits Amyloid Beta Aggregation in LPS-Induced neuroinflammation Mouse Model
  5198. Transcranial Ultrasound Improves Behavioral Performance via Anti-neuroinflammation
  5199. Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation
  5200. Transcription factor T-bet drives the pathogenesis of TH17-mediated neuroinflammation
  5201. Transforming growth factor-beta 1 signaling regulates neuroinflammation and apoptosis in mild traumatic brain injury
  5202. Transfusion of old red blood cells induces neuroinflammation and cognitive impairment
  5203. Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation
  5204. Transgenic inhibition of astroglial NF-κB improves functional recovery in EAE by suppressing chronic neuroinflammation.(50.7)
  5205. Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1
  5206. Transglutaminase 2 and neuroinflammation
  5207. Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors
  5208. Transient glutathione depletion in the substantia nigra compacta is associated with neuroinflammation in rats
  5209. Transient neonatal sleep fragmentation results in long-term neuroinflammation and cognitive impairment in a rabbit model
  5210. Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra
  5211. Translational evaluation of translocator protein (TSPO) as a marker of neuroinflammation in schizophrenia
  5212. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
  5213. Translational strategies in peripheral neuroinflammation and neurovascular repair
  5214. Translocation of bone marrow-derived cells contribute to PVN neuroinflammation in hypoxia-induced PH
  5215. TRANSLOCATOR PROTEIN (TSPO, 18 KDA) IN neuroinflammation: INVESTIGATION OF ITS FUNCTIONAL ROLE IN PRIMARY HUMAN MICROGLIA
  5216. Translocator protein (TSPO): the new story of the old protein in neuroinflammation
  5217. Translocator protein and new targets for neuroinflammation
  5218. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats
  5219. Transplanted adult neural stem cells express sonic hedgehog in vivo and suppress white matter neuroinflammation after experimental traumatic brain injury
  5220. Traumatic brain injury increases levels of miR‐21 in extracellular vesicles: implications for neuroinflammation
  5221. Traumatic brain injury induces neuroinflammation and neuronal degeneration that is associated with escalated alcohol self-administration in rats
  5222. Traumatic brain injury, neuroinflammation, and post‐traumatic headaches
  5223. Treadmill exercise prevents increase of neuroinflammation markers involved in the dopaminergic damage of the 6-OHDA Parkinson’s disease model
  5224. Treating neuroinflammation: Exploring its potential in Parkinson’s disease
  5225. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
  5226. Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier
  5227. Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of …
  5228. Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma
  5229. TREATMENT WITH CALCIUM DOBESILATE REDUCES neuroinflammation AND IMPROVES COGNITION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
  5230. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral …
  5231. Treg Cells Attenuate neuroinflammation and Protect Neurons in a Mouse Model of Parkinson’s Disease
  5232. Treg/Th17 imbalance-mediated neuroinflammation is involved in pathogenesis of Parkinson’s disease
  5233. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency
  5234. TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus
  5235. TREM2 Attenuates Aβ1-42-Mediated neuroinflammation in BV-2 Cells by Downregulating TLR Signaling
  5236. TREM2 deficiency aggravates α-synuclein–induced neurodegeneration and neuroinflammation in Parkinson’s disease models
  5237. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
  5238. TREM2 Knockdown Exacerbates Aging-Related neuroinflammation And Cognitive Deficiency In SAMP8 Mice (P1. 241)
  5239. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson’s disease
  5240. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson’s disease
  5241. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated …
  5242. Triggering receptor expressed on myeloid cells 2, a novel regulator of immunocyte phenotypes, confers neuroprotection by relieving neuroinflammation
  5243. TRIM9-mediated resolution of neuroinflammation confers neuroprotection upon ischemic stroke in mice
  5244. Triple-target treatment for Alzheimer’s: Correcting hypometabolism, oxidative stress, and neuroinflammation
  5245. Triptolide improves learning and memory behavior of the 5XFAD transgenic mice accompanied by suppressed neuroinflammation and reduced Aβ aggregation
  5246. Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis
  5247. Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway
  5248. Troxerutin exerts neuroprotection against lipopolysaccharide (LPS) induced oxidative stress and neuroinflammation through targeting SIRT1/SIRT3 signaling pathway
  5249. TRPM2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies
  5250. TRPV1 Sensory Neurons and Enteric Glia in ENS Link Tachykinins to neuroinflammation and Nociception
  5251. TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration
  5252. TSPO mediates neuroinflammation via Parkin and p62 regulation in microglia
  5253. TSPO PET Using [18F]PBR111 Reveals Persistent neuroinflammation Following Acute Diisopropylfluorophosphate Intoxication in the Rat
  5254. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis
  5255. TSPO versus P2X7 as target for neuroinflammation–an in vitro and in vivo study
  5256. Tualang Honey Reduced neuroinflammation and Caspase-3 Activity in Rat Brain after Kainic Acid-Induced Status Epilepticus
  5257. TUDCA reduces neuroinflammation and improves motor symptoms in a transgenic mouse model of Machado-Joseph disease
  5258. Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?
  5259. Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function
  5260. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity
  5261. Tumor necrosis factor and interleukin-1β modulate synaptic plasticity during neuroinflammation
  5262. Tumor necrosis factor receptor 2 promotes neuroprotection during chronic autoimmune neuroinflammation
  5263. Tumour necrosis factor α induces neuroinflammation and insulin resistance in immortalised hypothalamic neurones through independent pathways
  5264. Tuning apoptosis and neuroinflammation: TBK1 restrains RIPK1
  5265. Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of neuroinflammation
  5266. Two birds, one study: evaluating the therapeutic potential of amphibian ocellatin-PT4 and-PT9 peptides for application in leishmaniasis and neuroinflammation …
  5267. Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell …
  5268. Two-photon microscopy and neuroinflammation: Crosstalk between T cells and neurons
  5269. Two-Pore Domain Potassium Channels (K2Ps) as Drug Targets in neuroinflammation
  5270. Type 1-skewed neuroinflammation and vascular damage associated with Orientia tsutsugamushi infection in mice
  5271. Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer’s disease
  5272. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
  5273. Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
  5274. Ulinastatin alleviates neuroinflammation but fails to improve cognitive function in aged rats following partial hepatectomy
  5275. Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and β-amyloid peptide expression in the brain
  5276. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords
  5277. Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats
  5278. Umbilical cord occlusions in near-term ovine fetus induce increased beat-to-beat heart rate variability correlating to decreases in neuroinflammation: a case for the …
  5279. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin‐2
  5280. Understanding risk factors for Alzheimer’s disease: interplay of neuroinflammation, connexin-based communication and oxidative stress
  5281. Understanding the Cellular and Molecular Mechanism of Mouse Hepatitis Virus Induced neuroinflammation and Demyelination in an Experimental Mice Model
  5282. Understanding the pathogenesis of neuroinflammation using magnetic resonance imaging
  5283. Understanding the role of adenosine A2AR heteroreceptor complexes in neurodegeneration and neuroinflammation
  5284. Unesterified docosahexaenoic acid is protective in neuroinflammation
  5285. Unmedicated major depressive disorder is associated with neuroinflammation
  5286. Unravelling the role of extracellular small heat-shock proteins in neuroinflammation
  5287. Unsaponifiable and phenolic fractions from virgin olive oil prevent neuroinflammation skewing microglia polarization toward M2 phenotype
  5288. Untangling neuroinflammation in amyotrophic lateral sclerosis
  5289. Untangling the Web: Toxic and Protective Effects of neuroinflammation and PGE2 Signaling in Alzheimer’s Disease
  5290. Untersuchung des Einflusses der neuroinflammation auf das sporadische Parkinson Syndrom
  5291. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: suppression by curcumin
  5292. Up-regulation of corticocerebral NKD2 in lipopolysaccharide-induced neuroinflammation
  5293. Up-regulation of Dyrk1b promote astrocyte activation following lipopolysaccharide-induced neuroinflammation
  5294. Up-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation
  5295. Up-regulation of podoplanin involves in neuronal apoptosis in LPS-induced neuroinflammation
  5296. Up-regulation of PSMB4 is associated with neuronal apoptosis after neuroinflammation induced by lipopolysaccharide
  5297. Up-regulation of SGTB is associated with neuronal apoptosis after neuroinflammation induced by lipopolysaccharide
  5298. Up-regulation of Wip1 involves in neuroinflammation of retinal astrocytes after optic nerve crush via NF-κB signaling pathway
  5299. Upcoming in Neurology: Neuroimmunology & neuroinflammation
  5300. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study
  5301. Upregulation of connexin-43 is critical for irradiation-induced neuroinflammation
  5302. Upregulation of PLZF is associated with neuronal injury in lipopolysaccharide-induced neuroinflammation
  5303. Upregulation of Ras homolog enriched in the brain (Rheb) in lipopolysaccharide-induced neuroinflammation
  5304. Upregulation of SYF2 is associated with neuronal apoptosis caused by reactive astrogliosis to neuroinflammation
  5305. Upregulation of TREM2 attenuates neuroinflammation and dopaminergic neurotoxicity in MPTP model mice with Parkinson disease
  5306. Uptake of parasite‐derived vesicles by astrocytes and microglial phagocytosis of infected erythrocytes may drive neuroinflammation in cerebral malaria
  5307. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation
  5308. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
  5309. Urolithins attenuate LPS-induced neuroinflammation in BV2Microglia via MAPK, Akt, and NF-κB signaling pathways
  5310. Usage of multiparameter flow cytometry to study microglia and macrophage heterogeneity in the central nervous system during neuroinflammation and …
  5311. Use of Phytochemicals against neuroinflammation
  5312. Using functional and molecular MRI techniques to detect neuroinflammation and neuroprotection after traumatic brain injury
  5313. Using Human Cerebral Organoids to Study the Role of the Microbiome in neuroinflammation
  5314. Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors
  5315. USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation
  5316. USPIO-enhanced MRI of neuroinflammation at the sub-acute stage of ischemic stroke: preliminary data
  5317. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional …
  5318. Utilizing iNOS as an indicator of neuroinflammation in wild-type and knockout mice 24 hours after soman (GD) exposure
  5319. Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer’s disease …
  5320. Valproate reduces neuroinflammation and neuronal death in a rat chronic constriction injury model
  5321. Vascular endothelial growth factor (VEGF) expression and neuroinflammation is increased in the frontopolar cortex of individuals with autism spectrum disorder
  5322. VEGF and vascular changes in chronic neuroinflammation
  5323. Venenum Bufonis induces rat neuroinflammation by activiating NF-κB pathway and attenuation of BDNF
  5324. Venlafaxine prevents morphine antinociceptive tolerance: the role of neuroinflammation and the l-arginine-nitric oxide pathway
  5325. Venous Neurovascular Pathways to neuroinflammation in Neurodegenerative Disorders
  5326. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis
  5327. Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation
  5328. Viral infection and neurological disorders—potential role of extracellular nucleotides in neuroinflammation
  5329. Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection
  5330. Viral Infections of the Central Nervous System: Pathogenic and Protective Effects of neuroinflammation
  5331. Viruses, apoptosis, and neuroinflammation—a double-edged sword
  5332. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C] PK11195 and [11C] vinpocetine
  5333. Visualization and quantification of post-stroke neural connectivity and neuroinflammation using serial two-photon tomography in the whole mouse brain
  5334. Visualization of autoimmune processes in chronic neuroinflammation by means of two-photon laser scanning microscopy
  5335. Vitamin C alleviates LPS-induced cognitive impairment in mice by suppressing neuroinflammation and oxidative stress
  5336. Vitamin C and vitamin E double-deficiency increased neuroinflammation and impaired conditioned fear memory
  5337. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia …
  5338. Vitexin inhibits acrylamide-induced neuroinflammation and improves behavioral changes in zebrafish larvae
  5339. Volume, Metabolites and neuroinflammation of the Hippocampus in Bipolar Disorder–
  5340. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder–a combined magnetic resonance imaging and positron emission tomography …
  5341. Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer’s disease
  5342. Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer’s disease
  5343. WAVE-2 and Its Role in LRRK2 Mediated neuroinflammation
  5344. Wearing memory thin: the effects of high fat diet on neuroinflammation and memory
  5345. Welcome to Neuroimmunology and neuroinflammation: a new open access journal for neuroscience
  5346. Welcome to the Journal of neuroinflammation!
  5347. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence
  5348. What you eat is what you are–a role for polyunsaturated fatty acids in neuroinflammation induced depression?
  5349. When friend turns foe: central and peripheral neuroinflammation in central nervous system injury
  5350. When the tail can’t wag the dog: the implications of CNS-intrinsic initiation of neuroinflammation
  5351. White matter changes correlates of peripheral neuroinflammation in patients with Parkinson’s disease
  5352. White matter damage, neuroinflammation, and neuronal integrity in HAND
  5353. WHITE MATTER neuroinflammation IN PRECLINICAL ALZHEIMER DISEASE CAN BE QUANTIFIED BY DIFFUSION BASIS SPECTRUM IMAGING
  5354. Whole-body vibration at thoracic resonance induces sustained pain and widespread cervical neuroinflammation in the rat
  5355. Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice
  5356. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
  5357. Wip1 phosphatase involved in lipopolysaccharide-induced neuroinflammation
  5358. Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced neuroinflammation
  5359. Withania somnifera in a rat model for anxiety and neuroinflammation
  5360. Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes
  5361. Wnt/TLR dialog in neuroinflammation, relevance in alzheimer’s disease
  5362. WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity
  5363. Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice
  5364. Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice
  5365. Xenon prevents early neuronal loss and neuroinflammation in a rat model of traumatic brain injury
  5366. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn
  5367. Xuefu Zhuyu decoction ameliorates obesity, hepatic steatosis, neuroinflammation, amyloid deposition and cognition impairment in metabolically stressed APPswe …
  5368. Yes-associated protein reduces neuroinflammation through upregulation of Sirt3 and inhibition of JNK signaling pathway
  5369. YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation
  5370. Z-guggulsterone negatively controls microglia-mediated neuroinflammation via blocking IκB-α–NF-κB signals
  5371. Z‐Guggulsterone attenuates astrocytes‐mediated neuroinflammation after ischemia by inhibiting toll‐like receptor 4 pathway
  5372. Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters …
  5373. Zanthoxylum zanthoxyoides root extract inhibits hemozoin-induced neuroinflammation in BV2 microglia
  5374. Zileuton ameliorates depressive-like behaviors, hippocampal neuroinflammation, apoptosis and synapse dysfunction in mice exposed to chronic mild stress
  5375. Zoanthamine alkaloids from the zoantharian Zoanthus cf. pulchellus and their effects in neuroinflammation
  5376. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of …
  5377. α-lipoic acid attenuates obesity-associated hippocampal neuroinflammation and increases the levels of brain-derived neurotrophic factor in ovariectomized rats fed a …
  5378. α-Mangostin inhibits α-synuclein-induced microglial neuroinflammation and neurotoxicity
  5379. α7 nicotinic acetylcholine receptor stimulation attenuates neuroinflammation through JAK2-STAT3 activation in murine models of intracerebral hemorrhage
  5380. β-amyloid neurotoxicity in organotypic hippocampal slice culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation
  5381. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson …
  5382. β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer’s disease
  5383. β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia
  5384. γ‐Secretase in microglia–implications for neurodegeneration and neuroinflammation
  5385. Ω-3 fatty acids-supplementary in gestation alleviates neuroinflammation and modulates neurochemistry in rats
Related Posts

Remyelination

Ampk Activators

Nf-kb

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping